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Abstract
INVESTIGATION OF THE 
ROLES OF WT1+KTS AND WT1- 
KTS IN MURINE GENITO­
URINARY DEVELOPMENT
Diya Lahiri
The Wilms’ tumour suppressor gene, WT1, encodes a zinc finger 
transcription factor essential for the development of the urogenital 
system. Alternative splicing within the gene causes an insertion or 
deletion of three amino acids creating two classes of isoform, 
WT1+KTS and WT1-KTS. Mutation of the isoforms, and disruption of 
their ratios are linked to human disorders of the urogenital system. 
These isoforms are thought to have distinct roles within the nucleus. 
The aim of the work were to investigate the role of these isoforms in 
murine genito-urinary development. Transgenic lines of mice 
expressing a WT1-KTS transgene were generated, and bred to Wt1 
knockout animals to study the effects of the WT1- KTS isoform on 
genito-urinary development in isolation from the other isoforms. 
Analysis of these animals showed there may be an effect in animals 
expressing the WT1-KTS transgene and heterozygous for Wt1. Using 
green fluorescent protein fusion constructs in cell culture, it has been 
demonstrated that the dynamic subnuclear localization of the two 
isoforms result, in part, from the presence of a nucleolar localization 
signal within the zinc finger regions. Combining transgenic 
techniques with cell culture work, these findings help elucidate the 
mechanisms by which the Wt1 isoforms are distributed in the nucleus, 
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INTRODUCTION
1.1 Genito-urinary Development
The kidney and gonads are both organised within the genito-urinary system. 
WT1 is essential for the correct development of this system as illustrated by 
human disease studies and transgenic animal data. The function of the gene in 
gonad and renal development can be understood by firstly examining the 
development of both sub-systems, then looking at the roles of various interacting 
molecules and finally by analysing the mechanisms by which the WT1 gene acts.
1.1.1 Kidney Development
In birds and mammals three kidney like structures, metanephros, mesonephros 
and pronephros appear during development. The pronephros and mesonephros 
are transitionary and the functional kidney develops from the metanephros. The 
mesonephros plays a key role in gonadal development, giving rise to the gonadal 
somatic cells. In lower vertebrates such as fish and amphibians, the pronephros 
acts as the functional kidney in the immature stages whereas the mesonephros 
is the functional adult kidney (Slack, 2001).
The metanephric kidney of mammals is composed of a set of nephrons. These 
are the basic structural units of the kidney consisting of the glomerulus and its 
associated tubule and collecting duct. Blood vessels invade the kidney and are 
closely associated with the collecting duct system at the Bowman’s capsule (BC) 
in the glomerulus. It is here that waste fluid is filtered out of the blood and is then
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passed into the tubule where it undergoes ion exchange and corresponding 
movements of water before passing into the collecting duct, ureter, bladder and 
out of the body as urine. The nephrons of the kidney, working together allow the 
kidney to remove waste from the system, and failure for this system to develop 
can have severe implications for the viability of the organism as illustrated by 
many diseases of the kidney. In the mouse, development of the kidney 
(nephrogenesis), starts at around embryonic day 10.5 and continues until after 
birth (Saxen, 1987). Nephrogenesis involves a series of inductive interactions 
between mesenchymal and epithelial tissues, resulting in a complex functional 
kidney (Figure 1) (Davies and Bard, 1998 Review). Grobstein originally 
described evidence for the existence of inductive interactions using cultured 
kidney explants (Grobstein, 1955), since then many molecules playing a role in 
nephrogenesis have been uncovered and a variety of interactions can be 
mimicked in culture. The first event marking the beginning of kidney 
development is the induction by the metanephric blastema of a ureteric bud (UB) 
from the Wolffian duct. At the same time, the mesonephros, axial and paraxial 
structures running along the length of the embryo either side of the midline, gives 
rise to the Mullerian duct (MD), which will then form the gonads. The 
metanephric mesenchyme (MM) continues to induce the UB to grow and 
bifurcate whilst reciprocal inductive signals from the epithelial UB cause the 
mesenchyme to condense and differentiate. These signals from the UB block 
apoptosis of the MM, causes it to aggregate, condense, epithelialise and 
undergo a series of morphological changes (progressively including stereotypical 
comma-shaped and s-shaped bodies), before elongating to form the tubules of 
the nephron. The glomerulus forms at the proximal end of the tubule and 
consists of a cup shaped BC lined with a single layer of podocyte cells at the 
membrane, aptly named for their unusual foot processes, and the collection of 
capillary blood vessels where they come into contact with the kidney (Figure 2).
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Figure 1. Nephrogenesis
Nephrogenesis begins around E10.5 in mice and involves a series of 
inductive interactions between mesenchymal and epithelial tissues, 
resulting in a complex kidney. The epithelial ureteric bud (UB) induces the 
surrounding metanephric mesenchyme to condense and epithelialise 
resulting in the formation of the glomeruli and renal tubules. In parallel, 
the MM induces the UB to grow and bifurcate to form the collecting duct 
system. The fully developed metanephric kidney of mammals is 
comprised of a set of nephrons consisting of the glomerulus and its 
associated tubule and collecting duct. Capillaries invade the kidney and 
waste is filtered out of the blood before being passed into the tubules and 
undergoing ion exchange and corresponding movements of water. Waste 
is finally removed through the ureter, and out of the body as urine.
Figure 2. Nephron formation
Following inductive interactions, the UB causes the MM to aggregate, 
condense and epithelialise. During these processes, the MM undergoes a 
number of morphological changes. The MM progresses through 
structures such as the comma shaped and s shaped bodies before 
elongating to form the tubules of the nephron with the glomerulus at the 
proximal end. The tubules convolute and differentiate and the distal end 
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The tubules convolute and differentiate to become the site for selective 
reabsorption of the fluid whilst the distal part fuses to the collecting duct (Davies 
and Davey, 1999 Review). The epithelial structures derived from the bud form 
the collecting duct system of the kidney whilst the mesenchyme gives rise to the 
glomeruli and tubules (Wolpert et al., 1998). This process of nephrogenesis 
continues throughout development, until about 6 weeks before birth in humans, 
and hours postnatally in the mouse, with the newer nephrons located 
peripherally to the older, existing nephrons. Development of the definitive kidney 
can be viewed as having three phases. The first is the initial induction of the UB 
into the metanephric blastema, the blocking of apoptosis of the MM and 
differentiation into stem cells at the periphery. This phase occurs from around 
E10.5-13.5 in the mouse and is followed by the second phase, when arborisation 
of the UB continues whilst nephrons form and begin to function (E13.5 till birth). 
Nephrogenesis slows down in the final phase, the blast cells are lost and the 
kidney begins to function normally. A fine balance of growth and apoptosis 
underlies kidney development with interactions between multitudes of molecules 
giving rise to the mature kidney (Bard, 2002 Review).
1.1.2 Molecules involved in Kidney Development
Over the last decade, research into the embryonic regulation of kidney 
development has uncovered a plethora of genes implicated in renal 
development. Whilst this report studies the function of the Wilms’ Tumour 
suppressor 1 gene, it is crucial to note the role of other molecules of importance 
in the development of a mature kidney. These include a variety of families 
ranging from transcription factors to extracellular matrix proteins which reflect the 
variety of processes involved in nephrogenesis such as inductive signals, 
morphogenetic interactions between mesenchyme and epithelium, interactions
4
between the epithelium, neurons and blood vessels, and the regulated pattern of 
differentiation and pattern formation. A list of over 300 molecules involved in 
kidney function can be found in the kidney database 
(http://golgi.ana.ed.ac.uk/kidhome.html), a number have associated transgenic 
animal data supporting their roles in kidney development and function (Davies, et 
al. 2003). Many of the molecules that regulate these processes have important 
roles elsewhere in the embryo but for the purposes of this report, the discussion 
will be limited to the control of nephrogenesis. Some of the key molecules are 
described below to illustrate the pathways involved in nephrogenesis. Amongst 
them are transcription factors, for example Pod-1 (Quaggin et al., 1999) and Lim- 
1 and also homeobox containing genes such as Emx-2 and hoxb7. Adhesion 
molecules such as Cadherin-6 (Mah et al., 2000), signalling molecules including 
those involved in angiogenesis and vascularisation like vascular endothelial 
growth factor (VEGF) (Miquerol et al., 1999), and its receptor flk-1 (Kappel et al., 
1999), have also been shown to have a role in kidney development.
1.1.2.1 Glial derived neurotrophic factor and its receptor RET 
GDNF and RET form a signalling complex that regulates ureteric bud growth 
(Lechner and Dressier, 1997). RET, a member of the receptor tyrosine kinase 
family was found to be expressed fairly early in embryonic development in the 
Wolfian Duct and the UB. Later, RET expression was seen to be restricted to 
the tips of the UB (Schuchardt et al., 1994). Targeted inactivation of RET in mice 
resulted in renal agenesis (Schuchardt et al., 1994; Schuchardt et al., 1996) and 
it is an important marker of the UB (Srinivas et al., 1999a). GDNF was originally 
found as a factor promoting survival of midbrain dopiminergic neurons (Lin et al., 
1993) and was later identified as the RET ligand. GDNF expression can be first 
observed at about embryonic day 11.5 (E11.5) in the MM and later restricted to
5
the peripheral mesenchyme, complementing RET expression (Hellmich et al., 
1996). Kidneys fail to form in both gdnf and ret knockout mice and these mice 
die shortly before birth (Sanchez et al., 1996; Schuchardt et al., 1994). 
Investigation of the heterozygous knockout phenotype highlighted the 
abnormalities. The tubules in gdnf heterozygous knockout mice form but these 
mice lack UBs (Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996) 
similar to the phenotype described in ret heterozygous knockout mice 
(Schuchardt et al., 1994). Mesenchymal GDNF signal is transmitted via the RET 
receptor, to epithelial cells and may result in inducing proliferation of epithelial 
cells.
1.1.2.2 LIF, WNT-4 and EMX-2
Once induced, the UB invades the MM and grows, branches and induces 
nephron formation. Leukaemia inhibitory factor (LIF) has been found to be 
essential in the induction of nephrogenesis in cultured explant experiments, 
however, there may be a certain degree of redundancy in its function as lif-1 
knockout mice do not show kidney abnormalities. It has been postulated that 
additional factors such as fibroblast growth factor-2 is probably the inducing 
signal for the mesenchyme and both WNT-4 and BMP-7 may also be required in 
vivo for this process (Stark et al., 1994). The homeobox-containing transcription 
factor EMX-2 may be a regulator of blastemal condensation as its expression is 
restricted to the UB and in Emx-2 knockouts, the UB invades the MM normally 
but after that the kidneys fail to develop (Miyamoto et al., 1997). It may be that 
EMX-2 regulates the function of WNT-4 and LiF-1 (Schedl et. al., 2000).
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1.1.2.3 PAX-2
Pax-2 is a transcription factor expressed within the developing kidney (Dressier 
et al., 1990). It has been seen to be expressed in the earliest condensates of 
MM and in the comma-shaped bodies. Expression declines in s-shaped bodies 
and is absent in mature kidneys (Dressier and Douglass, 1992). Pax-2 knockout 
(null) mutant mice lacked tubules or genito-urinary tracts and the heterozygous 
animals had much smaller kidneys than normal as a result of increased 
apoptosis and a reduction of ureter branching. Thus, Pax-2 has been thought to 
be one of the factors essential for kidney growth (Ryan et al., 1995) and seems 
to be required for the mesenchyme to epithelium transition as illustrated by the 
transgenic animals and in patients with Pax-2 heterozygous mutations 
associated with the development of dysplastic kidneys. Pax-2 levels have been 
shown to be increased in Wilms’ tumours (Dressier and Douglass, 1992) and the 
relationship between Pax-2 and Wilms’ tumour will be further discussed later.
1.1.2.4 BMP-7
BMP-7 is a member of the TGFp superfamily of secreted signalling molecules 
which have many roles in morphogenic events (Kingsley, 1995). BMP-7 
transcripts were found in mesonephric ducts, tubules and later in metanephric 
condensates, comma-shaped and s-shaped bodies (Dudley et al., 1995). 
Knockout mice died soon after birth with dysplastic kidneys (Dudley et al., 1995; 
Godin et al., 1998). BMP-7 is a potential target for both WT1 and PAX-2 as it 
may be controlled by signals from the ureter. It is thought to be secreted by the 
metanephric blastema and controls the rate of nephrogenesis by suppressing 
tubulogenesis.
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1.1.3 Transgenic models of kidney development
Bearing in mind the limitations of transgenic models, for example, phenotypes of 
null animals may not provide a correct representation of human disorders, 
transgenic data still provides some of the best indication of gene function and 
there have been a number of transgenic mice generated for some of the 
molecules involved in kidney development. A detailed list can be found in the 
kidney database (Davies et. al., 2003) but the discussion in this report will again 
be limited to the transgenic models of genes interacting with WT1 or involved in 
similar processes. Gdnf knockout mice had no kidneys as the ureteric bud failed 
to grow (Sanchez et al., 1996). Bmp-7 knockout mice had smaller kidneys and 
died soon after birth with severe hypoplasia, fewer nephrons and collecting ducts 
and polycystic tubules (Godin et al., 1998). Pax-2 mice heterozygous knockouts 
had much smaller kidneys while homozygous knockouts lacked genito-urinary 
tracts altogether (Ryan et al., 1995). Wt1 homozygous null mice exhibited 
kidney agenesis (Kreidberg et al., 1993) and the WT1 transgenic data will be 
discussed further later in Section 1.2.
1.1.4 Gonadal Development
Gonadal development also falls within the genito-urinary system and therefore 
exhibits many of the same features as kidney development. Although they have 
much in common, the development of the gonads is a fascinating and unique 
process in mammals resulting in either male or female gonads which are quite 
distinct from each other and therefore definitive features of sex determination. A 
brief discussion of some of the key aspects of gonad development in mammals 
will be presented in this section.
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Gonadal development can be divided into two phases. Early gonad 
development when the gonads are deemed to be indifferent, that is, the same in 
both sexes. Early gonad development commences at about embryonic day 10 in 
mice. Late gonad development is when sex determination comes into play and 
the male and female gonads develop differently, the sex determination switch 
occurs at around embryonic day 12.5. The gonads are derived from the 
intermediate mesoderm. The gonads develop in mammals in close association 
to the mesonephros (mentioned earlier is the introduction as an embryonic 
kidney). The Wolffian duct (WD) originates within each mesonephros. Another 
pair of ducts, the Mullerian duct (MD) also run parallel to the WD. In early, 
indifferent gonads, both set of ducts are present. The gonads arise from a 
thickening of the ventrolateral surface of each mesonephros. Ceolomic epithelia 
(CE) within each mesonephros invaginate to form the WDs which turn towards 
the midline and fuse. Around E11-13, while the gonads are developing, the 
germ cells migrate from the base of the allantois across the gut and into the 
gonads. Meanwhile, the epithelial cells from the coelum form sex cords which 
undergo differentiation into the mesenchyme that will eventually surround the 
germ cells on the genital ridge (Ginsburg et al., 1990 Review). Up to this point, 
there is no difference between the male and female gonads. The germ cells will 
eventually be surrounded by three cell types which all have bipotential fates, 
these are the supporting cells (sertoli or follicular), the hormone secreting cells 
(Leydig or Thecal) and connective tissue. The supporting cells are derived from 
the coelomic epithelia, the steroidogenic cells produce the sex hormones for the 
development of secondary sexual characteristics, and the interstitial cells of the 
connective tissue line the structures of the gonads (Slack, 2001 Review).
After the sex determination switch, in the male, the cords of cells growing into the 
germinal ridge go through a transition from sex cords to testis cords, then form a
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complex system of semi-niferous tubules composed of epithelium containing a 
number of cell types including the Sertoli cells which will surround the germ cells 
and provide them a growth environment. The Leydig cells differentiated from the 
mesenchyme between the tubules are the supporting cells, responsible for 
secretion of testosterone. The tubules become connected to the WD, which will 
give rise to the vas deferens, they shorten and become encapsulated to form the 
testis and the MD regresses and degenerates. The tubules remain solid until 
after birth when they hollow out and the germ cell derived spermatogonia 
appear.
In the female, the cords of cells remain near the surface as granulosa 
(follicle) cells which will surround the germ cells and provide the growth 
environment for the oogonia. The mesenchyme differentiates into Thecal cells 
which have a similar function to the Leydig cells in the male, to provide the sex 
hormone oestrogen. The gonad becomes encapsulated to form an ovary and 
the posterior end of the MDs fuse to form the proximal vagina and uterus, while 
the anterior end forms the oviducts (Fallopian tubes) while the WD degenerates 
(Swain and Lovell-Badge, 1999 Review).
1.1.5 Molecules involved in gonad development
Mutation studies have helped identify some of the genes involved in sex 
development. The pathways are not always clear as the consequences of 
mutation are often too severe. The molecules can be divided into those 
essential for early development, necessary in both male and female gonad 
development before E12, and those necessary for sex determination, hence late 
development after E12, which are more sex specific.
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1.1.5.1 Molecules involved in early gonad development
In early development, one of the earliest molecules to be expressed in the 
presumptive gonad is steroidogenic factor 1 (SF1) which belongs to the orphan 
receptor family of nuclear receptors, and has no known specific activating ligand. 
SF1 encodes a two zinc finger transcription factor and was found to be involved 
in steroid biosynthesis in areas associated with endocrine function such as the 
gonads, pituitary, hypothalamus and adrenals (Ingraham et al., 1994). SF1 is 
necessary for differentiation and maintenance of development. As mentioned in 
the section on kidney development, LIM-1 and PAX-2 were found in the 
mesenchyme and were needed for the differentiation of intermediate mesoderm, 
they were
also required for the same function in gonad development. Another molecule 
discussed earlier was the transcription factor EMX-2. EMX-2 was also found to 
be required for normal gonad development, and was seen to be expressed in the 
genital ridge, WD and Coelomic epithelia (Miyamoto et. al., 1997).
1.1.5.2 SRY, SOX9 and the sex determining switch
The sex determining switch marks the end of early gonad development. Until 
E12 male and female gonads are morphologically identical. Sex determination is 
a cell fate decision. The Y-linked Sry gene has been thought to trigger the switch 
for sertoli cell fate in a cell that would otherwise become a follicle cell. SRY is a 
HMG box, transcription factor and expression is seen just before sexual 
dimorphism and appears in a wave so that each cell expresses SRY for only a 
few hours from E10.5-11. We can presume that SRY is therefore not involved in 
the maintenance of cell identity or function but must act on downstream genes. 
With the discovery of SRY, it was thought that the mechanism for sex 
determination had been solved. XY mice with a null mutation for Sry were 
female and XX mice with an Sry transgene were phenotypically male (Koopman
11
et al., 1991). Sox-9 however, has also been found to be vital for the sex 
determination process. The protein has been detected in low levels in both male 
and females but by E11.5, before sexual dimorphism appeared and after Sry 
expression, the levels in males increased and it was switched off in females. By 
E12.5 one can see Sox-9 expression in Sertoli cells and this expression persists 
in Sertoli cells but not in ovaries. This suggests that while Sry may be the 
determination switch (Swain and Lovell-Badge, 1999), the signal is maintained 
by Sox-9. The precise details of the mechanisms by which Sry and Sox-9 
function are still unknown.
1.1.5.3 DAX-1 and female development
Dax-1 encodes a nuclear hormone receptor protein, and could be thought of as 
the “antitestis” gene (Swain et al., 1997). It acts antagonistically to Sry and is 
expressed in the genital ridge at the same time as Sry but as differentiation 
proceeds, Dax-1 levels decreased in the testis but persisted in the ovaries. Dax- 
1 had an inhibitory effect on Wt1 and Sf-1, which are both activators of the anti 
Mullerian hormone (AMH), a member of the TGFp family (Parker et al., 1999). 
AMH was seen to cause the regression of the MDs in males, and is suppressed 
in females to allow the MD to form the uterus and oviducts (Hoyle et al., 2002; 
Jeffs et al., 2001). It can be said that sertoli cell fate is the key sex determination 
event. After this switch, very little is known about later development. The sex 
hormones, of course, are thought to play a large role in maintenance of sexual 
characteristics, testosterone in males, progesterone and oestrogen in females, 
however not much is known about the molecules involved in the direct 
differentiation of the testis, cord formation and other late events.
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1.1.5.4 Late sexual development
WNT-4 is a molecule involved in controlling steroid production. Leydig cells start 
producing testosterone after testicular cord formation and this is thought to be 
regulated by Wnt-4 (Swain and Lovell-Badge, 1999). The default sex for germ 
cells is female and the differentiation is thought to be controlled by factors 
produced by Sertoli cells. In early differentiated testis the germ cells undergo 
mitotic arrest and in early ovaries, they undergo meiotic arrest. The Sertoli cells 
sustain germ cells during development and spermatogenesis by cell-cell 
interactions and Desert hedgehog (D/#?) is a gene involved in this process. Sox- 
9 activation of Dhh may be the mitotic signal for germ cells in males as this is 
absent in ovaries (Bitgood et al., 1996).
1.1.6 Transgenic models of gonad development
As in kidney development, transgenic animal data provides some of the most 
incisive data regarding gene function in gonad development. This method is 
especially problematic in sex development as there may be severe phenotypes 
resulting in non-viable animals or animals that are unable to reproduce. Out of 
the genes involved in early gonad development, Sf1 homozygous knockout 
animals had no gonads even though the genital ridge still forms, no ventro-lateral 
hypothalamus and impaired gonadotrope function (Ingraham et al., 1994). This 
correlates with its role in differentiation and maintenance of early development. 
Lim-1 knockout mice had no gonads (Shawlot and Behringer, 1995,Tsang, 2000 
#112) and although Pax-2 knockout mice had no kidneys, the gonads still formed 
so there seems to be a redundancy in Pax-2. Emx-2 knockouts did have gonads 
but they were poorly developed, the mesonephric tubules degenerate. Emx-2 
may respond to a signal downstream of WT1, as WT1 expression was not 
affected in Emx-2 mutants (Guo et al., 2002a; Miyamoto et al., 1997).
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In later development, XY knockout mice for Sry were phenotypically female and 
XX mice carrying Sry transgenes were phenotypically male. Mutations in Sox-9 
in XY mice resulted in male to female sex reversal, whilst ectopic Sox-9 in XX 
gonads, was sufficient to induce testis formation, therefore substituting for Sry 
(Koopman etal., 1991; Vidal et al., 2001).
1.1.7 Human developmental disorders of the geniio-urinary system 
In humans, developmental disorders of the kidney and sex organs illustrate 
defects in the genes reported earlier in this discussion. There are numerous 
diseases with defects in genito-urinary system characterised by loss of function 
or gain of function mutations. In sexual development, many of the syndromes 
can be characterised by sex reversal, dysplasia or neoplasia, and with the 
exception of sex reversal, the same characteristics as found in many kidney 
diseases.
Human mutations in the SRY gene resulted in gonadal dysgenesis and XY sex 
reversal. SOX-9 mutations caused the human skeletal disorder campomelic 
dysplasia and its associated XY gonadal dysgenesis (Guo et al., 2002a; Parker 
et al., 1999; Vidal et al., 2001). WNT-4 mapped to a chromosomal region 
associated with duplications that cause ambiguous gonads and internal 
feminisation of XY patients (Staal et al., 2001). The SF1 gene functioned in both 
the adrenal and gonads and as expected, mutations in the gene, caused adrenal 
failure and XY dysgenesis. XY dysgenesis was also a symptom of a multigene 
deletion affecting the DMRT1 gene (Hoyle et al., 2002). A duplication of the 
“antitestis” gene Dax-1 resulted in adrenal hypoplasia (the adrenals and gonads 
developed from the same primordia) and hypogonadism (Hoyle et al., 2002; Jeffs
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et al., 2001; Swain et al., 1997), whilst human mutations in the AMH gene 
resulted in persistence of MD derivatives in XY but no sex reversal (Beau et al., 
2001; Munsterberg and Lovell-Badge, 1991). WT1 mutations resulted in 
syndromes with sex reversal and XY pseudohermaphrotidism (to be discussed in 
Section 1.2).
Human kidney disease resulting from developmental abnormalities often 
manifests itself with a variety of other symptoms as many of the genes have 
multiple roles in development. For example, somatic rearrangements of RET 
resulting in its constitutive overexpression, have been associated with some 
papillary thyroid carcinomas. Deletions or mutations with decreased activity of 
RET and GDNF were associated with autosomal dominant forms of 
Hirschprung’s disease whilst germline mutations caused multiple endocrine 
neoplasia. Only recently have RET and GDNF been implicated in unilateral 
aplasia of the kidney in association with Hirschprung’s disease (Lin et al., 1993; 
Pichel et al., 1996; Schuchardt et al., 1994; Srinivas et al., 1999b). PAX-2 has 
also been implicated in many non-renal disorders but it is also strongly 
associated with human kidney diseases. PAX-2 haploinsufficiency leads to 
renal-coloboma syndrome, an autosomal dominant disease characterised by 
kidney, optic nerve and retinal defects. The other renal abnormalities associated 
with PAX-2 include bilateral hypoplasia, unilateral aplasia, and glomerular and 
interstitial fibrosis. Persistent PAX-2 expression has also been associated with 
human renal disorders. Human fetal and infantile multicystic dysplastic kidneys 
displayed persistent PAX-2 expression as did other proliferative kidney diseases, 
such as autosomal dominant polycystic kidney disease, renal cell carcinoma and 
Wilms’ tumour (Schedl and Hastie, 2000). Fetal kidney abnormalities, renal 
dysplasia and anuria have been found to be associated with mutations in the 
angiotensin receptor gene (Schedl and Hastie, 2000). Finally, WT1 has been
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implicated in numerous kidney disease and neoplasias and the following section 
will concentrate on WT1 structure, roles and characteristics of WT1, as well as its 
involvement in human disease and mouse models of these disorders.
1.2 Wilms’ tumours suppressor 1 (WT1)
1.2.1 WT1, Wilms’ tumour, and human developmental disorders 
One of the main reasons for investigating the function of WT1 is its association 
with a wide range of disorders many involving abnormalities of the genito-urinary 
system but also leukaemia, and other neoplasias. WT 1 was first identified from 
cases of Wilms’ tumour over a decade ago and since then, the number of 
syndromes associated with the gene have steadily increased. Wilms’ tumour 
(nephroblastoma) is the most common pediatric intra-abdominal solid tumour. It 
affects 1 in 10,000 children, most within the first five years of life (Hastie, 1993). 
The tumours are derived from undifferentiated kidney mesenchymal cell Rests 
(Knudson and Strong, 1972) and it is often associated with other syndromes, 
such as WAGR, Denys-Drash, Frasier and Beckwith-Weidman syndromes. 
WAGR syndrome has a particularly high incidence of Wilms’ tumour, hence the 
name WAGR (Wilms’ tumour, Aniridia, Genitourinary abnormalities and mental 
Retardation) (Franke et al., 1979), and chromosome 11 p13 is deleted in many 
WAGR cases (Rose et. al, 1990; Miles et. al., 1998). This provided strong 
evidence that the 11 p13 locus was important in WAGR and therefore in Wilms’ 
tumour. The Wilms’ tumour suppressor 1 gene (WT1) was eventually mapped to 
this region (Pritchard-Jones et al., 1990). WT1 disruption is linked to 10% of 
sporadic Wilms’ tumour cases, while there is a loss of heterozygosity at the 
11 p15 locus (containing the WT2 gene) in a further 40% of cases, it is also 
associated with many of the characteristics of WAGR syndrome such as the 
genito-urinary abnormalities WAGR patients display (Hastie, 1993). Mutations in
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WT1 are also associated with Denys Drash syndrome (DDS), a sporadic 
syndrome resulting in pseudohermaphroditism, kidney defects and Wilms’ 
tumour. Frasier syndrome (FS) is similar to Denys Drash, and manifests itself in 
renal disease, XY gonadal dysgenesis and gonadal tumours (Frasier et al., 
1964). Patients with either of these syndromes often develop abnormalities in 
their glomerular epithelium leading to diffuse mesangial sclerosis, and either 
focal or segmental sclerosis respectively (Koziell et al., 2000). On occasion, 
WT1 mutations have been associated with cases of the three different types of 
renal sclerosis in the absence of DDS or FS (Schedl and Hastie, 2000).
There are a number of neoplasias including leukaemia, also associated with 
disruptions in the WT1 gene. WT1 overexpression has often been seen in many 
types of leukemia in humans, especially acute myeloid leukemia and the protein 
has been shown to be expressed in heamopoietic precursor cells. Mesothelioma 
is a rare tumour derived from the peritoneal lining and often associated with a 
history of asbestosis. Missense mutations in WT1 have been found in cases of 
mesotheliomas where asbestosis does not factor (Hastie, 1993). Other solid 
tumours in which WT1 mutations have been implicated are desmoplastic small- 
round cell tumours, gonadoblastomas (in children with WAGR syndrome with 
WT1 deletions), and some DDS associated granulosa cell tumours of the ovary 
(Mrowka and Schedl, 2000). The wide range of WT1 associated diseases of the 
genito-urinary system and neoplasias demands questions about its gene 
structure and function that cause it to be essential in maintaining normal 
development and cell cycle regulation. The role of the gene in genito-urinary 
development and cell cycle regulation can be investigated by looking more 
closely at the structure of the gene and protein.
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1.2.2 WT 1 gene and protein
The Wilms’ tumour suppressor 1 gene was mapped to chromosomal locus 
11 p13 in humans and the corresponding homologous region in the mouse is 
proximal to chromosome 2 at 0.58 centimorgans (Pritchard-Jones et al., 1990) 
(https://www.ensembl.org). It was discovered that the gene contains 10 exons 
encoding a possible 24 different protein isoforms as a result of RNA editing and 
alternative splicing with four main isoforms resulting from 2 possible alternative 
splicing events (Scharnhorst et al., 1999). The WT1 gene encodes a 56-65 KDa 
protein (size depending on the isoform) with a zinc finger domain at the C- 
terminal (4 zinc fingers encoded by a different exon each), and a 
proline/glutamine rich N-terminal (Haber et al., 1990). It is a zinc-finger 
transcription factor containing a transregulatory region, DNA binding region, self­
association domain, nuclear localisation signal, activation and repression 
domains (Figure 3) (Haber et al., 1990). Computer modeling has demonstrated 
the presence of a potential N-terminal RNA recognition motif similar to that in 
constitutive splicing factors (Kennedy et al., 1996). Truncated WT1 protein that 
contained either the N-terminal domain or the zinc-finger domains was enough to 
confer nuclear localisation. Furthermore, yeast two hybrid experiments 
demonstrated the first 182 residues of the protein contain a dimerisation and 
oligormerisation domain that it has been suggested as an explanation of 
dominant-negative mutation, particularly those prevalent in DDS. However, the 
reasons for WT1 self-association are as yet, unclear (Davies et al., 2000).
Transient transfections and promoter-reporter assays have helped identify the 
proteins which WT 1 may transcriptionally activate. Many molecules containing 
WT1 binding sites have been described, for example, WT1 repressed promoters 
of the genes encoding insulin-like growth factor II (IGF-2) (Caricasole et al., 
1996; Duarte, 1997; Ward et al., 1995), PAX-2 (Ryan et al., 1995; Yang et al.,
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Figure 3. WT\ gene and protein
The Wilms’ tumour suppressor 1 gene (WT1) contains 10 exons encoding 
25 possible isoforms of a 56-65Kda protein. The gene consists of 4 
kruppel-like zinc fingers located at the C-terminal and a proline/glutamine 
rich N terminal. The protein is a transcription factor containing a 
transregulatory region, DNA binding region, self-association domain, a 
nuclear localisation signal, and activation and repression domains. Four of 
the isoforms arise through alternative splice events. The first alternative 
splice event results in the presence or absence of 17amino acids in exon 5 
while the second results in the insertion or deletion of 3 amino acids, 
lycine, Ihreonine or serine (KTS) between the third and fourth zinc finger.
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1999), and TGFp (Jin et. al., 1999), whilst it was essential for the transcriptional 
activation of DAX-1, SRY-1 and P21 to name but a few (Parker et al., 1999). 
Other molecules such as platelet-derived growth factor (PDGF) and BCL-2 have 
been shown to either be activated or repressed (Jin et. al., 1999 #51; Little et. al., 
1995; Jin et. al., 1999) and WT1 was shown able to repress its own activity by 
self-association (Hastie, 1993). These transcriptional properties are essential for 
the tumour suppression role of WT1 in cell cycle regulation. The 
transactivational properties of WT1 are mainly attributed to the DNA binding 
properties of one isoform (WT1-KTS) (Bickmore et al., 1992; Hamilton et al., 
1998; Little et al., 1995). DNA binding is mediated by the four, Kruppel-like C2H2 
zinc fingers of WTI, three of which show a high homology to the three zinc 
fingers of the early growth response 1 gene (EGR-1) and can therefore also bind 
to the EGR-1 binding site. Two other potential binding sites within the protein 
allowed interaction with molecules such as PDGF-1 and BCL-2 respectively (Jin 
et al., 1999; Little et al., 1995).
It is likely that WT1 functions not only as a transcription factor but also has 
posttranscriptional roles. The proposed nontranscriptional roles are mostly 
carried out by the WT1+KTS isoform. Localisation of the protein to potential 
nuclear assembly sites suggested an interaction with elements of the cell splicing 
machinery (Larsson et. al., 1995; Hastie et. al., 2001; Charlieu et. al., 1995; 
Bickmore et. al., 1992; Kohsaka et. al., 1999). More recent studies have 
demonstrated a protein-protein interaction between WT1 and splicing factors 
including U2AF65 and small nuclear ribonucleoproteins (snRNPs) (Davies et al.,
1998). Mechanisms by which WT1 may mediate aspects of mRNA processing 
are as yet unclear.
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1.2.3 WT1 iso forms
Two alternative pre-mRNA splicing events have given rise to distinct gene 
products. The first alternative splice event resulted in the insertion of three 
amino acids, lysine, threonine and serine (KTS) between the third and fourth zinc 
finger. The isoforms are known as WT1+KTS (insertion of the three amino 
acids), and WT1-KTS (ommision of the three amino acids) (Figure 4) (Davies et 
al., 1998; Haber etal., 1990; Larsson et al., 1995; Renshaw et al., 1997). These 
two isoforms result from the use of alternative splice donor sites, separated by 9 
nucleotides, at the 3’ end of exon 9. WT1 zinc fingers 2, 3 and 4 are similar in 
structure to the zinc fingers of EGR-1 and the WT1-KTS isoform is able to bind 
DNA sequences resembling the EGR-1 consensus target site. Insertion of KTS 
was thought to disrupt the critical spacing between zinc fingers and alters the 
DNA binding capacity of the protein. It is for this reason that WT1-KTS is 
involved in transcriptional activation whilst WT1+KTS seems to play a role in 
RNA processing. For example WT1-KTS is linked to the induction of cell cycle 
arrest via the induction of the cyclin dependent kinase inhibitor P21 (Englert et 
al., 1997). Ectopic expression of WT1-KTS in some cell types leads to a Gi cell 
cycle arrest. Following the stable transfection of WT1-KTS in rhaboid tumour cell 
lines, there was a marked increase in levels of BCL-2 (Del Rio-Tsonis et al.,
1996). DAX-1 and MIS activation by WT1-KTS are essential for gonadal 
development (Parker et al., 1999). Less is known about the roles of WT1+KTS 
in RNA processing but as mentioned earlier, it is associated with different 
molecules of the splicing machinery and mRNA processing.
The KTS isoforms are conserved throughout evolution in most species. The 
pufferfish Fugu ripens is one known exception where the KTS has been changed 
to KPS but the homologous isoforms still exists as WT1+KPS or W T1- KPS 
(Miles et al., 1998). Mutation studies showed that insertion of residues other
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Figure 4. WT1+KTS and WT1-KTS isoforms
One of the two alternative splice events resulted in the insertion or deletion 
of three amino acids, lycine, threonine and serine (KTS) between the third 
and fourth zinc finger of the WT 1 protein. Insertion of the KTS has been 
thought to disrupt the structure and hence the DNA binding of the isoform 
resulting in two isoforms with distinct properties. It is for this reason that 
WT1-KTS is thought to have higher DNA binding affinity and 
transactivational activity whilst WT1+KTS seems to play a role in RNA 
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than KTS can influence the binding properties of WT1 in a yeast two-hybrid 
system (Davies et al., 2000). Following site directed mutagenesis, the C-terminal 
portion of WT1 including a KPS motif was introduced into a yeast two-hybrid 
system. The C:WT1+KPS displayed as strong an affinity as the C:WT1+KTS 
constructs in binding the splicing factor U2AF65. In fact, mutagenesis of any or 
all of the amino acids failed to affect the binding with U2AF65. The addition or 
deletion of amino acids also did not seem to alter protein function in vitro. 
Mutants with insertions containing additional amino acid (KTTS and KTATS) 
behaved similarly to the WT1+KTS protein, as did proteins with smaller 
insertions (AA and A). Only when the whole region was deleted, AKTS, was 
U2AF65 binding completely diminished. These results suggested that although 
the two isoforms have different properties, these differences do not rely on the 
precise amino acid content, or size of the insertion, rather important factor was 
the disruption of the zinc finger spacing resulting from the addition of extra amino 
acids (Davies et al., 2000).
The second alternative splice event occurs at exon 5. By inclusion or exclusion 
of the entire exon, isoforms are expressed that either have or do not have the 17 
amino acids encoded by exon 5 located between the transactivation and DNA- 
binding domains. This alternative splice is evolutionarily conserved but only 
within mammals (Natoli et al., 2002b). The precise function of the 17 amino acid 
insertion remains unclear although some transcriptional activation is seen when 
the 17 amino acids were fused to a DNA binding domain in reporter assays, 
however, no phenotype was seen in mice when exon 5 was knocked out (Natoli 
et al., 2002a). Expression of the various WT1 isoforms is evolutionary 
conserved in terms of temporal and spatial patterns, and also the WT1- 
KTS;WT1+KTS splice isoform ratio. Transcripts encoding the KTS insertion 
appear to account for about 80% of the cellular mRNA, while those encoding
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exon 5 account for about 60%. The ratio between WT1+KTS and WT1-KTS is 
approximately 2:1, this is highly conserved and essential for development, a fact 
illustrated by Frasier syndrome when these ratios were altered (Larsson et al., 
1995; Little et al., 1995; Natoli et al., 2002b).
Additional isoforms of WT1 have been reported, resulting from RNA editing and 
the use of an upstream CUG initiation codon. An alternative initiation codon at 
an internal AUG results in yet another WT1 isoform, a truncated 36-38kDa 
protein. The physiological significance of these isoforms is still unclear 
(Scharnhorst et al., 1999) although recently it was shown that animals lacking a 
mammalian specific alternative N terminal extension isoform developed normally 
and were viable (Miles et al., 2003).
1.2.4 WT 1, Denys Drash and Frasier syndromes
Denys Drash and Frasier syndromes were mentioned earlier in the introduction. 
They are key to understanding the role of WT 1 in normal development as both 
are diseases of the genito-urinary system arising from mutations in the zinc 
finger region of the WT1 gene. DDS mutations of the WT1 gene are point 
mutations always affecting single amino acids in the zinc fingers. Mutations of 
WT1 involving the KTS alternative splice events were found in patients with 
Frasier syndrome and are therefore particularly relevant to this report as they 
underline the significance of the WT1 KTS isoforms. The abnormalities in kidney 
and sexual differentiation that are evident from patients with DDS and FS 
highlight the critical role of WT1 in normal gonadal as well as renal development.
Denys Drash is a rare, congenital childhood syndrome primarily affecting males. 
The genito-urinary defects are often variable but include ureteral abnormalities,
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horseshoe kidneys, and urethral malformations (Coppes et al., 1993). Mesangial 
sclerosis, pseudohermaphrotidism and predisposition to Wilms’ tumour are more 
developmental abnormalities that have been seen to arise from specific 
mutations of the WT1 gene (Bardeesy et al., 1994). Podocytes exhibited 
decreased or absent WT 1 expression but persistent Pax-2 expression (Yang et 
al., 1999). Over 60 germline mutations have been described which leave much 
of the WT1 protein intact but affect the DNA-binding zinc finger domain. Most of 
the mutations were missense mutations within exons 8 and 9, and the others, 
deletions, insertions and premature terminations which resulted in truncated 
proteins. All of the mutations had one thing in common, they altered the 
structure of the DNA-binding domain, and changed the ability of the protein to 
bind DNA and RNA (Pelletier et al., 1991). It was suggested that the mutant 
protein acted in a dominant-negative manner, as DDS patients present more 
severe defects in comparison to patients with heterozygous deletions of WT 1. In 
gene targeted experiments using a truncated form of the WT 1 in the zinc finger 
region, mice demonstrated a phenotype with some of the characteristics of DDS, 
even though the mutant allele accounted for only 5% of the total amount of WT1 
protein (Patek et al., 1999). The mutant protein may be altered in its ability to 
dimerise with the wild type protein and might perhaps associate with other gene 
products.
Frasier syndrome (FS) presents in a pattern similar to DDS with some key 
clinical differences (Frasier et al., 1964). The nephropathy tends to occur later in 
life and progression to renal failure is more gradual, suggesting that WT1 is 
necessary for normal kidney function even after development is completed. 
There is no predisposition to Wilms’ tumour but gonadoblastoma has been seen 
to be far more common than in DDS and complete male to female gender 
reversal occur more frequently in patients with Frasier syndrome. Gonadal
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development is normal in XX female patients. FS was found to arise from point 
mutations downstream of the second splice donor site in intron 9 (Barbaux et al.,
1997). The intronic mutations interfere with recognition of the splice donor site 
and result in the loss of WT1+KTS from the mutated allele (with a presumptive 
concomitant rise in WT1-KTS production from the allele), while the wild type 
allele still produces both WT1+KTS and WT1-KTS isoforms. Therefore, 
changing the ratio of the two isoforms could be sufficient to cause the severe 
defects seen in FS. Although the two syndromes are different, due to their 
overlapping features and the involvement of WT1, there were cases when DDS 
or FS patients were misdiagnosed and vice versa, resulting in confusion of the 
clinical data (McTaggart et al., 2001). Classification should therefore be 
performed at the molecular level with DDS giving rise to a dominant negative 
function due to the presence of a mutant protein, and FS arising from a change 
in the isoform ratio but no production of abnormal WT1 proteins (Koziell and 
Grundy, 1999).
1.2.5 WT 1 Transgenic animal data
The animal data on WT 1 mutation has provided some of the best evidence for 
gene function. Bearing in mind that animal models have their limitations in 
studying the human form of a disease, and the fact that, to date, no mice have 
been seen to develop Wilms’ tumour (one chimeric animal for the DDS truncation 
mutation was seen to develop a renal tumour (Patek et al., 1999)), they still 
supply a powerful tool in the research into WT1. Null mutations were introduced 
into the murine WT1 gene, by gene targeting in embryonic stem cells (ES cells) 
(Kreidberg et al., 1993). The mutation resulted in embryonic lethality in 
homozygotes (on certain strain backgrounds null mutants can survive till birth but 
then die shortly after) and mutant embryos demonstrated a failure to develop
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kidneys and gonads. Specifically, at E11, the cells of the metanephric blastema 
underwent apoptosis, the UB failed to grown out from the WD, and the inductive 
events that lead to the formation of the metanephric kidney did not occur. In 
addition, the mutation caused abnormal development of the mesothelium, 
spleen, heart and lungs. This illustrates the crucial role that WT1 plays in early 
urogenital development. Previously, it was thought that heterozygous WT 
knockout mice had no phenotypic defects but recent data shows there is a 
degree of abnormal kidney function, illustrated by increased levels of albumin 
and protein in the urine, in comparison to negative levels in the Wild type 
(Wagner, 2003). Rescue of the null phenotype has been attempted to examine 
whether the human WT1 gene is able to complement the knockout mutation in 
mice. This was done using a 280kb yeast artificial chromosome (YAC) in an 
attempt to introduce the entire genomic locus, to ensure proper expression of all 
the isoforms and correct transcriptional regulation of the WT1 gene (Moore et al., 
1999; Moore et al., 1998). The transgene only partially rescued the knockout 
phenotype when crossed onto the knockout background. These mice were 
viable for 48h after birth and although complete rescue of the epicardial and 
diaphragmatic abnormalities was achieved, these mice died. Further analysis of 
the kidneys of these mice showed renal abnormalities ranging from, failure of 
ureteric budding, branching, or normal nephrogenic development until formation 
of comma-shaped bodies. Mature glomeruli never formed however and this may 
result from the absence of crucial modifier genes or essential regulatory 
sequences, absent from the YAC. Interestingly, the YAC has been shown to 
rescue ocular defects that have been recently reported in W T7' mutants, 
illustrating a role for WT1 in the normal development of the retina (Wagner et al., 
2002).
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Creation of a mouse model of DDS has also been attempted. Expression of a 
truncated form of WT1 from a DDS-like mutation, targeted to one of the 
endogenous Wt1 alleles, did show features which are characteristic of patients 
with analogous mutations, such as diffuse mesangial sclerosis and gonad 
dysgenesis, however a mouse line carrying this mutation could not be 
established due to infertility associated with the mutation although it was reported 
that one mouse developed a renal tumour (Patek et al., 1999).
More recently, mouse strains have been generated in which a specific isoform of 
WT1 has been removed to identify functions of WT1+KTS and WT1-KTS 
(Hammes et al., 2001). Heterozygous mice with a reduction of WT1+KTS 
develop glomerulosclerosis and represent a model for Frasier syndrome, and 
show complete XY sex reversal (due to the reduction of Sry expression). 
Homozygous mutants of both strains die after birth from kidney defects. This 
data again demonstrates different functions for both splice variants. Lack of 
expression of WT 1 in podocytes is a key factor in DDS patients, and it has been 
suggested that primary lesions in the podocytes causes glomerular disease 
which is one of the most common causes of renal failure. The mechanisms by 
which these glomerulopathies occur are poorly understood. It has been recently 
demonstrated, by combining Wt1 null mice and inducible YAC transgenes, that 
reduced expression levels of WT1 result in some of these glomerular 
abnormalities depending on gene dosage (Moore et al., 1999). At the same 
time, the podocyte specific genes, nphsl and podocalyxin are dramatically 
downregulated in mice with decreased levels of Wt1 (Palmer et al., 2001), 
suggesting that these genes act downstream of Wt1.
Gene targeting of exon 5 of WT 1, encoding the other splice event resulting in the 
presence or absence of 17 amino acids, has resulted in viable, fertile adult mice.
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This data suggests that the mammal specific exon of WT 1 is not essential for 
development or fertility (Natoli et al., 2002b). Similarly, the knockout of a 
mammal specific alternative leader also resulted in normal development and 
fertility in mice (Miles et al., 2003).
1.2.6 Role o f WT 1 during genito-urinary development
The expression pattern of WT1 during embryogenesis is highly complex. The 
gene has been shown to be only weakly expressed in uncondensed metanephric 
mesenchyme therefore it is likely that the initial differentiation is independent of 
WT1. During mesenchyme to epithelium transition when the comma-shaped 
and s-shaped bodies are formed there was a significant increase in levels of 
WT 1. Expression reached its highest levels at the proximal part of the s shaped 
bodies where the glomerular podocytes are formed. Levels then decreased until 
expression was limited only to the podocytes of the BC by the time the kidney 
reached full development. The expression pattern of WT1 during kidney 
development allows us to infer WT 1 activity is necessary for the transition of cells 
between mesenchyme to epithelium. As well as the kidney, high levels of WTI 
are found in the spleen, gonads, and the mesothelium layer surrounding the 
body cavity and thoracic organs (Armstrong et al., 1993; Little et al., 1992). The 
complex pattern of WT1 expression and the resulting phenotypes from mutations 
of the gene lead us to believe that WT1 is required at multiple stages during 
kidney development. In the knockout (null) mice (Kreidberg et al., 1993), the 
metanephric blastema underwent apoptosis. Apoptosis even occured when this 
knockout blastema was recombined with ureteric buds from wild type animals in 
organ culture, suggesting it was necessary for both the inductive signal, inducing 
outgrowth of the ureter, and for receiving the survival signal from the ureteric bud 
(Kreidberg et al., 1993). A multitude of positive and negative feedback
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mechanisms operate during the formation of the kidney. The mechanism that 
establishes the metanephric blastema remains unknown but the next key event 
is the expression of WT1. In its absence, the blastema undergoes spontaneous 
apoptosis, in its presence, the MM synthesises GDNF, which signals to the duct 
system via RET, which in turn signals back to the MM. WT1 is responsible for 
the subsequent development of the MM, and clearly has a role in growth. In its 
absence, cells undergo apoptosis and mutations can lead to uncontrolled 
proliferation as illustrated by Wilms’ tumour.
PAX-2 interaction with WT1 is essential for the following phases of 
nephrogenesis in the blast cells that cap the duct tips and are the site of future 
nephrons (Ryan et al., 1995). PAX-2 was seen to be down regulated in the 
prepodocytes at the same time as WT1 is at it highest levels, and the inhibition of 
blast cell proliferation marking the cessation of nephrogenesis is likely to be 
regulated by WT1 (Mrowka and Schedl, 2000). Binding studies have shown that 
WT 1 can repress PAX-2 promoter activity but regulation of WT 1 activity by PAX- 
2 has also been described. Insulin-like growth factor II (IGF-2) is thought to be 
another growth response gene in the proliferation of blast cells and has shown to 
be repressed by WT1 (Drummond et al., 1992). This could explain the increased 
levels of IGF-2 in Wilms’ tumours where WT1 function has been perturbed. The 
late occurrence of FS and the expression of WT1 in podocytes (Guo et al., 
2002b), which persists throughout adult life, and the glomerular abnormalities 
seen in the podocytes of DDS patients, allow us to argue that WT1 is also 
needed well beyond nephrogenesis.
The importance of WT1 in the gonads has also been illustrated by the 
phenotypes of mutant mice and human disease. WT1 is expressed diffusely in 
the undifferentiated gonads. Its expression becomes more restricted following
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sexual differentiation, in the pre-Sertoli and Sertoli cells of the testis, and the 
follicle and epithelial cells of the ovary (Pritchard-Jones et al., 1990). This 
suggests that WT1 is required at the earliest stage of the undifferentiated gonad, 
before sex determination occurs and that it also has a later role within the 
supportive cells of the mature gonad. WT1 mutations have been reported in 
undifferentiated gonadoblastomas arising in patients with DDS but not in more 
mature ovarian and testicular tumours (Pelletier et al., 1991). There is 
coexpression of WT1 and the orphan receptor SF1 in Sertoli cells and both 
transcription factors display similar knockout phenotypes. It is thought that there 
is an interaction between the two factors and the regulation of early gonad 
development by activation of SF1, through the direct binding of WT1-KTS, has 
been described (interestingly WT1+KTS does not interact with SF1). The 
interaction of the two proteins has a direct effect on the activation of the AMH 
promoter which is consistent with male to female sex reversal associated with 
DDS, resulting from the inactivation of WT1-KTS and hence, reduced 
expression of AMH.
DAX-1 is another nuclear orphan receptor whose function is linked to the role of 
WT 1 in gonad development. DAX-1 protein also has been shown to have WT 1 
binding sites and may modulate the regulation of AMH by WT1 and SF1. This 
modulation of WT1 and SF1 is thought to repress AMH, preventing the 
regression of the Mullerian duct, thus promoting progression to female 
characteristics. Finally, the interaction between WT1 and SRY still remains 
unclear but SRY associated induction of WT1 transcripts has been described 
(Lee and Haber, 2001). WT1 function with relevance to gonadal differentiation is 
likely to involve interactions with these well-characterised regulators of gonadal 
development and others, which as yet, remain to be identified.
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1.2.7 WT 1 interacting proteins -  Brain acidic soluble protein (BASP1) 
Mechanisms by which WT 1 function is regulated by interacting proteins have to 
some extent been covered in previous sections. To date, the protein has not 
been shown to associate with transcriptional co-repressors. As described 
previously proteins such as SF1 and Sry are thought to be co-activating proteins 
as well as proteins such as PAR-4 and WTAP (Little et al., 2000). The WT1 
transcriptional suppression domain of WT 1 is thought to be located within its N- 
terminus and is proposed to function by recruiting a cosuppressor protein to WT 1 
that blocks the function of the transcriptional activation domain. Using a 
functional assay, a group led by Dr Stefan Roberts, have provided evidence that 
the WT1 suppression domain contains a co-suppressor. Brain acidic soluble 
protein (BASP-1) has been identified as a component of the WT1 co-suppressor 
to regulate its transcription function during development (Carpenter et al., 2002). 
Despite no phenotypically difference in knockout mice of the 17amino acid 
alternative splice insert, the WT1 17AA isoform can be overexpressed in Wilms’ 
tumours and other malignancies and has been shown to have effects both on 
cell division and cell survival. Protein truncations of WT1 were tested in an in 
vitro transcription assay. Analysis of Gal-4 fusion proteins described that just 10 
amino acids of WT 1 at the N-terminal were sufficient to confer inhibition of an 
SP1 transcriptional activation domain. The isolated WT1 suppression domain 
was able to titrate a cosuppressor, later identified to be BASP-1. The 
implications for the identification of a cosuppressor to WT 1 are great, as they 
may give us an insight into mechanisms by which the protein functions.
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1.3 Subcellular localisation of WT 1
1.3.1 Sub nuclear compartmentalization
As described earlier, the WT1+KTS and WT1-KTS isoforms of WT1 have 
distinct roles dependent on their structure and their localisation within the 
nucleus. It can be assumed that protein structure may be the pivotal element, 
with alternative conformations resulting from differences in isoform structure or 
mutation that allow the binding of diverse groups of protein families (Section
1.2.7 describes the differential binding of some of the isoforms or mutants). 
These alterations in protein structure, including binding domains (DNA binding 
and RNA binding) and localisation signals, restrict the protein to specific regions 
of the nucleus and may allow it to interact with different factors. It is therefore 
necessary to understand the role and structure of the nucleus before we can 
understand how WT 1 may function.
The nucleus was originally described in 1802 and was the first intracellular 
structure discovered. It has only been the development of powerful microscopy 
and molecular techniques since then, that have allowed in depth study of the 
nucleus. Findings from recent research have shown that the nucleus is a highly 
dynamic organelle containing distinct sub-compartments (Dundr and Misteli, 
2001). These structures are characterised by the absence of delineating 
membranes but are still considered compartments for several reasons. Firstly, 
they contain specific resident proteins and can be morphologically identified by 
light and electron microscopy. More recently, most of them have been visualised 
in living cells by the use of green fluorescent protein (GFP) technology. Finally, 
some of these compartments can be isolated biochemically (Lamond and 
Earnshaw, 1998). The mechanism by which these subcellular compartments are 
isolated and processed has been the subject of much research and as yet,
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remains unclear (Misteli, 2001a). The main function of the interphase nucleus 
includes transcription, pre-mRNA splicing and ribosome assembly.
1.3.2 The Nucleolus
The best studied nuclear component of the nucleus is the nucleolus. It is the 
most prominent nuclear structure originally discovered due to its high refractive 
index and density. It is assembled around clusters of tandemly repeated 
ribosomal genes which are transcribed by RNA pol I. The regions containing the 
tandem arrays of rDNA genes constitute the nucleolar-organising region (NOR) 
and are the basis of the structural organisation of the nucleolus responsible for 
the targeting of all processing and assembly components required for ribosome 
biosynthesis (Lyon and Lamond, 2000). The nucleolus itself can be separated 
into three distinct regions depending on their morphology. Fibrillar centres (FCs), 
are surrounded by dense fibrillar centres (DFCs), and granular components 
radiate out from the DFCs. Nascent rRNA transcripts move away from the DNA 
template and are detected first in the dense fibrillar component and later in the 
granular component (Carmo-Fonseca et al., 1991). Biogenesis of rRNA involves 
a complex set of post-transcriptional processing reactions and it is well 
established that the initial pre-RNA resides in the DFCs, whereas late processing 
events take place in the granular component. Finally pre-ribosomal particles are 
translocated to the cytoplasm through the nuclear pores. In situ hybridisation 
experiments have shown that active rDNA genes are located to the periphery of 
FCs and are excluded from the FC (Scheer and Hock, 1999). The DFCs are 
thought to be the site of transient accumulation of elongating and primary 
transcripts as indicated by the absence of rDNA from the DFC. Pre-rRNA 
cleavage is initiated in the DFC and is finished in the granular component. 
Nascent pre-RNA transcripts enter the DFC where they undergo a series of
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processing steps. Later, processing and assembly steps occur in the granular 
component before they are fully processed and with the association of ribosomal 
proteins, are assembled into large and small preribosomal subunits before being 
exported to the cytoplasm (Dundr and Misteli, 2001). The nucleolus is also a site 
for the functional pathways of methylation and of the conversion of uridine to 
pseudouridine of pre-RNA, which also occur in DFCs. These processing and 
modification events are assisted by small nuclear ribonucleoproteins (snRNPs). 
Two major classes of small nucleolar RNAs have been identified, some of which 
(U3, U8, U14, and U22) are required for pre-rRNA cleavage (Scheer and Hock,
1999). Fibrillarin is a protein located at the DFCs and necessary for pre-rRNA 
methylation. There is evidence suggesting that the nucleolus not only carries out 
ribosome biogenesis, but it is also the site of assembly and interaction between 
multiple ribonucleoprotein machines, as well as processing and transcriptional 
modification of splieceosomal small nuclear RNA (U6)(Dundr and Misteli, 2002).
In addition to being a site dedicated to ribosome biogenesis, and maturation of 
transcripts, the nucleolus acts as a sequestering compartment for cell cycle 
regulatory complexes. For example, the nucleolus is implicated in the regulation 
of the tumour-suppressor protein p53, retention of the p53 interacting protein, 
MDM2 within the nucleolus by p19ARF, prevents the degradation of p53 and 
results in the activation of p53 nuclear import and accumulation. Primary 
fibroblasts isolated from p19ARF deficient animals are able to proliferate 
indefinitely, suggesting the presence of p19ARF in the nucleolus is a key 
regulator of proliferation and the cell cycle (Lohrum et al., 2000).
In animal and plant cells, nucleoli are very dynamic structures. Fully active 
nucleoli are large, with no clear boundaries visible between the three 
components. In contast, cells following induced transcriptional arrest
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(Actinomycin D or RNAse inhibition treatment), have small and compact nucleoli 
where the three components tend to segregate into adjacent blocks (Olson et al.,
2000). The nucleolus of multicellular organisms disassembles during mitosis 
and various nucleolar proteins leave the structure. The granular centre of the 
nucleolus disappears first followed by the DFC as the NORs simultaneously 
become visible on chromosomes. At the end of mitosis, small round structures 
called pre-nucleolar bodies (PNBs) appear in the newly formed nuclei, before the 
onset of transcription initiation by RNA pol I triggering the recruitment of PNBs to 
the NORs to form a complete nucleolus (Dundr and Misteli, 2001).
1.3.3 Cajal bodies and Coilin
Initially described as “nuclear accessory bodies” by Cajal over a century ago, 
also called coiled bodies, due to their characteristic appearance as coiled fibrillar 
strands in using electron microscopy, Cajal bodies (CBs) are small spherical 
structures present as 1-5 copies per nucleus and are of varying size. CBs are 
generally found within the nucleus and are highly mobile structures, mostly found 
within the nucleoplasm but known to associate with, and maybe even pass 
through the nucleolus (Matera, 1998). The nucleopcytoplasmic-shuttling protein 
p80-coilin has been identified as a marker of CBs and has lead to evidence 
suggesting the functional associated of the CBs and the nucleolus (Hebert et al.,
2001). Firstly, the formation of CBs inside the nucleolus can be induced by a 
single point mutation of p80-coilin as well as the Nopp140 protein, which is 
known to associate with coilin in vitro. Furthermore, treatment of cells with the 
protein phosphatase inhibitor Okadaic acid causes the redistribution of Coilin to 
the nucleolus.
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Recent research suggests that CBs might be involved in transport and 
maturation of snRNPs. GFP-tagged proteins firstly localise to CBs before they 
pass through the nucleolus and reach their final destination in the FC (Matera, 
1999; Tucker et al., 2001). An alternative model for CB function suggests that 
CBs are the assembly sites for the transcription machinery of the nucleus 
(Hebert et al., 2001). This is supported by the observation that factors involved 
in transcription and capping were initially targeted to CBs. The observed 
localisation of some pol I and pol II components to CBs has indicated that CBs 
also function as a platform for assembly of pol I and pol II transcriptiosomes. 
Although much is to be discovered about the precise role of CBs, there is a 
definite link between CBs and the nucleolus. CBs may be involved in trafficking 
and storage of proteins between the nucleoplasm and nucleolus and like the 
other components of the nucleus, have a dynamic structure.
1.3.4 Speckles and paraspeckle domains
Splicing of pre-mRNA takes place in the nucleus by a two-step transesterification 
mechanism characterised by the “spliceosome” or splicing machinery. The 
major subunits of the splicing machinery are the U1, U2, U5 and U4/U6 snRNAs, 
which assemble with additional protein splicing factors to form the active 
complex. Each snRNP comprises one or two small nuclear RNAs (snRNAs). 
The spliceosome is another dynamic structure that goes through cycles of 
assembly and disassembly during the splicing of each intron. Splicing factors 
are located in clusters of interchromatic granule-associated zones, (“speckles”), 
gem bodies (see below) and coiled bodies. Immunofluorescence, microscopy 
and GFP data has shown that most active genes are either excluded from, or lie 
at the very periphery of these speckles and that many of the splicing factors such 
as U2AF 35, are located to these areas of interchromatin granules. It is for this
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reason that a speckled staining pattern colocalises with many splicing factors. 
Often associated with the Cajal bodies are the gem bodies, these nuclear bodies 
are found in the nucleus and cytoplasm. The survival of motor neurons protein 
(SMN) was first identified as mutated in the disease spinal muscular atrophy. It 
has since been found that SMN is tightly associated with gem bodies in the 
nucleous and interacts with Sm proteins, another component of spliceosomal 
SnRNPs and splicing machinery. Hence the gem bodies are also involved in the 
mechanisms of splicing.
Recently a proteomic study of purified human nucleoli has identified novel 
proteins, including the Paraspeckle Protein-1 (PSP1) (Andersen et al., 2002). 
This study showed that PSP1 accumulated in a new nucleoplasmic 
compartment, named paraspeckles. 10 to 20 paraspeckles were detected in the 
nuclei of a number of human cell types. The paraspeckles corresponded to 
discreet bodies within the nucleoplasm, often located adjacent to splicing factors 
which relocalised at the nuclear periphery when transcription is inhibited (Fox et 
al., 2002). The function of these bodies is unclear but they could provide yet 
another clue to the functional complexity of the nucleus.
1.3.5 Nuclear proteins and localisation signals
Proteins in common pathways often concentrate into specific areas of the 
nucleus. This was one of the ways in which the different compartments of the 
nucleus were identified. For example, even though proteins involved in pre- 
mRNA splicing moved rapidly around the nucleus, they appeared to concentrate 
into speckles, in the same way as the proteins involved in rDNA processing and 
ribosome biogenesis located within the nucleolus. A combination of mass 
spectrometry, in combination with database analysis and the possibility of
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purifying and fractionating the nucleus, have allowed the identification of the 
nuclear protein content. Proteomics, has allowed the characterization of 
subnuclear components including the spliceosome, nucleolus and nuclear pore 
complex to allow investigators to identify families of proteins and hence elucidate 
some of the characteristics of the proteins and the functions of the organelles in 
which they reside. Proteomics has added to our knowledge of some novel 
amino acid sequence motifs, such as nucleolar localisation signals (NLS) and 
novel subcompartments of the nucleus (the paraspeckle domain) (Bickmore and 
Sutherland, 2002).
The ability of a protein to localise to a particular subcompartment of the nucleus 
could be due to its amino acid content, and isoelectric point (pi). For example, 
the speckles and Cajal bodies contain the most basic proteins whereas proteins 
located to the periphery of the nucleus tend to be more acidic. A variation of the 
pi of different proteins, reflects differences in the amino acid content. Nuclear 
proteins often have higher occurrences of lysine and arginine residues, perhaps 
due to the presence of nuclear localisation signals in these proteins. These 
proteins are often found located to the interior of the nucleus while proteins 
without an NLS may be found at the nuclear periphery suggesting they use 
diffusion as a mechanism to enter the nucleus.
Proteomic analysis of the motifs showed that 80-86% of nuclear proteins 
contained an NLS, the others were thought to enter the nucleus by diffusion or 
by their association with other proteins. Apart from an NLS, proteins localizing to 
the nucleolus tended to have both nucleic acid binding domains and protein- 
protein interaction domains. Speckle-localizing proteins had more complex 
structures with over half of their proteins containing RNA recognition motifs. 
Although the nucleolus is also involved in RNA processing, the RNA recognition
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domains were not so abundant in the nucleolus. Despite the functional 
relationship between speckles and Cajal bodies, the Sm proteins were the one 
type of common protein between the two components. There were of course 
many proteins that fell outside of the characterisation but proteomics remains a 
potentially powerful tool in understanding nuclear organisation (Bickmore and 
Sutherland, 2002; Lamond and Earnshaw, 1998; Lamond and Gasser, 2002).
The presence of NLSs have been well characterised in proteins. However, the 
existence of nucleolar localisation signals (NoLS) is much less clear. A 
prerequisite for nucleolar accumulation is translocation of a protein from the 
cytoplasm to the nucleoplasm. In the nucleoplasm, proteins may bind by their 
functional domains. Nucleolar accumulation could then proceed by two possible 
mechanisms: one in which the process is an active mechanism, either mediated 
by a signal in the protein that directs it to the nucleolus, or mediated by its 
association with other molecules or complexes that are actively transported to 
the nucleolus. The second process would involve a passive mechanism of 
nucleolar entry, mediated by diffusion and accumulation would result from 
retention by binding to nucleolar components. Research into this area has 
provided evidence for both mechanisms.
It is known that NoLS signals are often basic regions and many proteins which 
accumulate in the nucleolus contain basic elements which, when knocked out, 
destroy nucleolar localisation in the protein. The basic region of p80-coilin when 
uncovered by the deletion of an acidic region, results in the accumulation of coilin 
in the nucleolus (Tucker et al., 2000). Herpesvirus protein MEQ and PRRSV 
nucleocaspid protein, and two cellular proteins, rat spermatidal protein TP2 and 
human HICp40 have all been reported to contain NoLSs consisting of stretches 
of basic residues. Other data describes characterisation of specific amino acid
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sequences, point mutations of which, results in the abolishment of nucleolar 
localisation. For example the nucleolar retention of U3 snRNA is mediated by a 
C’D box motif (Speckmann et al., 1999). The NoLS of human angiogenin (amino 
acids IMRRRGL) is sufficient to import GFP into the nucleolus (Lixin et al., 2001). 
The ING1 candidate tumour suppressor uses the RRQR amino acid sequence to 
direct GFP to the nucleolus. This sequence was also conserved in other 
nucleolar proteins including HIV-Tat and HIV-Ret (Scott et al., 2001). One group 
has described proline-rich nucleolar retention motifs that require phosphorylation 
to regulate them (Catez et al., 2002). Another group described the presence of 
two NoLSs within one protein, both of which were required for nucleolar retention 
and the deletion of either was sufficient to impede localisation (Scott et al., 2001). 
Many of the sequences involved in nucleolar localisation seemed to involve 
Arginine repeats. Arginine is a basic amino acid, and the requirement for a 
simple basic repeat structure is consistent with data favoring the passive method 
of nucleolar localisation, however, point mutation of these specific sequences is 
enough to change nucleolar localisation which suggests a more active method is 
involved.
As the data suggest, there are definite factors involved in nucleolar retention, and 
this may involve a mixture of passive and active mechanisms. Research has 
uncovered a number of sequences involved in nucleolar localisation and many of 
the proteins involved can be grouped together by their shared characteristics.
1.3.6 WT1 subcellular localisation
Colocalisation and Immunoprecipitation studies have shown that the subnuclear 
localisation pattern of WT1 was very similar to the speckled pattern described for 
splicing factors. They colocalise in the two major nuclear domains known to
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contain snRNPs, the speckles and coiled bodies. The subnuclear localisation of 
WT1 has been shown to be dynamic, with actinomycin D treatment, known to 
inhibit cellular transcription and causing some splicing factors to relocate to large 
foci or surround the remnants of the nucleolus, leading WT1 to locate to areas 
surrounding the nucleoli (Englert, 1998; Larsson et al., 1995).
WT1 was coimmunoprecipitated by monoclonal antibodies against a number of 
well-defined splicing factors and transcription factors such as U3, a component 
of the splicing machinery. When the individual splice isoforms were investigated, 
the subnuclear localisation depended on the presence or absence of the KTS 
insert. WT1-KTS GFP constructs localised in a diffuse pattern with some 
domains of localisation but no nucleolar staining in Cos7 cells. WT1-KTS 
isoforms failed to relocate to the nucleolus upon actinomycin D treatment 
whereas WT1+KTS GFP constructs localised to speckled areas in a similar 
pattern to that of many speckling factors. Actinomycin D treatment of WT1+KTS 
transfected cells, caused the WT1+KTS to relocate to the periphery of the 
nucleus. Staining the cells with antibodies specific for splicing and transcription 
factors identified WT1-KTS to be colocalised in a transcription factor-like pattern 
(colocalisation with the transcription factor Sp1), and WT1+KTS to be 
colocalising with splicing speckles (Larsson et al., 1995), though location of 
WT1+KTS was different from the essential splicing factor SC35 (Englert et al., 
1995). This correlates with the idea of WT1-KTS being involved in transcriptional 
activation and WT1+KTSs involvement with the splicing machinery.
Interestingly, expression of WTAR, a naturally occurring Wilms’ tumour 
associated mutation with an in-frame deletion of Zinc finger 3, and WT1 delZ, a 
construct lacking the entire zinc finger domain (analogous to a Denys Drash 
mutation), result in enhanced speckling (Englert et al., 1995). It is suggested
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from this data that the N-terminal region of the WT1 protein is required for its 
association with speckles, a hypothesis backed up by the study of deletion 
constructs showing that amino acids 76-120 of the WT1 protein were enough to 
confer the speckling characteristics (Englert, 1998). Involvement of the KTS in 
binding to the splicing factor U2AF65 has been mentioned previously. Davies et 
al. (2000) used KTS mutations (replacement of the KTS region with various 
insertions, discussed further in Section XX (Chapter 4) to investigate the effects 
on nuclear distribution. The mutant proteins were transiently transfected into 
Cos7 cells and the nuclear localisation examined. All the mutants displayed 
good colocalisation with splice factors and showed similar speckled patterns to 
WT1+KTS within the nucleus. Only AKTS (deletion of the entire KTS region) 
mutants adopted the WT1-KTS distribution patterns. This data corroborates the 
group’s findings that differences in the function of the two KTS isoforms result 
from disruption of the zinc fingers. Interestingly, although WT1+KTS binds to 
U2AF65 and the speckling pattern results from the presence of WT1+KTS and 
not WT1 -KTS, the N terminus is required for the speckling (but not binding with 
U2AF65). Thus the localisation of WT1 with speckles and the association with 
U2AF65, a factor of the splicing machinery, are separable features of WT1.
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1.4 Aims of the thesis
The underlying reason for studying the KTS isoforms of WT1 is their implication 
in disease phenotypes. Animal experiments and human diseases have 
highlighted that the balance of these isoforms is essential for normal genito­
urinary development. Patients with DDS produce dominant mutant WT proteins 
impeding the function of normal protein. This can be reconstructed in animal 
models where a truncation of WT1 mimicking a mutation analogous to DDS 
results in similar phenotypes of the disease in mice. In Frasier syndrome, 
patients lose the production of WT1+KTS from the mutant allele, resulting in a 
reversal of the normal 2:1 ratio of WT1+KTS: WT1-KTS. Overall, the amount of 
protein appeared to be unchanged with elevated levels o f-KTS being produced, 
at the expense of WT1+KTS which was reduced to half the normal amount. 
Mice with similar heterozygous mutations of WT1+KTS had a phenotype with 
features similar to FS patients. That this isoform ratio is crucial can be seen not 
only by human disease but by the fact that homozygous mice for either 
mutations of WT 1+KTS or WT1-KTS, die from kidney defects. Furthermore, the 
isoforms appear to play different roles in transcription and RNA processing and 
this is reflected both by their interactions with other proteins, and their subcellular 
localisation.
There are however, many questions that still remain unclear and this project 
attempts to answer some of them by investigating the function of the isoforms 
both in vivo in the mouse (Chapter 3) and in vitro, with cell culture experiments 
(Chapter 4). The report can be divided into two areas: Firstly, the investigation 
of the differential localisation of the WT1+KTS and WT1-KTS isoforms in cell 
culture with regards to their function. The second area of experiments
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investigates the overexpression of a single WT 1 isoform with regards to genito­
urinary development in the mouse.
1.4.1 Overexpression of WT 1 -KTS in transgenic animals 
Transgenic experiments were used alongside cell culture experiments to give a 
comparison of in vitro versus in vivo analysis of the role of KTS isoforms in 
genito-urinary development. The mice reported to have heterozygous mutations 
within either isoform provide a good model for the effect of reduced levels of 
isoform in development. The effects of reduced levels of WT1+KTS resulted in 
animals presenting clinical characteristics analogous to Frasier Syndrome. 
Another method of looking at one isoform in isolation from another is to look at 
the overexpression of one particular isoform. Previously in our lab, transgenic 
lines were generated overexpressing WT1-KTS by the insertion of a transgene 
containing WT1-KTS under the regulation of the IGF2 P3 promoter and H19 
enhancer sequences. The P3/H19 regulatory region allows the transgene to be 
expressed temporally and spatially in at least some sites of WT1 expression 
allowing the overexpression of WT1-KTS in wild type mice. To look at the effects 
of the transgene on a WT1 null background, mice carrying the transgene 
(P3:WT1-KTS) were crossed to mice heterozygous for the null allele (WT1+/'). 
As WT1 homozygous knockouts (WTT/_) are embryonic lethal, the resulting 
WTT/_;P3:WT1-KTS mice were analysed at embryonic day 11.5 to allow 
examination for any evidence of rescue of the null phenotype by the expression 
of the single WT1-KTS isoform. Analysis of heterozygous WT1 knockout 
animals expressing the transgene (WT1+/';P3:WT1-KTS) was also carried out to 
identify possible dosage effects of changes in isoform ratios.
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Analysis of the resulting animals was carried out with a variety of methods. 
Animals were genotyped and both histological and molecular analyses used to 
identify any phenotypical changes. Depending on phenotypic abnormalities, the 
organs of mutant animals, or mutant embryos underwent a series of tests. 
Detection of antibodies to proteins of interest identified changes in the normal 
expression of these proteins, abnormal proliferation or apoptosis events were 
also characterised in samples of interest. Finally, kidney function was assessed 
by urine analysis in adult mice with no other detectable phenotypes. These 
experiments answered questions about the function of WT1-KTS when isolated 
from WT1+KTS and provided one possible method of developing a mouse model 
for Frasier syndrome. Embryos with no WT1+KTS carrying the WT1-KTS 
transgene (WTT^PSiWTI-KTS), animals with normal endogenous WT1 isoform 
ratios carrying the WT1-KTS transgene (WT1+/+;P3:WT1-KTS) (therefore 
increasing the amount of WT1-KTS while maintaining normal levels of 
WT1+KTS), animals with half the amount of WT1+KTS and WT1-KTS carrying 
the transgene (WT1+/‘;P3:WT1-KTS) (therefore these animals expressed half the 
amount of both endogenous isoforms but also expressed transgenic WT1-KTS) 
were studied with the aim of evaluating isoform dosage effects on genito-urinary 
development.
The expression pattern of WT1 protein, apoptosis and proliferation in the Ob 
mouse, a mutant previously described in the group with defective 
spermatogenesis, was used for comparison with WT1 transgenic mice with 
genito-urinary defects. This highlighted differences in abnormalities occurring 
from defects in the WT 1 pathway as opposed to other mechanisms involved in 
renal and gonad development. The Ob mouse mutant provided us with positive 
controls for abnormalities of protein expression, histological tests and analysis of
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kidney function and allowed us to compare different mechanisms resulting in the 
pathogenesis of developmental disorders.
1.4.2 Investigation of the differential subcellular localisation of the KTS 
isoforms
To investigate the differential subcellular localisation of WT1, a series of cell 
culture experiments were carried out. It has been shown that WT1+KTS and 
WT1-KTS localise to different structures within the nucleus. Firstly, the nature of 
this localisation was characterised in a number of cell lines either expressing or 
not expressing endogenous WT1, using GFP:WT1+KTS and GFP:WT1-KTS 
fusion proteins. Treatment with Actinomycin D inhibits the activity of RNA 
polymerase in cells so the localisation of the KTS isoforms in transcriptionally 
quiescent cells upon actinomycin D treatment was also investigated. This data 
allowed a visualisation of the subcellular locaslisation of KTS isoforms, to identify 
those regions of the cell to which wild type WT1 KTS isoforms locates, both 
under normal conditions, and in response to the inhibition of transcription.
After a general characterisation of WT1-KTS and WT1+KTS localisation had 
been made, the next step was to identify which organelles and sub­
compartments the molecules localised to. This was done by colocalisation 
analysis with molecules known to be associated with different compartments of 
the cell through the use of antibodies and GFP fusion proteins. Upon complete 
analysis of the subcellular localisation of wild type KTS isoforms, the final 
objective was to identify mutations in the structure of the protein that affect its 
function or its localisation within the cell and hence identify regions of importance 
in the proteins. This was achieved by mutational analysis of the isoforms to 
create mutants by site directed mutagenesis. Analysis of these mutants gave us
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insights into the protein structure with relation to its function. Finally, any regions 
which when mutated changed the localisation of the protein alerted us to 
sequences encoding a putative signal directing the protein to its correct location.
48
C h a p t e r  2
MATERIALS AND METHODS
2.1 Molecular biology and Microbiology
2.1.1 Growth media, antibiotics, and bacterial host-strains
The growth media used for bacterial cultures, preparation and storage are as 
follows:
LB (Luria-Bertani) medium; 1% (w/v) bacto-tryptone, 0.5% (w/v) bacto-yeast 
extract, 1 % (w/v) NaCI
LB agar; as above with the addition of 1% (w/v) agar
SOB medium; 2% (w/v) bacto-tryptone, 0.5% (w/v) bacto-yeast extract, 0.05% 
NaCI, 2.5mM, 2.5mM KCL, 10mM MgCI2.
All media was autoclaved to sterilise for 20 minutes at 15lb/sq. in.
All bacteria were cultured in LB medium in a shaking incubator (G25 New 
Brunswick Scientific), or on Agar plates at 37°C overnight. Plasmid vectors 
containing antibiotic resistance genes were grown in media supplemented with 
the appropriate antibiotic:
Ampicillin or Carbenacillin (sigma) 50pg/jJ. Bacteria transformed with vectors 
containing the lacZ gene such as pBluescript II (Stratagene), were grown on LB 
agar plates in the presence of IPTG (isopropyl-p-D-thiogalactopyranoside) and 
X-GAL (5-bromo-4-chloro-3-idoyl-p-D-thiogalactopyranoside) as detailed in 
Sambrook et al. 1989. For short-term storage of bacterial cultures, stock plates 
were prepared by streaking the desired culture onto solid medium. These stocks 
were stored at 4°C. Long-term stocks were prepared by the addition of sterile
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glycerol (BDH) to overnight bacterial cultures to a final concentration of 20% 
(v/v). These stocks were kept indefinitely at -70°C.
2.1.2 Cloning vectors
The following cloning vectors and constructs were used for subsequent 
experiments.
Cloning Vector Size Vector Details Source
pBluescript II KS+ 2.96 kb Phagemid cloning vector 
Ampicillin resistance
Stratagene
pcDNA3 5.4 kb Cloning vector 
Ampicillin resistance
Invitrogen
pGFP 6 . 1  kb PcDNA3 containing 714bp 
cDNA encoding GFP 
Ampicillin resistance
Dr James Dutton 
University of Bath
NucGFP 6 . 1  kb PcDNA3 containing 714bp 
cDNA encoding GFP 
Ampicillin resistance





8 . 6  kb PGFP containing WT1 
coding cDNA, either with 
WT1+KTS, WT1-KTS or 
WT1DDS stop mutation 
R394
Dr James Dutton 
University of Bath
2.1.3 Preparation of electrocompetent DH10B bacteria
The bacteria were streaked out from a frozen glycerol stock onto an SOB-Mg
agar plate (15g agar per litre of SOB Section 2.1.1, and 5ml sterile 2M MgCh
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was added just before pouring) and grown up overnight in a 37°C incubator. A 
single colony was then grown up in 1ml of SOB-Mg media and then inoculated 
into a 500ml flask containing 50ml SOB. The culture was grown for 12 hours at 
37°C in an orbital shaker. 4ml of the culture was used to seed 400ml of SOB, 
incubated at 37°C with shaking until OD550 = 0.75. The cells were collected in 
chilled 250ml beakers and pelleted by centrifugation at 4500rpm at 4°C for 12 
minutes, the supernatant was decanted and cells kept on ice. In the cold room 
the pellets were resuspended in 2 0 0 ml of chilled sterile 1 0 % glycerol and then 
pelleted before another 200ml 10% glycerol was used to resuspend them. The 
cells were pelleted a final time and all the supernatant removed. The cells were 
resuspended and pooled and the OD measured and adjusted to a density of 250 
OD units per ml. Finally the cells were stored in 40jliI aliquots and snap frozen 
on dry ice/ethanol and stored at -80°C.
2.1.4.1 Transformation of DNA into DH10B cells by electroporation
40|al DH10B electrocompetent cells were thawed on ice 2\i\ of the DNA or 
ligation mix were added and the reaction held on ice for 45 seconds. The cells 
and DNA were placed in a chilled Pulser cuvette, 0.1cm electrode (BIO RAD). 
The cuvettes were placed in the eloectroporator (Gene Pulsor set to 1.25kV) and 
the voltage applied. 1 ml of SOB was then immediately added and the sample 
transferred to a 10ml tube (Falcon) and incubated at 37°C for 1 hour. 10pil and 
100fil of the transformations were then plated onto LB agar plates.
2.1.4.2 Transformation of DNA into DH5a chemically competent cells
40|il competent cells were thawed on ice, and 2jnl of the DNA or ligation were 
added. This reaction was incubated on ice for 30 minutes and then heat
shocked at 90°C for 42 seconds. The reaction was then incubated on ice for a 
further 10 minutes before the addition of 1ml pre-warmed LB. The 
transformations were shaken for 1 hour at 37°C in a shaker incubator before 
being plated out (1 OOpil of transformation) onto LB agar with appropriate antibody 
selection.
2.1.4.3 Transformation of DNA into XL-10 Ultra competent cells (Stratagene) 
These cells were used when increased transformation efficiency was required. 
The manufacturers protocol was followed as a guide. An aliquot of the cells was 
thawed on ice. Each aliquot contained about 140pl cells, enough for 2 
transformation reactions. 3pl 2-Mercaptoethanol (Stratagene) was added to 70jil 
of cells in a 15ml tube (Falcon). The tubes were incubated on ice for 10 minutes 
with regular swirling. 1.5pl DNA was added to the tubes and they were 
incubated on ice for a further 30 minutes. Following incubation, the tubes were 
heat shocked at 42°C for 30 seconds and placed on ice for 2 minutes. After the 
addition of pre-warmed LB, the tubes were placed in a shaker incubator for 1 
hour before plating 200jil onto LB Agar plates with appropriate antibiotic 
selection.
2.1.5 Plasmid miniprep protocol
2 ml aliquots of LB broth supplemented with 50pg/ml ampicillin were inoculated 
with the required bacterial clone and incubated overnight at 37°C in an orbital 
incubator with vigorous agitation. 1.5ml of the overnight culture was placed into 
an eppendorf tube and pelleted by centrifugation at 1 2 ,0 0 0 rpm for 2  minutes. 
The supernatant was removed and 400pl of resuspension buffer was added 
(50mM Tris.HCI pH 8.5, 5.0mM EDTA, 15% sucrose) and the cell pellet
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resuspended by vortexing. 50|il (12mg/ml in sucrose resuspension buffer) was 
added and the sample incubated at room temperature for 5 minutes. 300pil lysis 
buffer was added (70mM Tris.HCI pH 8.0, 70mM EDTA, 50mM EGTA, 0.2% 
Triton X-100, and solution titrated to pH8.0 with NaOH), the sample mixed and 
incubated at 70°C for 10 minutes, followed by centrifugation for 10 minutes at 
13,000rpm. The resulting lysed cell pellet was removed using a toothpick and 
1|il Diethyl pyrocarbonate (DEPC) was added. The sample was incubated at 
70°C for 10 minutes, incubated on ice for 10 minutes, centrifuged at 13,000rpm 
for 2 minutes and the supernatant poured into a fresh tube. 900jil 100% EtOH 
was used to precipitate the DNA at room temperature and centrifuged for 15 
minutes to pellet the DNA. The pellet was washed with 200|il 70% EtOH which 
was removed after centrifugation, the pellet was air dried and resuspended in 
55jal TE with 10pg/ml of RNase added.
2.1.6 Large Scale plasmid preparation
Large-scale preparations (Maxi preps) were carried out using the Concert prep 
kit (Gibco) according to the manufacturers protocol.
2.1.7 Restriction digests
All restriction digestions were carried out in the buffer conditions recommended 
by the manufacturer (Promega) as most suitable for a particular enzyme. All 
enzymes used were Promega enzymes. The reactions were carried out in 10- 
100(il final volume with 1-5 units of enzyme per fig of DNA. For genomic tail 
digests, 45jil DNA containing approximately 500|ig of DNA from a genomic 
preparation was used in a 50fil reaction with 0.5|il enzyme and 5|il buffer. These
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reactions were incubated at the temperature recommended by the 
manufacturers overnight. When digesting plasmid DNA from minipreps, 5pl of 
the preparation was used with 1 pl of enzyme and 1 pl 1 0 x buffer in a 1 0 pil 
reaction. These reactions were left for at least 1 hour at appropriate 
temperatures. The enzyme was often heat inactivated at 75°C for 10 minutes or 
reactions which were to undergo further digestion were extracted with 
phenol:chloroform:isoamyl alcohol (25:24:1), and ethanol precipitation then 
resuspended in water before subsequent use.
2.1.8 DNA modification
To fill-in DNA with 3’ overhangs DNA polymerase 1 large fragment (Klenow 
fragment) was used (1 unit) in the presence of dGTP, dATP, dTTP and dCTP 
(each to a final concentration of 1mM), the Promega core buffer was used with 
the enzyme, and the reaction was allowed to proceed at room temperature for 1 0  
minutes. To render blunt ends of DNA with 5’ overhangs, T7 polymerase was 
used in the presence of dNTPs and these were added to the heat inactivated 
restriction digest then incubated, for 1 0  minutes at room temperature.
2.1.9 Ligation o f DNA molecules
The correct fragment of DNA was excise and purified by Qiagen gel extraction 
and ligated as follows. To obtain the optimal ratio of vector to insert DNA two 
combinations, 1:1 and 1:3 molar ratio of vector to insert were tried. Up to 100ng 
of insert and vector DNA was used with 1 unit of T4 ligase (Promega) in 10 x 
ligation buffer (30mM Tris.HCI, pH 7.8, 10mM MgCI2, 10mM DDT, 1mM ATP) in 
a final volume of 1Opl. The ligation reactions were incubated overnight at room
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temperature. The ligations were transformed and analysed by electrophoresis 
and digestion.
2.1.10 Agarose gel electrophoresis
Agarose gel electrophoresis was used for both analysis and separation of 
plasmid DNA and restriction fragments (Sambrook et al. 1989). 1% (w/v)
agarose gels (1g agarose (USB) dissolved in 100ml 1x TAE) were used for most 
plasmid or genomic DNA analysis or separation and 2% gels were used for 
analysis of PCR products. Gels were made and electrophoresed in 1x TAE 
buffer (40mM Tris-acetate, 1mM EDTA). The agarose was dissolved by heating 
in a microwave and allowed to cool to around 55°C before the addition of 
ethidium bromide to a final concentration of 0.5pg/pl. The gel was then poured 
into gel trays (Bio Rad) and run at 60-100V for 1-6 hours. The DNA was 
visualised under long wavelength UV illumination on a transilluminator and 
photographs were taken using a Nikon imaging system. DNA size and quantity 
were estimated by comparison with standards of known size such as 1 kb or 
100bp DNA ladders from Promega.
2.1.11 Purification of DNA by Gel Extraction (Qiagen gel extraction protocol) 
The gel slice containing the DNA fragment of interest was cut out of the agarose 
gel and 3x volume solubilisation buffer (Qiagen UK gel extraction kit) was added. 
The sample was incubated at 60°C with regular vortexing until the agarose gel 
had completely dissolved. 1 x the volume of propanol was added and the sample 
was poured into a Qiagen spin column placed in a collecting column. The 
column was centrifuged for 1 minute at 13,000rpm and the solution in the column 
was discarded. 500pl solubilisation buffer was added to the spin column and
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centrifuged for 1 minute at 13,000rpm. The column was washed by addition of 
750pl of wash buffer which was allowed to stand for 1 minute before centrifuging 
for 1 minute at 13,000rpm. Finally the DNA was eluted by the addition of 30(J 
TE which was left for one minute before centrifuging for 1 minute at 13,000rpm.
2.1.12 Site directed mutagenesis
Following the Stratagene Quikchange protocol. Two WT1 20-nucleotide primers 
(forward and reverse) were designed across the WT1 region of interest flanking 
the potential nucleolar localisation signal to be mutated with an approximately 
equal number of bases on either side of the site to be mutated. The primers 
include the mutated nucleotides instead of the wild type base (primers produced 
by Invitrogen). Mutagenesis PCR was carried out on 200ng of the relevant 
plasmid using a Techne thermo cycler. Reactions were as follows: 200ng DNA, 
25jiM dNTP mix, 40pM reverse and forward primers, 5jJ 10x buffer, in a total 
volume 50pl. The reactions were placed in the thermo-cycler at 95°C for 5 
minutes and then allowed to cool to room temperature before being incubated on 
ice. 1 pl pfu turbo was added to each reaction and placed back in the thermo­
cycler on the mutagenesis programme: 55°C for 25min then 18 cycles of 95°C 1 
minute, 55°C 1 minute, 6 8 °C 20 minutes. When the programme was complete, 
1 0 p,l of each reaction was analysed by agarose electrophoresis, the remainder 
was digested with 1pl Dpn1 (NEB) for 1 hour. 1(il of this final reaction was 
transformed into electrocompetent cells then after DNA preparation, the mutants 
were sequenced with appropriate primers.
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2.1.13 Sequencing
All sequencing was carried out in the University of Bath Sequencing facility using 
the ABI prism sequencer. Sequencing reactions were set up containing 5pmol 
DNA, sequencing primers in a total of 6 |il.
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2.2 Transgenic animal experiments
2.2.1 Mouse breeding plan
WT1 knockout (WT1K0) strains were maintained. WT1K0 is a null mutation 
resulting from targeted mutation of exon 1 of Wt1 (Kreidberg et al., 1993). In 
addition, 3 strains of mice expression a WT1-KTS overexpression construct 
(P3:WT1-KTS) (Duarte, 1997) were also maintained (Wani, Wefi and Wines). 
The WT1KO mice were crossed with the P3:WT1-KTS and the resulting litters 
were genotyped. Mice heterozygous for the WT1KO allele, carrying the 
transgene (WT1+/';P3:WT1-KTS) were bred and crossed to WT1+/' mice. The 
females were checked daily for the presence of a vaginal plug and then 
sacrificed 11 days after the appearance of a plug. The embryos were presumed 
to be 11.5 days into gestation at this point. Adult mice from the age of 4 months 
were also monitored and sacrificed for histological analysis.
2.2.2 Genomic DNA preparation
Approximately 0.5cm tail tip biopsies were taken from anaesthetised mice and 
525pl tail buffer (50mM Tris. HCI pH 8.0, 100mM EDTA, 100mM NaCI, 1% SDS), 
and 35pl (10mg/ml) proteinase K (Boeringher Manheim) was added. This was 
digested overnight at 55°C and then treated with 0.7pg/ml Rnase A for 1 hour at 
37°C. NaCI was added to 1.25M, and then an equal volume of 
chloroform/isoamyl alcohol 24:1 (vol/vol) was added and gently mixed for 2 hours 
at room temperature. The solution was centrifuged at 15000 rpm for 10 minute, 
and the upper, aqueous layer removed to a fresh microfuge tube. An equal 
volume of isopropanol was added and mixed gently to precipitate the DNA. This 
was then centriguged at 15000rpm for 1 0  minute, and the supernatant aspirated 
off. The pellet was washed for 1 hour at 4°C with 300pl ice-cold 70% ethanol,
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centrifuged and the ethanol aspirated off. The genomic DNA pellet was then 
dissolved in 200pl TE (10mM Tris.HCL pH 8.0, 1mM EDTA) by mixing on a roller 
overnight.
2.2.3 Southern blotting
50jliI of the genomic DNA was digested with 1pl Bgl II (Promega) and 5pl Buffer 
D (promega) overnight at 37°C. The samples were then run for 5 hours on a 1% 
agarose gel. The gel was denatured by submerging in denaturation solution 
(0.5M NaoH, 1.5M NaCI) with constant gentle agitation for 15 minutes at room 
temperature. The denaturation solution was then poured off and this was 
repeated for another 15 minutes. The gel was then submerged in neutralisation 
solution (0.5M Tris-HCI, pH 7.5, 3M NaCI) at room temperature for 15 minutes, 
and this was also repeated using fresh neutralisation solution for another 15 
minutes. The gel was then placed on to a Whatman 3MM paper wick in a tray of 
20x SSC. A piece of nylon membrane (Hybond-N+, Amersham) was placed in 
contact with the gel. On top of this, were placed 3 pieces of Whatman 3MM 
paper and a stack of paper towels. The whole apparatus was weighted down 
with a glass plate and sealed with saran wrap and capillary transfer of the DNA 
from the gel to the nylon membrane was allowed to proceed overnight. After 
transfer, immobilisation of the DNA was achieved by cross-linking in a UV 
crosslinker (UVP CL-1000) at 120,000nJ/cm2.
2.2.4 Probe preparation
Two probes were used for genotyping mice, one recognising the IGF2 gene P3 
promoter region and the other recognising exon 1 of the WT1 gene (Kreidberg 
et. al., 1993).
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The P3 probe was isolated from the P3mm construct (Caricasole et al., 1996) by 
digesting 10pl of DNA with 3pl EcoR1 and 3pl EcoR1 buffer (promega) in a 30pl 
reaction at 37°C for 2 hours. The sample was run on a 1% Agarose gel with 3pl 
loading dye (Promega). The 1kb insert fragment was excised and purified 
(Qiagen gel extraction, Section 2.1.4).
The WT 1 knockout probe was sent as DNA on paper. The probe was prepared 
by soaking in TE buffer at room temperature for 30 minutes and then 
transformed into electrocompetent DH5a cells (Section 2.2.1). The DNA was 
extracted from bacterial culture (Section 2.2.2) and digested for 2 hours at 37°C 
with 3pl EcoR1 and 3pl Buffer D (promega). The DNA was run on a 1% Agarose 
gel and a 500bp fragment was excised and gel extracted.
2.2.5 Radiolabelling DNA probes
Random-primed DNA labelling was carried out using 4pl High Prime labelling 
(Boeringer Manheim), 4pl 32P dCTP (Amersham) and 25ng of denatured (heated 
to 95°C for 5 minutes) probe DNA in a final reaction volume of 20pl. The 
reaction was incubated at 37°C for 1 hour after which the unincorporated label 
was separated by chromatography through a sephadex G-50 resin (Pharmacia) 
spin column. The probe was denatured by boiling for 5 minutes before use in 
Southern blot hybridisation (Section 2.2.6).
2.2.6 Southern blot hybridisation
Prehybridisation, hybridisation and washing were carried out in rotating 
hybridisation bottles in 30ml of solution, in a hybridisation oven (Techne) set at 
65°C. The filter was prehybridised for 2 hours in 5x SSC (750mN NaCI, 75mM 
sodium citrate, pH 7.0), 5X Denhardt’s reagent (50x Denhardt’s contains 5g
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Ficoll (type 400, Pharmacia), 5g polyvinylpyrrolidone, 5g BSA (fraction V; Sigma) 
and distilled water to a final volume of 500ml], 1 mg/ml sonicated and denatured 
salmon testis (Sigma). Following prehybridisation the denatured probe was 
added and hybridisation was allowed to continue overnight. After hybridisation 
the filter was then washed twice in 2x SSC, 0.1% SDS for 15 minutes each, 
followed by two washes in 1x SSC, 0.1% SDS for 15 minutes each. The filter 
was then briefly air dried, wrapped in Saran wrap and autoradiographed with 
Kodak X-OMAT AR film at -70°C in an autoradiography cassette with 
intensifying screens (Kodak). Exposure varied from overnight to one week 
before the film was developed (X-OGRAPH Compact developer).
2.2.7 Embryo genotyping by PCR
The embryo yolk sac was used as the source of DNA for genotyping. Part of the 
yolk sac was placed in a 1.5ml microfuge tube, 200jJ TE buffer was used and 
the sample was boiled. A dilution of 1 in 100 was made of this DNA solution and 
1pl of this was used for each PCR reaction.
1pl genomic DNA solution was added to 24.9pl PCR reaction master mix to give 
final PCR reaction conditions (optimised for Mg2+ concentration) of: 75mM 
Tris.HCI pH 9.0, 20mM (NH^SO ^ 0.01% Tween-20, 3mM MgCh, 250pm dATP 
(promega), 250pM dCTP, 250pM dGTP, 250pM dTTP, 0.5units Taq polymerase 
(promega) and 0.2pM of the following primer pairs (but note that the 3 primers 
used for the knockout status and the three used for transgene status were used 
in two reactions).
ForWTI knockout status:
WT1+WT1ex1 detected the presence of an endogenous WT1 band 
WT1+WT1ko detected the presence of the null allele
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WT1 5’ CAGCTCCCGTACGGCAGGATCG 3’
WT1ko 5’ GCATCGCCCGGCAGGACGTCC 3’
WT1ex1 5’ CATCGGCAGGGCCATAGCCGG 3’
For Transgene status:
WT12.5 and P3 detected the presence of endogenous P3 
WT12.5 and WT1Tg detected the presence of the transgene 
P3 5’ CTGTGAGAACCTTCCAGCCTTTTC 3’
WT1.2 5’ GCCCAGCGACCCGTAAGC 3’
WT1Tg 5’ GAGCCATCCGGACCGGAGTCC 3’
PCR reactions were carried out in a Techne heated lid PCR machine. This was 
programmed to denature the samples for 5 minutes at 94°C, then cycle at 94°C 
for 1 minute, 60°C for 1 minute, 74°C for 1 minute for 40 cycles, followed by a 
10-minute extension at 74°C. Loading dye was added to the samples and they 
were run on 1 .8 % agarose gels, stained with ethidium bromide, and then 
examined and photographed under UV.
2.2.8 Histology
Embryos were fixed in Zamboni’s fixative overnight at 4°C, prepared by mixing 
200ml 0.2M sodium phosphate buffer pH 7.3 with 200ml 2% paraformaldehyde 
and 70ml saturated picric acid. The fixed embryos were then dehydrated 
through 70%, 80%, 90%, 95%, 95% 100% and 100% EtOH (30minutes-1hour 
each depending on the embryo size), cleared in Histoclear (National Diagnostics) 
and embedded in paraffin wax. Tissue sections were cut at 5^M, floated on a 
water-bath and dried onto slides that had previously been subbed with TESPA 
(3-aminopropyltriethoxysilane) (Sigma).
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2.2.9 Haematoxylin and Eosin (H&E) staining
Ehrlich’s haematoxylin was purchased pre-prepared (Raymond Lamb). Slides 
were dewaxed in Histoclear 2 x 3  minutes, then rehydrated through 100%, 
100%, 95%, 90%, 70% and 50% ethanol (2 minutes in each), followed by 1 
minute in deionised water and 10 minutes in Ehrlich’s haematoxylin. Slides were 
washed in running cold tap water for 1 minute until the stain turned blue, rinsed 
in deionised water, then dipped in acid alcohol (1% (w/v) HCI in ethanol) for 15 
seconds followed by 30 seconds in 1% NH3 in 70% ethanol. Slides were then 
left in 70% ethanol for 1 minute and stained for 1 minute in Eosin Yellow (BDH) 
(0.1% in 70% ethanol). Slides were then dehydrated though an ethanol series: 1 
minute each in 70%, 90%, 95%, 100%, 100% ethanol, 2 x 2  minutes in 
Histoclear and mounted under coverslips in DPX (a mixture of distyrene, tricresyl 
phosphate and xylene) mountant (BDH).
2.2.10 Periodic acid-Schiff reaction (PAS) staining
Slides were dewaxed in Histoclear 2x 3 minutes and rehydrated through 2 x 
100%, 95%, 90%, 70% and 50% ethanol (2 minutes each), followed by 1 minute 
in deionised H20. They were then incubated for 6  minutes in 1% (w/v) periodic 
acid (BDH) in distilled H20, followed by 3 minutes wash in running tap water and 
1 minute in distilled H20. The samples were then incubated for 15 minutes in 
Shiffs reagent (Sigma) that had been allowed to warm to room temperature. 
Slides were finally washed for 5 minutes in running H20  before counterstaining in 
Haematoxylin, dehydration and mounting as described in H&E staining with the 
one modification of reducing the incubation in haematoxylin to 1 minute.
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2.2.11 Immunohistochemistry
Antibody staining was carried out on embryo, and adult organ sections whose 
preparation was described earlier (Section 2.2.8). Slides were dewaxed in 
Histoclear 2 x 5  minutes and they rehydrated through 100%, 100%, 95%, 70% 
and 50% EtOH (1 minute in each), and placed in PBS. Slides were incubated in 
10mM citric acid in a microwave oven for 3 x 5 minutes, then in 0.3% hydrogen 
peroxide for 30 minutes at room temperature followed by rinsing in PBS for 5 
minutes. Each area to be stained was drawn around with an image pen and 
covered with DAB block (1% BSA (Sigma), 1% Tween 20(Sigma) in PBS). 
Slides were incubated for 1 hour at room temperature in a humidity chamber. 
The DAB block was flicked off and fresh DAB block was applied to half the slides 
whilst dilutions ranging from 1/100 to 1/2000 (Table 2.1) of the primary antibody 
were applied to the other half. The slides were incubated at 4°C overnight in a 
humidity chamber. After overnight incubation, the slides were washed in PBST 
(51 PBS + 50ml Tween 20 sigma) 3 x 5minutes at room temperature. All slides 
were then incubated at room temperature for one hour with the secondary 
antibody (1/200 in DAB block). After washing slides in PBST 3 x 5  minutes, the 
sections were covered with Vector Elite ABC reagent (Vector R.T.U Vectastain 
kit) and incubated at room temperature for 45 minutes. Slides were then 
washed in PBST 3 x 5  minutes before developing the stain with 14pl DAB and 
7pl hydrogen peroxide (Vector vectastain kit) in 1 ml PBS. When the stain had 
developed (about 5 minutes) the slides were dehydrated through ethanol 70% 
and 95% for 15minutes, 100% x 2 for 1 min, then into histoclear mount 2 x 
2minutes and finally mounted with DPX.
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The following antibodies were used for immunohistochemistry of mouse 
histological sections.
Table 2.1 Antibodies used in immunohistochemistry
Antibody Source Dilution Secondary Antibody
ocWT1 C19 Santa Cruz Antibodies 1 / 1 0 0 0 aRabbit biotinylated
ctBASPI Dr Stefan Roberts 
University of Manchester
1/500 aRabbit bioinylated
aPCNA3 Santa Cruz Antibodies 1/500 aUniversal biotinylated
2.2.12 In-situ hybridisation
2.2.12.1 Probe preparation
A concert preparation of pBS-BASP1 DNA (2fag/jil) was used for the probes. For 
the creation of a sense and antisense probe 20jag of DNA was digested either 
with 2|J Not1 (for the sense probe) or 2\i\ ECOR1 (for the antisense probe) with 
the equivalent buffers in a total volume of 50|il. Electrophoresis on an agarose 
gel showed linearisation of the plasmids and the digestions were purified by PCR 
purification. In vitro transcription reactions were carried out on 1 pig linearised 
plasmid DNA o/n by adding transcription buffer 5x, 2^\ NTP labelling mix, 2 |J 
DTT, Rnase inhibitor and T3 RNA polymerase for the sense probe and T7 RNA 
polymerase for the antisense stage. The reactions were incubated overnight at 
37°C.
2.2.12.2 In-situ hybridisation
All the following solutions were made with DEPC treated water. Slides were 
dewaxed in Histoclear dewax for 2 x 10 minutes before rehydration in ethanol
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100% 2 x 5  minutes, 95%, 90%, 80%, 70%, 50%, 30% each for 1 minute, then 5 
minutes in PBS, 30 minutes in 4% PFA (in PBS) and finally 2x 5 minutes PBS. A 
proteolysis reaction was carried out on the slides by incubating them in 
Proteinase K for 2 minutes followed by a wash with PBS and then refixing in 4% 
PFA. The slides were washed with PBS 2 x 5  minutes then prehybridised with 2 
x SSC for 2x 5 minutes then in Tris-glycine buffer for 30minutes. 1 jul of the probe 
was added to 20ml hybridisation solution (40% formamide, 100x Denhardts, 20x 
SSC, tRNA, denatured herring sperm (Boehringer Manheim) 100pg/pl) and 
heated at 95°C for 5minutes. 6 |il hybridisation buffer was added to each slide 
and placed in a humidity chamber and incubated for 24-48 hours at 65°C. 
Following hybridisation, the slides were washed in varying concentrations of SSC 
and post-hybridisation buffer (20% formamide, 0.5x SSC). Washes of 5x SSC 3 
x 15 minutes room temperature, post-hybridisation buffer at 60°C for 40minutes, 
2xSSC 15 minutes room temperature were carried out followed by Rnase 
solution 37° 15 minutes. Final washes of 2x SSC room temperature washes for 
15 minutes, post-hybridation buffer at 60°C 20minutes and 2x SSC 2 x 15 
minutes room temperature were carried out. The aBASP 1 antibody was added 
(200pl per slide, 1/2000 dilution in blocking solution Roche), slides were covered 
with parafilm and incubated in a humidity chamber o/n at 4°C. After the addition 
of the primary antibody, slides were washed in PBS 3 x 1 0  minutes, 3 x 30 
minutes and 2 x 1  hour. The stain was developed with incubation in NTMT 
staining buffer for 3 x 10 minutes (20ml 5M NaCI, 50ml 1 M MgCfe, 100ml 1M 
TrisHCL pH 9.5, 5ml 20% Triton), 0.5 ml staining solution was added to each 
slide (1 NBT/BCIP tablet in 10ml MQ H20) in the dark until a signal was seen 
and the reaction stopped by incubation in 1mM EDTA/PBS. Slides were 
counterstained in Fast Red (Vector), dehydrated through an ascending ethanol 
series and mounted in DPX.
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2.2.13 Detection of Apoptosis in mouse tissue sections
The Apoptag Flourescein kit (Intergen Company) was used to detect apoptotic 
cells in paraffin tissue sections as per the manufacturers instructions and 
sections were analysed using fluorescent microscopy techniques (Section 2.3.4)
2.2.14 Coiiection and analysis o f mouse urine
Urine samples were collected from mice directly into 1.5 ml microfuge tubes and 
proteinuria was determined by placing approximately 5jil of urine onto urine test 
strips (urinestix SG). Albuminuria was determined by running 5pil of the urine 
sample (with 5fil sample buffer and boiled for 10 min) on a Bio-Rad criterion 
ready gel for 1 hour at 200 V and subsequently stained for 30 minutes with 
Commassie Brilliant Blue before destaining in 40% MeOH, 10% HOAC for an 
hour.
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2.3 Tissue culture and associated protocols
2.3.1 Standard tissue culture
Tissue culture was carried out following standard techniques (Paraskeva 1984). 
Cultures were grown in Tc 75cm2 coated flasks (Gibco BRL) in a humidified 
incubator at 37°C with 5% C02 (v/v). The medium used was Dulbecco’s 
modified eagle medium (DMEM) with sodium pyruvate, and glutamax-1 (Gibco), 
supplemented with 10% foetal bovine serum, 5% penicillin, and amphotericin 
(Gibco). Cells were frozen in freezing medium (10% DMSO in fetal bovine 
sereum (FBS)) into 1ml vials and stored in liquid nitrogen.
2.3.2 Cell Lines
The following cell lines were used in experiments all using standard tissue 
culture techniques.
Table 2.2 Cell lines used in cell culture experiments
Cell Line Derived From Source
Cos7 Monkey kidney ECACC
HeLa Human breast cancer Dr Judith Sleeman 
University of Dundee
MCF7 Human breast cancer Dr Judith Sleeman 
University of Dundee
M15 Mouse kidney ECACC
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2.3.2 Transient transfections
For transient transfections, cells were plated at approx. 150,000 cells per 35mm 
diameter Tc dish (Gibco) and transfected the following day with FuGene 6  
Transfection Reagent (Roche) and 2pg DNA according to the manufacturers 
protocol. HeLa cells were transfected with Effectene (Qiagen) per the 
manufacturers instructions. Transfections were analysed the following day (after 
approx. 18 hours) under GFP fluorescence (FITC fluorescence) and DIC using a 
60x objective on a fluorescence microscope (Nikon Eclipse E800 or E1000).
2.3.3 Protein Biochemistry
2.3.3.1 Sample preparation
Trypsinised cells were resuspended in PBS at a concentration of 1 x 106 cells/ml. 
1 x 106 cells were pelleted in a 1.5ml microfuge tube by centrifugation at 
13,000rpm for 3 minutes and the supernatant removed. The cell pellet was 
resuspended in 10Opil of gel sample buffer (62.5 mM Tris-HCL, pH6.75, 10%(v/v) 
glycerol (AnalaR BDH), 5%(v/v) 2-mercaptoethanol (Sigma), 4%(w/v) SDS 
(AnalaR BDH), 0.01%(w/v) bromophenol blue). The cell lysate was boiled for 5 
minutes and stored at -20°C until required.
2.3.3.2 Preparation of polyacrylamide gels
Gels were poured on Mini PROTEIN II slab cells (Bio-Rad) with 1.5mm spacers 
and a 7mm well former. A Resolving gel was poured (10% gel 9.67ml 30%(w/v) 
acrylamide/0.8%(w/v) bis-acrylamide (37.5:1) (National Diagnostics), 7.25ml 
1.5M Tris-HCI, pH 8 .8 , 0.4% SDS, 12.08ml distilled water, 145pl 50%(w/v) 
ammonium persulphate (Sigma), and 4.7pl Tetramethylethylenediamine 
(TEMED) (Bio-Rad). The stacking gel was also made (4.5% gel 9.67ml 
30%(w/v) acrylamide/0.8%(w/v) bis-acrylamide (37.5:1) (National Diagnostics),
69
2.6ml 0.5M Tris-HCI, pH 6 .8 , 0.4% SDS, 5.9ml distilled water, 75jul 50%(w/v) 
ammonium persulphate (Sigma), and 2.4pl TEMED (Bio Rad). Cell lysates were 
loaded onto gels as well as 10pl rainbow markers (14.3-200kDa Amersham). 
The gels were electrophoresed in running buffer (192mM glycine (Sigma), 25mM 
Tris (Sigma), 0.1%(w/v) SDS (AnalaR BDH)) at 200V until the bromophenol blue 
reached the bottom of the gel.
2.3.3.3 Western Blotting
Gels were soaked in transfer buffer (192mM glycine, 25mM Tris) for 15 minutes. 
A piece of Immobion-P polyvinylidine difluoride (PVDF) membrane was cut to the 
same size as the gel and washed in methanol for 5 minutes. The membrane 
was rinsed with distilled water and soaked in transfer buffer. Proteins were 
electroblotted onto the membrane in transfer buffer using the Mini Transblot Cell 
(Bio-Rad) at a constant current of 250mA for 2-4 hours. After the transfer, the 
membrane was washed in milk blocking buffer (10mM Tris-HCI, pH 7.4, 150mM 
NaCI (AnalaR BDH), 4% 9(w/v) Tween 20 (Sigma)) for 1 hour at room 
temperature. It was then incubated with primary antibody (aWT1 C-19 1:400) 
diluted in 10ml milk block buffer overnight, at 4°C, in a dark plastic box, on a 
rocking platform. After overnight incubation, the membrane was washed in milk 
blocking buffer 2 x 10minutes, Tween buffer (10mM Tris-HCI, pH7.4, 150mM 
NaCI, 0.2% Tween 20 (Sigma)) 2 x 10minutes, milk block 1 x 10minutes. After 
the washes, secondary antibody was applied (a goat biotinylated) in 1 0 ml milk 
block at 4°C for 1 hour. The membrane was washed following incubation in 
secondary antibody in milk block 1 x 30minutes, Tween buffer 1 x 10minutes and 
rinsed in distilled water. Detection of protein bands was carried out by 
chemiluminescence using the CSPD ready to use system (Roche). 5 drops of 
the reagent were placed onto the membrane, which was then sealed into plastic
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bags and placed in an autoradiograph cassette for 5 minutes before developing 
the autoradiograph (Kodak x-omat).
2.3.3.4 Protein assay
Soluble protein in cell lysates were measured spectophotometrically by using the 
Biorad protein assay system as prescribed by the manufacturers. This system 
exploits a dye-binding assay based on the Bradford protocol. 10pil aliquots of cell 
lysates were diluted with water to a final volume of 800jil, mixed with 2 0 0 pil of 
protein assay reagent and allowed to stand for 10-20 minutes. 10Opil aliquots 
were then dispensed into a flat-bottomed microtiter plates (Nunc). Protein- 
dependent colour development was measured spectrophotometrically at 620nm 
employing a Titertek Multiskan MCC/340 machine. By comparison with a series 
of protein standards of known concentration (bovine serum albumin), soluble 
protein content was estimated by extrapolation from a standard curve and 
expressed as mg soluble protein/ml of lysate using the Biosoft software 
programme.
2.3.4 Immunofluorescence
Cells transfected with WT1 GFP constructs were stained with a variety of 
antibodies (see below). The cells were grown in 35mm dishes and transiently 
transfected as described above. After approximately 18 hours, 2jxl 4% 
parafomaldehyde was added and swirled around as an intial fixing step. The 
media was then pipetted off the dishes and 2ml 4% PFA added for 10 min at 
room temperature. The cells were washed with PBS and blocked for 30 minutes 
with DAB block. The appropriate dilution of the primary antibody in DAB block 
was added to the cells and the dishes left at 4° overnight. After the overnight 
incubation, the cells were washed 3x 10 min in PBST before addition of the
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secondary antibody (Table belbelow). After a further 1 hour incubation at room 
temperature the cells were washed 3x 10 min before addition of streptavidin 
texas red 1/400 for 30 min. The cells were viewed under fluorescence on the 
fluorescence microscope (Nikon Eclipse E800 or E1000).
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C h a p t e r  3
INVESTIGATION OF THE ROLE OF WT1 ISOFORMS IN MURINE 
DEVELOPMENT
3.1 Summary
The role of WT1 in genito-urinary disease was discussed in Chapter 1. This 
chapter describes a series of experiments designed to further investigate the 
importance of the WT1+KTS and WT1-KTS isoforms in murine development. 
Breeding WT1-KTS transgenic mice (P3:WT1-KTS) with mice hetereozygous for 
the Wt1 null allele (WT1+/'), allowed the generation of mice heterozygous for the 
WT1 null allele and also carrying a WT1-KTS transgene (WT1+/‘; P3:WT1-KTS). 
Offspring resulting from such crosses allowed us to investigate the affects of 
expressing the WT1-KTS isoform in mice with different levels of endogenous 
WT1 and hence altering the ratios of WT1 isoforms. WT1 knockout embryos fail 
to survive and have severe genito-urinary abnormalities (Kreidberg et al., 1993). 
Analysis of embryos homozygous for the WT1 null mutation alongside WT1'7'; 
P3:WT1-KTS embryos at similar time points showed the presence of the 
P3:WT1-KTS transgene is not sufficient to rescue the WT1 null phenotype in 
WTT7'; P3:WT1-KTS embryos. Analysis of adult mice revealed that WT1+/'; 
P3:WT1-KTS animals over 6 months of age develop renal and genital 
abnormalities with 14/49 mice from two different P3:WT1-KTS transgenic lines 
presenting with a range of genito-urinary defects and other abnormalities in 
comparison with their age matched WT1+/' and Wild type littermates.
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3.2 Introduction
3.2.1 WT 1 null and transgenic mice
Transgenic mice were generated previously in our lab carrying a WT1-KTS 
expression construct consisting of cDNA sequences encoding WT1-KTS under 
the control of the Igf2 P3 promoter and H19 enhancer sequences (the P3:WT1- 
KTS transgene) (Duarte 1997). The P3 promoter and H19 enhancer of Igf2 have 
been shown to be expressed strongly in the liver, kidney and gut (Brenton, 1999) 
and were intended to allow temporal and spatial expression of the transgene 
coincident with at least some aspects of endogenous WT1 expression. This 
experimental strategy was preferred to the use of regulatory elements for the 
WT1 gene since these remain ill-defined. Moore et a l 1999 reported that the 
presence of a 280kb YAC spanning the Wt1 gene and regulatory elements was 
able to rescue the midgestational lethality and cardiac defects of null mice. 
However this YAC failed to rescue the genito-urinary abnormalities, suggesting
i
that further, essential WT1 regulatory regions lie outside of this 280kb region 
(Moore et al., 1999). Even more recently the production of transgenic mice 
carrying a 470kb YAC spanning the Wt1 locus also failed to completely rescue 
the null phenotype (Guo et al., 2002). Given the disruption of the normal isoform 
ratio in the pathogenesis of Frasier syndrome, it was thought that the phenotypes 
of our P3:WT1-KTS transgenic mice might show similarities to this human 
disorder. Previous analysis of RNA in three transgenic lines named Wani, Wefi 
and Wines detected the presence of P3:WT1-KTS transgene-derived RNA by 
RT-PCR, although no obvious developmental abnormalities or embryonic 
lethality was observed in transgenic animals (Duarte 1997).
The second set of animals used in these experiments, were the WT1 null 
animals (Kreidberg et al., 1993) previously described in Chapter 1. A null allele
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of Wt1 results from a targeted mutation and animals homozygous for the null 
allele (WT1 knockout mice) die before birth. Heterozygotes have been 
previously seen to be phenotypically normal and viable but recent research has 
suggested that these animals do develop renal abnormalities such as proteinuria 
and glomerular sclerosis late in adult life (Wagner et al., 2003).
As previous analysis of the P3:WT1-KTS lines has shown no major renal or 
genital abnormalities and the WT1+/‘ animals showed a lesser degree of renal 
abnormality, a combination of the two was to be tested for evidence of enhanced 
phenotypic defects. Other transgenic experiments disrupting WT1-KTS or 
WT1+KTS isoform ratios have been described in Chapter 1, in which the 
resulting mice developed features similar to those of FS or DDS (Hammes et al., 
2001; Patek et al., 1999). Hammes et al. 2001 described mouse strains in which 
specific isoforms were removed. Heterozygous mice with reduced levels of 
WT1+KTS develop glomerusclerosis and represent a model for FS. 
Homozygous animals die after birth from kidney defects (Hammes et al., 2001). 
This data suggests that there is a fine balance in the ratio of the two isoforms. It 
is known that there is a certain degree of redundancy between WT1+KTS and 
WT1-KTS but the exact function of the isoform ratio balance is as yet unknown. 
It is therefore possible that the expression of additional WT1-KTS on a wild type 
WT1 background as in our P3:WT1-KTS animals may not be sufficient to 
significantly alter the ratio of WT1-KTS:WT1+KTS. However, in animals 
heterozygous for the null allele and also carrying the P3:WT1-KTS construct 
(WT1+/‘; P3:WT1-KTS animals) the splice isoform ratio would be further 
perturbed and could provide further insight into the importance of the ratio 
balance between the two isoforms. It may be that decreasing the overall amount 
of WT 1 whilst increasing the amount of a single isoform may be required for the 
pathogenesis of disease. It has been seen that the critical ratios are essential for
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normal human development, with the shift of ratios towards the WT1-KTS form 
as a result of mutations affecting exon 9 splice donor choice, being proposed as 
the cause of Frasier syndrome (Barbaux et al., 1997). In support of this, removal 
of specific WT1 isoforms in mice resulted in the development of renal and genital 
abnormalities, that mimic FS and DDS (Hammes et al., 2001). The experimental 
strategy of Hammes et al 2001 was to lower the level of WT1+KTS or WT1-KTS 
by knocking out the respective alleles in order to alter the ratio balance of 
WT1+KTS and WT1-KTS (interestingly, levels of WT1-KTS went up in proportion 
to WT1+KTS reduction). Our WT1+/"; P3:WT1-KTS mice has additional WT1- 
KTS (resulting from the P3:WT1-KTS transgene expression) whilst the levels of 
both endogenous WT1-KTS and WT1+KTS are reduced (heterozygous WT1 
knockout phenotyope), hence potentially tipping the balance towards WT-KTS 
even more than in previous studies. Our experiments might therefore help further 
define the critical WT 1 splice isoform ratios.
The experiments set out in this chapter result from mating animals from three of 
the P3:WT1-KTS transgenic lines Wani, Wefi and Wines, with animals 
heterozygous for the null allele (WT1+/‘). Resulting animals heterozygous for 
Wt1, and also carrying the transgene (WT1+/_; P3:WT1-KTS) were studied as 
adults. WT1+/'; P3:WT1-KTS mice were also intercrossed, or mated with WT1+/' 
animals, and offspring were analysed at embryonic day 11.5 (E11.5). Embryos 
and adults were genotyped by a combination of PCR and Southern analysis. 
Analysis of embryos and adult organs were analysed through histological, gross 
morphological and patho-physiological means.
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3.2.2 Characterisation o f the morphological abnormalities seen in in WT1+/ 
;P3:WT1-KTS mice
3.2.2.1 OB mutant mice
A third set of animals was used as a comparison model for genital development. 
The OB transgenic mice were identified from a screen of transgene insertional 
mutants in our laboratory (Paisley, 2000). Breeding from male homozygous 
transgenic mice from this line proved impossible suggesting these mice were 
infertile. Analysis of Ob testes has shown that the testes are reduced in mass in 
comparison to fertile hemizygous or wild type littermates. Examination of the 
contents of the vas deferens of Ob mutants identified the presence of little or no 
mature sperm in comparison with control (wild type or Ob heterozygous 
littermates) animals. Testes of Ob animals also exhibited a significant difference 
in the relative abundance of various spermatogenic cell-types although it was not 
obvious that any one cell type was completely absent. This indicated that sterility 
was due to defects in spermatogenesis. These mice provided us with a mutant 
line with genital defects that differed in comparison with abnormalities in the 
testes of WT1+/'; P3:WT1-KTS mice, highlighting that different mechanisms of 
spermatogenesis may be going awry in the two models. The gross morphology 
of the OB mice was investigated using immuno-histological methods.
3.2.2.2 Expression of WT1 and the putative co-suppressor protein Baspl
A further method of investigating processes resulting in the abnormal 
development of the genito-urinary system in the WT1+/'; P3:WT1-KTS mice was 
to examine the expression pattern of WT1 in all the mutant lines described 
above. WT1 is highly expressed in the developing kidneys and testis but in adult 
animals expression is restricted to the podocytes of the kidneys and sertoli cells 
of the testis (Pritchard-Jones et al., 1990). This adult expression of WT 1 in both 
kidneys and testes suggests that WT1 is functioning both at developmental
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stages and in the adult although the role the protein maybe playing later in life 
remains unclear. Detecting expression of WT1 in WT1+/'; P3:WT1-KTS, WT1+/' 
and OB animals allowed us ask whether the protein was still being produced and 
to detect any aberrant or ectopic expression. An antibody recognizing the Basp- 
1 protein was also used as a marker to address similar questions. Basp-1 was 
described in Chapter 1 as a possible co-suppressor of WT1 (Carpenter et al., 
2002). It should therefore be expressed in similar locations to WT1 for co- 
suppressing activity to take place in vivo. The anti-Basp-1 antibody was
therefore used to investigate abnormalities of the WT1 pathway in our mutants.
3.2.2.3 Cell cycle
The role of WT1 in cell cycle control is not clearly understood. WT1 has a role in 
growth regulation in the kidney as its loss was associated with widespread 
apoptosis of nephric mesenchyme (Kreidberg et al., 1993). WT1 mutations can 
lead to Wilms’ tumour, characterised by the uncontrolled proliferation of 
blastemal, epithelial and stromal cells (Lee and Haber, 2001). There is an 
increased frequency of gonadoblastomas in children with WAGR syndrome and 
a small proportion of girls with DDS also develop granulosa cell tumours of the 
ovary, however WT1 mutations have not been seen in sporadic granulosa cell 
tumours or Sertoli cell tumours of the testis (Hastie, 1993). WT1 seems to act on 
the cell cycle either by repressing the expression of genes required to maintain 
cells in cycle or by activating genes required to take the cells out of cycle and 
into a state of terminal differentiation. The list of genes, whose promoters are 
activated or repressed (thereby modulating their activity) by ectopic expression of 
WT1 in transient transfection assays include platelet derived growth factor-A 
(PDGF-A) (Gashler, 1992), IGF2 (Caricasole et al., 1996; Drummond et al., 
1992; Hastie, 1993), Pax2 (Ryan et al., 1995; Yang et al., 1999) colony 
stimulating factor 1 (CSF1) (Jin et al., 1999), Bcl2 (Bard; 2001), and amphiregulin
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(Lee, 1999) amongst others. The repression of a number of these genes, some 
of which encode embryonic growth factors, provides an attractive hypothesis to 
explain the tumour suppressor activity of WT1. The role of WT1 in Wilms’ 
tumour and other neoplasias highlights the essential role of the protein in the cell 
cycle.
To investigate changes in the cell cycle of our mutant mice, apoptosis and 
proliferation patterns in adult kidneys and testes were analysed using 
immunohistochemical means. It was expected that the WT1+/'; P3:WT1-KTS 
mutants with altered WT1 ratios might have altered proliferation and apoptosis, 
because of the existing evidence that WT1 functions in the cell cycle. In the OB 
mutant, in which the basis of the observed spermatogenesis defect was entirely 
unknown, it was thought that the analysis of apoptosis and proliferation might 
help to characterize the mutant phenotype.
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3.3 Results
3.3.7 Breeding and genotyping o f Wt1 nuli and P3:WT1-KTS transgenic 
animals
Mice were genotyped after weaning by either Southern blot analysis or PCR. 
Southern Blots were hybridized with the WT1KO probe (Kreidberg et al., 1993) 
or the Igf2 P3 probe (Chapter 2 Section 1) (Duarte 1997) (Figure 5).
3.3.2 Analysis o f embryos
Animals identified as WT1+/'; P3:WT1-KTS were either intercrossed or mated 
with those identified as Wt1+A and animals from three transgenic lines were 
studied between embryonic day E11 and E13.5. Lethality of Wt1v' animals was 
seen around E13.5 and for this reason embryos were routinely collected at 
E11.5. A total of 24 litters of embryos were analysed at this developmental stage 
(Table 1).
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Figure 5. Examples of PCR and Southern blot analysis used to 
genotype mice.
Genotyping of Wt1 and the P3:WT1-KTS transgene were carried out 
through Southern analysis or PCR. Panels A and B show genotyping by 
Southern analysis. (A) WT1 status of 6 mice. Mice 1, 2, 3 and 6 were 
heterozygous for the Wt1 knockout allele (Wt1+/-) and mice 4 and 5 were 
wild type animals (Wt1+/+). The Southern blot was hybridized with probe 
A resulting in the production of a 5Kb wild type Wt1 band and a 4Kb WtV1' 
band. (B) Transgene status of the same six animals. All animals had 
endogenous P3 and all six animals were transgenic for the P3:WT1-KTS 
transgene. Southern blots were probed with probe B which resulted in the 
production of 4.5Kb bands detecting endogenous P3 and a 4Kb band 
detecting the presence of the transgene. (C) The result of PCR 
amplifications used to genotype 7 different mice with primers specific for 
the wild type Wt1 allele (upper panel) and also the Wt1 knockout allele 
(lower panel). Sample 1 in was the negative (no DNA) control. Animals 
represented in lanes 3-6 were heterozygous for the Wt1 null allele, while 
samples 2 and 7 had only the wild type allele. (D). The result of PCR 
analysis used to genotype 7 mice with primers specific for the endogenous 
P3 allele (upper panel) and the P3;WT1-KTS transgene (lower panel). 
Sample 1 was the negative control. Animals 5, 6 and 7 show endogenous 
P3 while the transgene is present in animals 4, 5 and 6. (E) Diagramatic 
representation of part of the Wt1 allele and targeting vector regions 
showing location of southern probe A and PCR primers WT1 and WT1Ko. 
(F) A diagrammatic representation of the P3:WT1-KTS transgene showing 
the location of southern probe B and PCR primers P3 and WT1tg.
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Wani 10 8 5 12 14 4 4
Wefi 12 6 4 12 12 4 3
Wines 2 2 2 3 3 1 1
Chi square tests carried out for the three lines (Wani p = 0.772, Wefi p = 0.832, 
Wines p = 0.985) suggest that no embryos are being lost before birth and 
embryos were seen in the expected ratios.
The low number of Wines litters that were born from the breeding pairs over a 
number of months alerted us to a possible sterility phenotype associated with 
this line (discussed later). Histological analysis of WT1+/+ wild type embryos 
(Figure 6 A, D), WTT7' knockout embryos (Figure 6 B) and WTYI',P3:WT'\-KTS 
transgenic embryos (Figure 6 C) demonstrated that the knockout embryos were 
smaller in comparison to wild type littermates (Figure 6 A) and had severe 
developmental abnormalities including, cardiac defects and an absence of the 
kidney and gonads. Presence of the transgene (Figure 6 C) failed to rescue the 
knockout phenotype in the WTT^PSiWTI-KTS embryo. There were still cardiac 
defects and the gonads and kidneys again failed to develop correctly. At least 7 
animals of each genotype were examined histologically allowing the conclusion 
that the smaller size of the WTYI',P3:WT'\-KTS as seen in the figure was 
atypical. The WTT^PSiWTI-KTS were of a similar size to WTT7' littermates,
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Figure 6. Histological analysis and WT1 expression patterns in wild 
type, W t1 -/- and WT1-/ ;P3:WT1-KTS embryos.
Analysis of embryos resulting from matings of WT1+/-; P3:WT1-KTS with 
WT1+/- animals. (A-C) Hematoxylin and Eosin (H & E) stained sections of 
e11.5 embryos show the presence of the kidney (k) in WT1+/+ animals 
(A), which is missing in WT1-/- (B) and WT1-/-; P3;WT1-KTS embryos (C). 
In both Wt1-/- embryos (with or without the P3;WT1-KTS transgene) there 
is severe disruption in development of the heart that has resulted in 
bleeding into the pericardium (B and C). Higher magnification view of the 
thoracic region of a wild type embryo (D and E), showing morphology with 
H & E  staining (D) and anti-WT1 antibody staining (E). The kidney (k), 
genital ridge (gr), liver (I), heart (h) and mesothelium (m) are indicated. 
Scale bars A, B, C 10mm, D and E 5mm.

however, due to the general small size and the developmental abnormalities 
seen the embryos, it was not always possible to carry out histological analysis. 
The illustrated WTT^PSiWTI-KTS embryo provided a good example of the 
phenotypes seen in WTT^PSiWTI-KTS embryos. Immunostaining using an 
anti-WT 1 antibody detected the presence of WT1 protein in the kidney and 
genital ridge and the mesothelium lining of all the organs in a wild type embryo 
(Figure 6 E). In comparison, WT1 was not detected in either knockout embryos 
or knockout embryos carrying the transgene.
3.3.3 Analysis of adult organs
Organs of animals over the age of 6 months were also analysed for two 
transgenic lines Wines and Wani (Table 2). Out of a total of 49 animals, 14 
animals showed signs of gross abnormalities. The disorders ranged from liver 
tumours, kidney overgrowth and cysts, cystic or small testis and in one case a 
cystic eye none of these disorders were ever seen in wild type littermates. All of 
the disorders occurred in mice ranging from 6 to 9 months in age from 8 different 
litters. All mice were WT1+/';P3:WT1-KTS animals with the exception of one 
animal with the genotype WT1+/+;P3:WT1-KTS. Out of all the animals, 13/49 
were WT+/';P3:WT1-KTS mice and they all presented with morphological 
abnormalities. The data is mostly representative of the Wani transgenic line 
(47/49 mice), with only 2 mice from the Wines line. This was partly due to the 
fact that breeding of the Wines line was reduced due to the possible sterility of 
male animals. The cystic kidneys and testis seen in the Wines line were similar 
or less severe in pathology to the abnormalities seen in some of the Wani lines 
however given that the numbers of Wines animals analysed (2) were so small it 
is not possible to say whether the histopathology is consistent between the two 
lines.
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Table 2 Number and genotype of adult mice developing pathologic disorders
Line Genotype Number examined Pathology (number 
affected)
Wani W TT '+ 10 Normal (none)
WT1w+;P3:WT1-KTS 12 Liver tumour (1)
WT1+/- 12 Normal (none)
WT1+/';P3:WT1-KTS 13 Cystic kidney (5)
Cystic testis (2)
Liver tumour (1)
Cystic tesits, cystic 
kidney (1)
Cystic kidney, liver 
tumour (1)
Cystic kidney, cystic 
testis, liver tumour (1)
Small testis (1)
Cystic eye (1)
Wines WT1+/-;P3:WT1-KTS 2 Cystic kidney (2) 
Cystic testis (2)
3.3.3.1 Cystic Kidneys
Histological analysis of adult organs was carried out in a similar fashion to 
embryos. In wild type mice (Figure 7), PAS staining of the kidney allows 
distinction of the cortex (where the tubule system processes the waste fluid and 
finally passes it into the collecting system) and the medulla at the
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Figure 7. Histological comparison of wild type and mutant adult 
mouse kidneys.
(A-C) Periodic Acid and SchifTs (PAS) staining of a longitudinal section 
through wild type (6 month old male) mouse kidneys showing the normal 
kidney morphology . (A)Two different regions of the kidney, the cortex 
(co) and the medulla (m) can be distinguished. The glomeruli (G) of the 
nephrons are contained within the cortex and the medulla contains the 
collecting tubules system. These regions are compact and regularly
organised in the wild type kidney. (B) The glomeruli (G) are organised
within the cortex region of the kidney and are associated with the renal
vasculature and proximal collecting tubes (PCT). (C) The proximal
collecting tubules (PCT) can be identified by prominent staining of the 
brush border (BB), that is absent from the distal convoluted tubules (DCT). 
There are more PCTs within the cortex and away from the periphery an 
increasing number of DCTs can be seen. (D-F) The morphology of PAS 
stained WT1+/-; P3:WT1-KTS cystic kidney sections differs distinctly from 
their wild type littermates. (D) A number of fluid filled cysts (c) can be 
clearly seen. There is widespread disorganization of the structure of the 
kidney, making it difficult to distinguish between the medulla and the 
cortex regions. The number of glomeruli (G) and the general size of the 
kidney was increased. (E) The glomeruli (G) were larger than glomeruli in 
wild type littermates and a number of glomeruli were seen to be 
encapsulated within cysts (c). (F) The tubule morphology appears
disrupted, with the boundary between proximal collecting tubules (PCT) 
and distal convoluted tubules (DCT) less clear than in wild type sections. 
Tubule size is greatly increased with the brush border (BB) of proximal 
collecting tubules less clear than normal, with thickening of the distal 
convoluted tubules. Magnification x10 (A and D) or x60 (B, C, E and F). 
Scale bars 200pm

periphery (which contains the renal corpuscles where the glomerulus filters 
waste out of the capillary system). The wild type kidney is an ordered and 
compact structure with the medullary and cortical regions clearly defined (Figure 
7 C). A number of WT+/';P3:WT1-KTS mutant kidneys (see Table 2) contained 
fluid filled cysts although the figure represents the histopathology of an affected 
Wines animal (Figures 7 D and E), there was also a general disorganization in 
kidney structure and it was difficult to distinguish the cortex and medullary 
regions (Figure 7 E). The cystic kidneys were on average three times the size of 
the wild type kidneys (cystic kidney section length 9mm compared to 27mm wild 
type kidney section), due to the accumulation of fluid and a number of cysts were 
seen to surround enlarged glomeruli (Figures 7 E). Whereas the glomeruli of wild 
type kidneys were seen exclusively toward the periphery of the kidney (Figure 7 
A), there were glomeruli throughout the cystic kidneys and these glomeruli were 
enlarged (Figure 7 C and D). The tubule structures were also affected in mutant 
mice. In wild type kidneys the tubules are compact and well ordered. PAS 
differentiates between proximal collecting tubules by the prominent staining of 
their brush borders, compared with distal collecting tubules in which brush 
borders are absent (Figure 7 C). In the cystic kidneys, tubule structures were 
increased in size, tubules were engorged and brush borders appeared shriveled. 
The number of heamatoxylin-stained nuclei seemed to be greatly increased 
(Figure 7 F). The disorganization and increase in size was also apparent in the 
other cystic organs, and was associated with changes in cell proliferation and cell 
death (discussed later).
3.3.3.2 Abnormal Testes
In addition to the cystic kidneys, four Wani WT+/';P3:WT1-KTS animals also 
presented with abnormal testes (Table 2), 3/4 had enlarged testes while one 
animal had smaller testes than in wild type controls. Both of the Wines WT+/'
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;P3:WT1-KTS mice examined had enlarged, cystic testes. Upon histological 
analysis wild type testes were again, as with the kidney, found to be well ordered 
and compact structures. Tubules contained germ cells and spermatogonia in 
varying states of development. Spermatogonia are associated with sertoli cells 
that provide essential factors for germ cell development. Interstitial cells called 
Leydig cells provide hormones necessary for testis function (Figure 8 A and B). 
In the mutant testis (Figures 8 D), the testes contained large cysts. The section 
presented was from an affected Wines male however, the histopathology of the 
affected Wani animals was seen to be of a similar nature or less severe. The 
cysts seem to be derived from tubules and there was an apparent expansion of 
the interstitial cells associated with the abnormal tubules (Figure 8 C). 
Furthermore, it was not only organisation of the tubules within testes that was 
abnormal but also organisation within the tubules. Some tubules showed a 
complete lack of cells, and tubule conformation of others was visibly altered 
(Figure 8 C). This structural change was investigated further to see if there was 
an increase in proliferation resulting in the size increase seen, and at the same 
time any differences in apoptosis (see Section 3.3.5).
3.3.3.3 Liver tumours
Four animals were found to have liver tumours and the histological analysis of 
one of these can be seen in Figure 9. The liver is normally a compact structure 
tightly organised into small units, based on blood supply, called acini. These are 
characterised by an incoming blood supply in the portal tracts (branches of 
hepatic artery and portal vein), and a peripheral outgoing blood supply (central 
vein), associated with cords of hepatocytes. This hepatic triad can be clearly 
seen in the normal liver sections (Figure 9A) but is less apparent in the tumour 
section (Figure 9 B). There is an overall
Figure 8. Histological comparison of wild type and mutant adult 
mouse testes.
(A and B) PAS stained wild type adult (7 month) testis. (A) Organisation 
of a Wild type testis in histological section, with the seminiferous tubules 
(T) organised in a compact pattern, while the sertoli cells (S) are located at 
the periphery of the tubules and leydig cells (L) are found interstially 
between tubules. (B) H&E staining of the testes also identifies the same 
cell types and structures : Sertoli cells (S) of the testis located at the 
periphery of the tubules (T) while Leydig Cells (L) are found interstitially 
between tubules. (C and D) PAS stained WT1+/-; P3:WT1-KTS cystic 
testis (7 month) in histological section shows a greater disorganization 
than the testis of its wild type littermate. (C) There are greater gaps 
between the tubules (e) with an absence of cells within tubules, some 
tubules are totally devoid of cells (d) whilst others are surrounded by a 
larger mass of interstitial cells (f). (D) H&E staining of the cystic testis 
shows the presence of a large fluid filled cyst (c). Magnification x60 (A-D). 
Scale bars 200 pm

Figure 9. Histological comparisons of wild type and mutant adult 
mouse liver sections.
H & E  stained liver sections from males at 7 months of age. Animals were 
wild type (A) and WT1+/-; P3:WT1-KTS (B), highlighting differences 
between wild type and tumour histology. The portal triad (pt) can clearly 
be seen in wild type sections whereas there was an overall 
disorganization in WT1+/-; P3:WT1-KTS liver tumours. Large blood filled 
cavities can be seen (n) as well as multiple vesicles (v). Although both 
sections were stained together the wild type section stained much more 
brightly with Eosin than the tumour section highlighting the differences in 
morphology between the two sections. Scale bars 200^ 171

disorganisation within the tumour section associated with the presence of tumour 
cells. The liver was enlarged in each of the affected animals though the number 
of affected lobes varied in different animals (from one animal with only one 
affected lobe to another animal with only one seemingly normal lobe).
3.3.3.4 Enlarged eye
One of the Wani WT1+/';P3:WT1-KTS mice was found to have a grossly 
abnormal eye. Figure 10 shows histological analysis of a wild type eye (panels A 
and B) and the cystic eye (Panels C and D). The retina lines the back of the eye 
and is composed of three layers of nerve cell bodies and two layers of synapses. 
The outer nuclear layer contains the cell bodies of the rods and cones, the inner 
nuclear layer contains the cell bodies of the bipolar, horizontal and amacrine 
cells and the ganglion cell layer contains the cell bodies of ganglion cells. Light 
travels through the pigmented cells and the thickness of the retina before striking 
and activating the rods and cones. At a histological level, it was possible to see 
three layers of nucleated cells and the pigmented layer. Next to the pigmented 
layer, the first layer of nucleated cells is the outer nuclear layer, the second is the 
inner nuclear layer and the third is the nerve fibre layer. The mutant eye was 
greatly enlarged in comparison to the wild type and there seemed to be 
abnormalities in the different layers of the retina characterised by a 
disorganisation of heamatoylin stained cells and possibly changes in cell 
number, particularly of the retinal pigmented epithelium.
3.3.4 WT1 expression in adult organs
Using an anti-WT1 antibody WT1 expression was found to vary in different Wt1+/' 
;P3:WT1-KTS animals with abnormal adult organs, and all differed from that of 
the wild type expression pattern. In wild type animals, WT1 was
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Figure 10. Histological comparisons of wild type and mutant adult 
mouse eye sections.
Sections of eyes from wild type (A) and WT1+/-; P3:WT1-KTS (C) animals 
stained with H & E, illustrating the increased retinal size and 
disorganization within the mutant eye. There seem to be severe 
abnormalities in the retinal pigmentation (r). Anti-WT 1 immuno-staining of 
the wild type eye (B) fails to detect any WT1 protein, however there is 
WT1 staining apparent in the mutant eye (D). Magnification x100. Scale 
bars 100pm

expressed in the podocyte cells of adult kidneys (Figure 11 B) and in the sertoli 
cells of the adult testes (Figure 11 D), but there was no WT1 expression 
detected in wild type adult liver (Figure 11 F) or retinal (Figure 10 B) sections. 
The abnormal organs of WT1+/';P3:WT1-KTS mice however, showed a variety of 
atypical expression patterns (Figure 10 D and Figures 12a, 12b, and 12c). 
Kidney sections from some mutant animals showed ectopic expression of WT1 
in the tubules with a complete lack of expression in the glomeruli (Figure 12a A). 
Kidney sections from other mutant animals either showed WT1 expression in 
large foci associated with the glomeruli (Figure 12a C), or were found to be 
completely devoid of WT1 expression (Figure 12a B), or showed WT1 
expression ectopically, in cells dispersed throughout the kidney (Figure 12a D).
Similarly, a variety of WT1 expression patterns were seen in the testes of 
different animals. Some testes sections showed a lack of WT1 expression 
(Figure 12b b), others an abnormal, disorganized expression pattern (Figure 12b 
C and 12b D) while some sections] showed tubules with patterns similar to those 
of wild type WT1 expression (Figure 12b B).
An ectopic pattern of WT1 expression in hepatocytes was seen in the livers of 
mice with enlarged, cystic and tumourogenic organs (Figure 12c A, B, C and D). 
WT 1 expression was possibly in the nuclei of hepatocytes given that the protein 
is a nuclear factor although it was not clear from the images. The severity of the 
liver abnormalities was varied, ranging from enlarged livers and mice with one 
tumourous liver lobe, to a mouse with 3 lobes affected.
Finally, gross morphological and histological abnormalities were detected in one 
Wt1;P3:WT1-KTS mouse with a severely enlarged eye (Section 3.3.3.4) and this 
was associated with ectopic WT1 expression (Figure 10 D).
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Figure 11. Morphology and WT1 expression in adult tissues from 
wild type mice.
Sections of kidneys (A and B), testis (C and D), and liver (E and F), were 
stained either with H & E (A, C and E) or an anti-Wt1 antibody (B, D and 
F). In the kidney, WT1 expression was seen in the podocyte cells (p) of 
glomeruli (g) but not in tubules (t). In the testis, WT1 expression was seen 
in Sertoli cells (st) within seminiferous tubules (tu) and WT1 expression 
was not seen in wild type adult mouse liver sections. Scale bars 200pm

Figure 12a. WT1 expression pattern in adult mutant mouse kidneys.
WT1 expression in four WT1+/-; P3:WT1-KTS mice kidneys (littermates of
the animals in Figure 11) showed a range of patterns in kidneys (A, B, C,
D). One animal had ectopic WT1 expression within the kidney tubules (t) 
while the glomeruli (g) were devoid of expession (Panel A). A second 
animal had kidneys which were devoid of WT1 expression (Panel B). 
Another animal retained podocyte expression of WT1 in the kidney (p) but 
larger foci were seen in regions associated with the glomeruli (g) and foci 
(f) that were independent of glomeruli were also seen to express WT1 
(Panel C). The expression pattern of a fourth animal was similar to that of 
animal C with the kidneys showing ectopic WT1 expression in foci not 
associated with glomeruli (f) (Panel D). Panel E shows negative control 
mutant mouse kidney sections. Scale bars 200pm
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Figure 12b. WT1 expression pattern in adult mutant mouse testes.
WT1 expression in four WT1+/-;P3:WT1-KTS mice testes (corresponding 
testes to figure 12a) showed a range of patterns in four different animals 
(A, B, C and D). One animal had testes devoid of WT1 expression (A) 
whilst a second had a more normal pattern of WT1 expression possibly in 
the sertoli cells (st). A final two animals had ectopic and increased 
expression of WT1 within a number of tubules (tu) (C and D). Panel E 
shows the negative control mutant mouse testes. Scale bars 200pm

Figure 12c. WT1 expression pattern in adult mutant mouse livers.
WT1 expression in four WT1+/-;P3:WT1-KTS mice livers (corresponding 
livers to figures 12a and 12b) showed the presence of multiple ectopic foci 
of WT1 expression seen throughout the liver. Wild type adult liver lacked 
any WT1 expression (figure 11). Panel E shows the negative control 
mutant mouse liver section. Scale bar 200|am
E
3.3.5 Apoptosis and Proliferation in adult organs
In order to investigate changes in cell turnover cell proliferation and apoptosis 
were assayed in kidney and testis from both wild type and mutant mice. 
Apoptotic cells were detected, using a DNA end-labelling method, within sections 
from wild type and mutant kidneys (Figure 13 A-D) and testes (Figure 13 E and 
F). Overall, there was a dramatic increase in apoptotic cells as illustrated by the 
cells stained red in mutant sections (Figure 13 B, D and F) in comparison to Wild 
type cells (Figure 13 A, C, E). The glomeruli of the wild type kidney were devoid 
of apoptotic cells with no red staining visible (Figure 13 A), while stained cells 
were present in glomeruli of mutant kidney sections (Figure 13 B). Similarly, 
apoptosis events were rarely detected in wild type kidney tubules (Figure 13 C), 
but numbers were greatly increased among cells of mutant kidney tubules, 
irrespective of the type of tubule (Figure 13 D). Apoptosis within the testis of 
mutant animals was again much increased in comparison with wild type animals 
(Figures 13 E and F). Apoptotic cells were located at the periphery of the 
affected tubules and seemed to surround the multi-nucleated DAPI stained cells 
(Figure 13 F). The position of the apoptotic cells suggests they may be either 
Sertoli cells or primary germ cells, or indeed may include both cell types, 
however this has not been clarified.
Proliferation events, evaluated using an antibody recognizing proliferating cell 
nuclear antigen (PCNA), were also changed in cystic kidneys and testis. The 
differences between wild type sections (Figures 14 A, C, E and G) and mutant 
sections (Figures 14 B, D, F and H) were clearly apparent with large foci of 
proliferation in the abnormal kidneys as opposed to single cells that
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Figure 13. Comparison of apoptosis in wild type and mutant (WT1+/- 
;P3-KTS) adult mouse testes and kidneys.
Apoptosis within wild type kidneys (A and C), wild type testis (E), mutant 
cystic kidneys (B, D) and mutant cystic testis (F) at x60 magnification. 
DAPI stained cells (nucleated cells) stain blue under fluorescence 
whereas cells undergoing apoptosis fluoresce red. Wild type animals 
showed a negligible amount of apoptosis in the glomerulus (A) or kidney 
tubules (C) and in the seminiferous tubules of the testis (E). In WT1+/- 
;P3-KTS samples there was a marked increase in apoptosis at the 
periphery of glomeruli (B) and in all tubules (D) in the kidney, and at the 
periphery of seminiferous tubules in the testis (F). The mutant and wild 
type animals represented were littermates at 7 months of age. Scale bars 
100pm

Figure 14. Comparison of proliferation within wild type and mutant 
(WT1+/-;P3-KTS) adult mouse kidneys and testes.
Anti-PCNA stained wild type and mutant kidney and testis sections 
counterstained with hematoxylin identify proliferating cells within these 
organs. PCNA staining was prominent within glomeruli, of the wild type 
kidney (A) but was negligible within the tubules (C). In mutant animals, 
there was a marked increase of proliferation associated with cells around 
glomeruli (B) and within tubules (D). The pattern of proliferation in wild 
type adult testicular tubules was very specific and located to the periphery 
of seminiferous tubules (E and G). In mutant testes sections there was a 
dramatic change in proliferation with some tubules almost completely 
devoid of proliferating cells (i), others containing proliferating cells 
throughout the tubule (j), another subset of tubules seemed fairly normal 
(k) and a final group of tubules expressing proliferating cells in a 
disorganized pattern (I). All sections were photographed under x60 
magnification except that in Panel E at x30 magnification. Scale bars 
200pm
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were more evenly dispersed in the wild type. In the glomerular regions of 
abnormal kidneys (Figures 14 B) there were clustered regions of proliferation 
whilst in the tubular regions a marked increase of proliferation was seen (Figure 
14 D), however although the anti-PCNA foci of staining were also larger this may 
reflect the increase in size of the components of the kidney. The changes in 
proliferation in testes were easier to analyse as proliferation was entirely 
restricted to primary spermatogonia at the periphery of wild type tubules (Figure 
14 E and G). In the mutant, although some seminiferous tubules showed 
seemingly normal patterns of proliferation, some tubules contained almost no 
proliferating cells and others contained proliferating cells located towards the 
lumen of the tubule, not just at the periphery (Figure 14 F and H).
3.3.6 Measurement of renal function in adult mice
After two mice from the Wines transgenic line were found at necropsy to have 
profound renal and genital abnormalities, it was thought that renal problems 
might be detected at an earlier stage in other mice. Renal function of seemingly 
healthy adult mice was investigated by analysis of urine (Figure 15). When urine 
samples were tested with urine analysis sticks, proteinuria was observed in 
WT1+/';P3:WT1-KTS animals (Figure 15 A). Coomassie staining of urine 
samples on protein gels confirmed proteinuria in WT1+/';P3:WT1-KTS animals by 
detecting the presence of a 67 kDa protein band (Figure 15 B ). This band 
appeared in largest amounts from samples taken from WT1+/";P3:WT1-KTS mice 
although some WT1+/' littermates showed less, although detectable, protein. 
Protein was not seen in samples taken from wild type animals. Some WT1+/' 
mice seen to contain protein in the urine from the protein gel experiments failed 
to show proteinuria from urine stick analysis suggesting that the Coomassie 
urine detection method was
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Figure 15. Detection of protein in urine samples as a means of 
assessing renal function in adult mice
The urine from adult mice was analysed with urine analysis sticks (A) and 
by PAGE (B). In this example urine from a 7 month WT1+/-; P3:WT1-KTS 
animal (sample 3) was compared with its wild type and WT1+/- littermates. 
The proteinuria indicator showed high levels of protein were present in 
sample 3 (A) and the same sample also showed the presence of a 
prominent 67K protein band on the coomassie stained protein gel (B).
ANegative
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more sensitive. Proteinuria and coomassie staining of urine samples only 
yielded positive results in animals over the age of 4 months. Proteinuria is a 
symptom of aberrant kidney function when the kidney fails to reabsorb and filter 
out proteins so they are present in the urine. These results show that in 
seemingly healthy transgenic animals there is a degree of renal failure that may 
progress to the state observed in the two Wines animals with enlarged, cystic 
kidneys. Measurements of proteinurea were made on the urine samples of 52 
mice at ages ranging from 4-10 months (note that some mice were tested at two 
or more different ages)(Table 3). Out of these animals, 12 (1 WT1+/+;P3:WT1- 
KTS animal and 11 WT1+/‘;P3:WT1-KTS animals) were shown to have greatly 
increased proteinuria in comparison to wild type littermates. Upon histological 
analysis it was confirmed that these animals had kidney defects and furthermore, 
in some cases, abnormalities of their testes and/or liver (Table 2).
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Table 3. Number, age and sex of Wani animals, which showed over 20g/L 
protein using the urine stick analysis after raised protein levels in urine samples 
had been initially detected on a coomassie stained protein gel. A total of 52 
animals were analysed (note, animals were tested first from the ages of 4-6 
months and then again after 7 months).










WT1+/+ 0/5 0/5 0/1 0/1
WT1+/+
;P3:WT1-KTS
0/6 1/6 0/2 0/2
WT1+/- 0/9 0/9 0/10 0/10
WT1+/-
;P3:WT1-KTS
2/9 8/9 0/10 1/10
3.3.7 Comparison of morphology and protein expression between mouse 
mutants
The final group of experiments in this chapter, were an attempt to compare 
differences in genital development and protein expression patterns between wild 
type animals, WT1 mutants and another mouse model of sterility, the Ob mutant 
mouse. Morphology, immunostaining, apoptosis and proliferation analyses were 
carried out on the testis of adult Ob homozygous mice (Figure 16) and all adult 
testis and kidneys underwent immunohistological detection of WT1 and Baspl 
proteins using the corresponding antibodies.
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3.3.7.1 Ob mutants
Ob homozygotes had smaller testes than wild type animals, seminiferous tubules 
were decreased in size, with wider spaces between them and an increase in 
interstitial cells (Paisley, 2000). Within the seminiferous tubule there seemed to 
be less disorganization than in WT1+/-;P3:WT1-KTS mutant tubules (compare 
Figures 14 F and 16 B). Cell proliferation was decreased in Ob mutant testes 
(Figure 16 B) but still restricted to the periphery of the tubules as in wild type 
testis (Figure 16 A). Although apoptosis was mainly still restricted to the 
periphery of mutant tubules (Figure 16 D) the levels were increased in 
comparison with wild type tubules (Figure 16 C), there was however some 
apoptosis within the tubule suggesting that spermatogenic cells other than 
spermatagonia for example primary or secondary spermatocytes, were 
undergoing apoptosis. This pattern of apoptosis was not seen in testes of either 
wild type or WT1+/';P3:WT1-KTS (Figure 14 F) mutant mice. Finally, sertoli cells 
were still present at the periphery of Ob mutant seminiferous tubules, as shown 
by immunostaining with the WT1 antibody, a marker of sertoli cells (Figure 16 F). 
Notably, there were few gaps between the sertoli cells in Ob mutants (Figure 16 
F) compared with wild type littermates (Figure 16 E), suggesting that the germ 
cells, that do not express detectable WT1, are missing in this mutant, which does 
not seem to be the case in the WT1+/';P3:WT1-KTS mutants (Figure 14 F).
3.3.7.2 Immunohistochemistry with the Baspl antibody
An antibody raised against the putative WT1-interacting protein, Baspl, revealed 
that in the adult kidney Baspl protein was expressed in similar if
103
Figure 16. Histological analysis mousecomparing Ob mutant and 
wild type testes
Proliferation (assayed using an anti-PCNA antibody; A and B), apoptosis 
(C and D), and WT1 expression (assayed using an anti-WT1 antibody; E 
and F) in the testis of wild type (A, C and E) and Ob mutant (B, D and F) 
adult mice (littermates at 7 months of age). The Ob mutant testis showed 
differences in proliferation (B) from the wild type (A) with cell proliferation 
in the mutant being decreased in many seminiferous tubules. Where 
there was proliferation, it was located at the periphery of tubules in a 
pattern similar to that of wild type tubules. The apoptosis in mutant testis 
tubules (D) was increased compared to that of wild type littermates (C) 
and was also located to the periphery of tubules. W T1 staining remains 
similar in mutant testes (F) as compared with wild type animal testes (E). 
In mutants, proliferation was confined to cells at the periphery of 
seminiferous tubules but appeared fainter than the staining in wild type 
samples.
Magnification (A), (B), x30, (C), (D) x100, (E), (F) x60. Scale bars A, B, E, 
F 200pm, C and D 100pm

not identical locations to WT1 (Figure 17 A and B) , in what appear to be the 
podocyte cells of glomeruli. Some Baspl was also detected in certain tubules in 
the kidney (Figure 17B), where WT1 was never seen in wild type animals.
In wild type testes Baspl was located to the periphery of seminiferous tubules 
(Figure 17D), but was predominantly cytoplasmic, unlike the nuclear WT1. WT1 
was also expressed at the periphery of the seminiferous tubules (Figure 17C), 
were it is known to mark Sertoli cells, but it was not possible to tell if the proteins 
were expressed in exactly the same cell types. However, the persistence of 
Baspl staining in cells located away from peripheral cell layers suggests that 
Baspl was localised in the germ cells. Baspl expression patterns were 
unchanged in sections of kidney and testis from Wt1+/-;P3:WT1-KTS mutant 
mice (data not shown).
In cell culture, Baspl and WT1 expression was seen in both Cos7 cells (Figure 
17 E) and Hela cells (Figure 17F) although not in the same area due to the 
cytoplasmic localisation of the Baspl protein, in contrast to the nuclear 
localisation of WT1 protein.
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Figure 17. Baspl expression in the kidneys and testes of adult wild 
type mice and in cultured cells.
Comparison of expression patterns of Baspl and WT1 in kidneys (A and 
B), testes (C and D) and cell lines (E and F). The WT1 protein is 
expressed in glomerular podocytes (p) of the kidney (Panel A). Baspl 
was expressed in similar regions within the glomerlus (g) and also in a 
number of tubules within the kidney (tu) (Panel B). In the testes, WT1 was 
expressed in sertoli cells (st) (Panel C) and Baspl expression was also 
seen at the periphery of testicular tubules, probably including, though not 
necessarily restricted, to germ cells (tu) (Panel D). In Cos 7 cells (Panel
E) and HeLa cells (Panel F) both the proteins are expressed within the 
same cells however, WT1 is expressed within the nucleus of cells (n) and 
Baspl is seen in a cytplasmic pattern (c). In tissue sections endogenous 
proteins were detected using anti-WT1 (A and C) or anti-Basp1 (B and D) 
antibodies, using a secondary antibody conjugated to DAB (brown 
staining). In cultured cells (E and F) endogenous Baspl was detected 
using an anti-Basp1 antibody conjugated to Texas Red and viewed under 
fluorescence (red channel). The cells had been transfected with constructs 
expressing WT1+KTS:GFP fusion protein (viewed in the green channel). 
Scale bars A-D lOOjam, E and F 5(im

3.4 Discussion
The experiments in this chapter investigated a number of aspects of WT1 
expression. WT1 is essential for early genito-urinary development in mice 
(Kreidberg et al., 1993), however, its requirement in adults is less well 
characterised. A number of animal models exist where altered WT1 expression 
in mice result in abnormalities paralleling those of human disorders (Hammes et 
al., 2001; Kreidberg et al., 1993; Patek et al., 1999). It is thought that the 
WT1+KTS and WT1-KTS proteins are usually expressed in a ratio of 2:1 (Haber 
et al., 1990; Larsson et al., 1995; Little et al., 1992), this ratio is tightly conserved 
however some cell lines appear to have different ratios of these isoforms 
(Pritchard-Jones et al., 1990). It is thought that Frasier syndrome results from the 
reversal of the isoform ratio from 2:1 to 1:2, towards higher levels of WT1-KTS. 
This happens when WTi+KTS expression is lost from one allele, with a 
concomitant rise of WT1-KTS from the same allele as a result of mutations in 
intron 9 of the WT1 gene (Barbaux et al., 1997). Hence, Frasier syndrome not 
only highlights the essential requirement of WT1+KTS and WT1-KTS in the 
genito-urinary system, but the maintenance of their critical ratios. This chapter 
further investigates those critical ratios.
3.4.1 The P3:WT1-KTS transgene fails to rescue the phenotype of Wt1-/- 
knockout embryos
WT1 null embryos die prenatally at around E14.5 from cardiac defects. The 
kidneys and testes fail to form in these embryos (Kreidberg et al., 1993). A 
280kb YAC spanning WT1 and its surrounding regulatory elements was able to 
partially rescue the null phenotype. The cardiac phenotype was rescued 
allowing progression to birth although the genito-urinary system was still affected 
in these animals resulting in postnatal death (Hammes et al., 2001). This data 
suggests that there are other Wt1 regulatory elements outside this 280kb region,
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however, in areas where there was correct expression of the transgene, it was 
possible to rescue the null phenotype. The expression of a 460kb YAC was able 
to more fully rescue the null phenotype but the resulting mice did go on to 
develop nephropathy, suggesting a requirement for further elements to provide 
normal expression (spatial patterns or levels) of WT1 (Guo et al., 2002).
Our experiments were aimed at investigating the involvement of a single isoform 
of Wt1 in genito-urinary development. We utilized a transgenic approach with 
the creation of the P3:WT1-KTS transgene, in which a WT1-KTS cDNA 
sequence was placed under the control of the IGF2 P3 promoter and H19 
enhancer elements. These same regulatory elements were previously shown to 
drive a LacZ reporter gene in the kidney, gonads, and liver in a manner that was 
temporally consistent with WT1 expression (Brenton et al., 1999). The aims of 
the experiments were first, to see if overexpressing WT1-KTS in a wild type or 
heterozygous knockout Wt1 background (WT1+/+;P3:WT1-KTS and WT1+/' 
;P3:WT1-KTS transgenic mice) would result in any developmental disorders, 
either in embryos or in adult mice. WT1-KTS was chosen, rather than WT1+KTS 
specifically because the relative overexpression of WT1-KTS occurs in Frasier 
syndrome in humans. Second, we wanted to investigate whether it was possible 
for the single isoform to rescue any of the phenotypic features of the Wt1 
knockout (null) embryo (by generating WTY,'\P3:WTJ\-KTS embryos), and 
therefore understand better the level of redundancy between WT1 isoforms.
A total of 24 litters were analysed at embryonic stages from three transgenic 
lines (Section 3.3.2). Out of the 26 embryos that were WT1+/+;P3:WT1-KTS, 
there was no difference in morphology of these embryos in comparison with wild 
type littermates or for that matter, the WT1+/';P3:WT1-KTS embryos, following 
histological analysis after sectioning and H & E staining of 10 embryos from each
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genotype. The antibody detected the presence of the protein in wild type 
embryos but it was not possible to differentiate endogenous from exogenous 
protein in transgenic embryos. The WTT7' embryos exhibited agenesis of the 
kidneys and testes as expected and it is possible to see evidence of pericardial 
effusion characterised by blood surrounding the heart in these embryos. The 
same pathologic features were also seen in the 12 WTT^PSiWTI-KTS embryos 
examined, indicating that the presence of the transgene was not able to rescue 
the null phenotype. We know the P3:WT1-KTS transgene is expressed from the 
results of RT-PCRs carried out previously (Duarte 1997) although levels of 
expression were not obtained. However, RT-PCR was carried out only on liver 
from 3 day old transgenic animals. Some further evidence of expression from 
the transgene was seen in hepatocytes of the adult liver in at least some 
transgenic samples. Since there is not usually any detectable WT1 expression in 
the liver of wild type animals it is possible that this expression was due to the 
transgene. Previous analyses of the Igf2 P3 and H19 enhancer have shown that 
these elements can direct expression in the embryonic liver, kidney, gonads and 
brain (Ward et al., 1997, Brenton et al., 1999). However, in these earlier studies 
the Igf2 and H19 regulatory elements were used to drive expression of reporter 
genes, the assays for which may be more sensitive than the anti-WT1 antibody 
used in this study. The P3:WT1-KTS transgene did not appear to cause any 
developmental disorders when present in WT1+/+ or WT1+/' embryos and failed to 
rescue the null phenotype of WTT/_ embryos. This lack of an effect is likely due 
to low levels, or absence, of expression from the transgene during 
embryogenesis in the Wani, Wefi and Wines transgenic lines.
As to why the P3:WT1-KTS transgene failed to rescue the null phenotype in 
WTT/_P3:WT1-KTS embryos, there are a number of possibilities. The relatively 
low amounts of protein produced from our transgene may not have been
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sufficient to compensate for intact WT1 function. This argument is supported by 
the fact that the antibody failed to detect transgenic protein in WT1V’;P3WT1- 
KTS embryos. Alternatively, although transgenic WTT^PSiWTI-KTS embryos 
may express WT1-KTS, they lack not only WT1+KTS but also the other 
isoforms of the protein, particularly those that include exon 5-encoded 
sequences. Transgenic experiments have shown that the splicing of the 
mammal specific exon 5 resulting the presence or absence of 17 amino acids 
within the protein, is not required for development or fertility (Natoli et al., 2002). 
However, these isoforms, along with the others must carry out some function and 
it is feasible that the action of the isoforms is carried not individually but in 
combination. It is possible that WT1-KTS cannot compensate for all WT1 
isoforms sufficiently to rescue the null phenotype. This can be further illustrated 
by looking at data from experiments where WT1+KTS or WT1-KTS were 
specifically knocked out. The resulting animals showed better genito-urinary 
development than animals with the WT1 null allele. These animals would have 
had a mix of exon 5 isoforms whereas the WT1-/-;P3:WT1-KTS embryos do not. 
Finally, we cannot rule out the possibility that the P3:WT1-KTS transgene fails to 
rescue the Wt1 knockout phenotype because it does not sufficiently recapitulate 
the correct expression of WT1. Although RT-PCR has shown that animals 
express the transgene (at least in the liver at 5 days of age) the transgene has so 
far been undetectable in embryos using the available antibody possibly due to 
the fact that the WT1-KTS is expressed in amounts too low for the antibody to 
detect.
3.4.2 WT1+/';P3:WT1-KTS adult mice display pathological abnormalities 
A number of mouse lines have been created with altered WT1 expression to try 
and unravel the enigma of WT1 function. I have mentioned the YAC rescue 
experiments (Moore et al., 1999; Moore et al., 1998) and the WT1 null (Kreidberg
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et al., 1993) earlier in this chapter. Two other important experiments parallel the 
aims described in this chapter, that is the creation of mouse models of human 
disorders involving WT1 and the investigation of the roles of WT1+KTS and 
WT1-KTS function in murine development. Patek et al 1999 created a mouse 
line with truncations of Wt1 within the zinc finger region. Chimeric mice with cells 
carrying the heterozygous mutation showed urogenital abnormalities 
characteristic of DDS and illustrated that mice can develop urogenital 
abnormalities typical of human disease (Patek et al., 1999). Hammes et al 
(2001) developed transgenic animals where either the WT1+KTS or WT1-KTS 
isoforms were removed (Hammes et al., 2001). They reported that the complete 
removal of either isoform resulted in lethality with severe abnormalities in the 
kidneys of the pups. Heterozygous animals with reduced levels of WT1+KTS 
developed normally and were fertile however 70% of them went on to develop 
severe albuminuria and died due to renal insufficiency. Histological analysis of 
the kidneys demonstrated the presence of glomerusclerosis and nephropathy 
characteristic of FS as well as defects in the male sex determination process. In 
contrast, heterozygous animals with reduced levels of WT1-KTS had 
hypodysplastic kidneys and the presence of streak gonads showing that 
although both WT1 isoforms are require for correct urogenital development, they 
have differing functions.
Our transgenic approach was aimed at creating a similar imbalance of WT1- 
KTS:WT1+KTS ratios, but using an alternative strategy. The P3:WT1-KTS 
transgene allowed us to come up with a number of variables of isoform ratio in 
our mice when crossed with WT1+/' knockout (null) mice. The P3:WT1-KTS 
transgene was unable to exert a substantial effect in \NTY,'\P3^NT^-KTS 
embryos as discussed earlier in this chapter. In these embryos any shift of 
isoform ratio caused by transgene expression was towards an excess of the
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WT1-KTS isoform and the embryos died in mid-gestation with a similar pathology 
to both WTT7' null mice (Kreidberg et al., 1993) and those animals with a 
homozygous reduction of WT1+KTS (Hammes et al., 2001). Previous analysis 
in our lab had revealed no pathological change in WT1+/+;P3:WT1-KTS mice. 
This might be because the WT1 isoform ratio was not shifted far enough towards 
the WT1-KTS isoform, as is seen in FS and in the FS mouse model (Hammes et 
al., 2001). However, the previous study of WT1+/+;P3:WT1-KTS mice was 
restricted to mice of up to 4 months of age and, although these were analysed 
histologically in reasonable numbers (16 wild type and 22 transgenic animals) 
(J.R. Dutton and A. Ward, personal communication) this may have been too 
early for the development of defects seen in this study.
3.4.2.1 Abnormalities in Wines animals
Two Wines WT1+/';P3:WT1-KTS transgenic males failed to produce any litters 
after a year of attempted breeding. These WT1+/';P3:WT1-KTS animals were 
culled and dissected. The necropsy revealed hugely enlarged kidneys and 
testis. Upon histological analysis it was demonstrated that both the kidneys and 
testes had been enlarged due to the presence of fluid filled cysts (Table 2 and 
Figure 7). The cystic testes were likely to have been the cause of the sterility of 
these males. The two animals were the only remaining Wines mice and we were 
therefore not able to analyse others from this line.
3.4.2.2 Abnormalities in Wani animals
Upon finding the cystic kidneys in the Wines mice, attention turned to the Wani 
P3:WT1-KTS transgenic animals. The breeding of this line was not obviously 
abnormal and these animals were seemingly healthy. The urogenital 
abnormalities of the Wines mice had not led to mortality, rather the mice were 
culled at 11 months to investigate the apparent sterility. Since these Wines
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males both had grossly abnormal kidneys it seemed possible that the renal 
function of Wani mice could be impaired but perhaps to a lesser degree. 47 
mice from the Wani line were tested regularly over the age of 4 months for renal 
function. Table 2 describes the findings. 12 mice developed severe proteinuria, 
of these the genotype of 1 mouse was WT1+/+;P3:WT1-KTS,whereas all the 
remaining 11 mice were WT1+/';P3:WT1-KTS. 100% of WT1+/‘;P3:WT1-KTS 
from all the litters taken, at ages ranging from 6-11 months developed signs of 
proteinuria. Histological analysis revealed a range of disorders including 
hyperplastic and cystic kidneys, hypoplastic or hyperplastic and cystic testes, 
liver tumours and a cystic eye (Section 3.3.3). It would seem likely that, despite 
the difficulty in detecting WT1 protein expressed from the transgene, the shift in 
isoform ratio in these animals towards WT1-KTS, together with a reduction of 
endogenous WT1+KTS was critical in the observed pathogenesis.
Immunohistochemistry with an anti-WT1 antibody suggested that there was a 
range of situations with some animals showing increased or ectopic WT1 
expression, whilst other had lost expression. Expression of WT1 protein in adults 
is normally restricted to podocytes of the kidney and sertoli cells of the testes. 
One affected animal had lost all sertoli and podocyte cell expression of WT1 
whilst another gained expression within the tubules of the kidney. Expression of 
WT1 in the remaining 10 affected mice seemed higher than normal although 
maintained in the correct structures. WT1 is a key regulator of podocyte function 
with key podocyte-specific genes being down regulated in mice defective for 
WT1 expression (Guo et al., 2002). A defective podocyte phenotype has 
consistently been found in patients with Denys Drash syndrome and it has been 
shown that a common DDS mutation in the WT1 gene can cause the 
development of glomerusclerosis when introduced into mice (Patek et al., 1999). 
The podocytes line the external surface of the blood vessels in the glomerulus
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and play an important role in the maintenance of the basement membrane 
resulting from their foot processes which create rigid and definite structures lining 
the basement membrane of the glomerulus. In addition they support the 
capillary tuft and may influence the glomerular filtration rate. Impairment of these 
podocyte functions has been linked with the development of glomerular sclerosis 
(Guo et al., 2002). The podocyte abnormalities in DDS patients with mutations in 
WT1, highlight the requirement of the gene, not only in development but also 
throughout adult life. Our WT1+/';P3:WT1-KTS mice developed urogenital 
disorders later in life and they showed defects of WT1 expression in the 
podocytes with ectopic expression around the glomerulus. In the abnormal 
testes, ectopic WT1 expression was also observed. The sertoli cells have role in 
the testes in supporting the surrounding germ cells. They are the only testis cell 
type in which expression of WT1 is maintained throughout life. It could be that 
the function of WT1 in sertoli cells is similar to its role in podoctyes, in that WT1 
could maintain the expression of downstream genes which are in turn 
responsible for the function of these key cell types with supportive roles within 
both the testes and kidneys. This would allow the podocytes to continue to 
maintain the glomerular filtration rate, essential for the normal function of a 
kidney, and the sertoli cells to maintain the germ cell population, essential for the 
normal function of the testes.
3.4.2.2.1 WT1 involvement in the liver
The ectopic expression of WT1 in certain hepatocytes could be due to the 
expression of the transgene in the liver (as argued above) since WT1 is not 
usually expressed in adult liver. A recent report has discussed the role of WT1 in 
the development of chronic hepatitis and cirrhosis and suggests the observation 
that WT1 is expressed in fetal liver but not in adult liver may be due to the role of 
WT1 in differentiation. In the same report, WT1 levels showed a marked
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increase in livers with chronic hepatitis and cirrhosis. The increase of WT1 levels 
was seen in both man and rats. The authors also reported that the increase in 
WT1 levels was in proportion to a decrease in expression of the HNF4 
transcription factor, which is thought to maintain liver function, metabolism and 
differentiation (Berasain et al., 2003). Therefore, WT1 is normally expressed in 
the immature, undifferentiated liver. The ectopic expression of WT1 in the 
abnormal livers of WT1+/';P3:WT1-KTS could result in a loss of differentiation 
and reversion to an immature, proliferating state. This would potentially explain 
the presence of liver tumours (provisionally diagnosed as hepatocarcinomas 
based on their morphology) in some of these mice. No other tumour was 
detected in these animals suggesting that the liver tumours were primary 
tumours. Only two types of primary liver tumour have been reported, the
epithelial bile duct derived tumour and the hepatocyte derived hepatocarcinoma. 
Expression of WT1 in the hepatocytes would suggest the tumours to be 
hepatocarcinomas. The ectopic expression of WT 1 in the liver was consistent 
with the idea that the transgene was expressed in tissues were the IGF2 P3 
promoter and H19 enhancer elements have been shown to drive expression. 
However, although the liver tumours were associated with the presence of the 
transgene we cannot rule out that some or all of the WT1 expression observed in 
adult liver section was derived from reactivation of the single endogenous Wt1 
allele that remains in the affected mice which is normally expressed only during 
development but not in the adult liver.
3.4.2.2.2 WT1 involvement in the retina
WT 1 involvement has been shown in the developing retina of the eye but the 
protein is not expressed in adult eyes (Pritchard-Jones et al., 1990). One of our 
WT1+/';P3:WT1-KTS animals presented with an enlarged eye and following 
dissection and histological analysis it was found that there was thickening of the
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retina associated with strong WT1 expression. This concurs with the findings of 
Wagner et al 2002 that embryos with a targeted disruption of Wt1 exhibit thinner 
retinas than age matched wild type littermates. They also reported that the WT1- 
KTS isoform could up-regulate the Pou4 transcription factor, which is critical for 
the survival of retinal ganglion cells (Wagner et al., 2002). In contrast, the retina 
of the cystic eye was thicker than its wild type. Maintenance or reactivation of 
WT1 expression in the eye (either from the transgene or from the endogenous 
Wt1 allele) after it has normally ceased might therefore have caused the 
enlarged and cystic phenotype.
3.4.2.3 WT1 involvement in the cell cycle
The role of WT1 in cardiac development, kidney development, and eye 
development as a switch of mesenchyme to epithelial states suggest that the 
protein is acing in the stimulation of cellular differentiation rather than 
proliferation. This is supported by the findings that WT1 levels are increased in 
Wilms’ tumours and other neoplasias that involve mutations of the WT1 gene 
(Hastie, 1993; Lee and Haber, 2001). This allows us to infer that mutations of 
WT1 might result in an increase in cell proliferation. On the other hand, in the 
absence of WT1, the meetanephric mesenchyme undergoes extensive 
apoptosis (Kreidberg et al., 1993), again highlighting the role of WT1 in growth 
regulation.
The WT1-KTS isoform of WT1 has been shown to have stronger transcriptional 
role than WT1+KTS. WT1-KTS is able to bind with higher affinity to DNA while 
WT1+KTS has a higher affinity for RNA (Caricasole et al., 1996; Laity et al., 
2000) (see further discussion in Chapter 4). WT1-KTS isoforms are generally 
more active in transcriptional regulation, binding regulatory regions of genes 
such as Steroidogenic factor SF1 (Cohen et al., 1997), P21(Englert et al., 1997),
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amphiregulin (Lee, 1999) and IGF2 (Drummond et al., 1992; Duarte, 1997). 
WT1-KTS is linked to the induction of cell cycle arrest via the induction of the 
cyclin dependent kinase inhibitor p21 (Englert et al., 1997). Ectopic expression 
of WT1-KTS in some cell types leads to a Gi cell cycle arrest. Following the 
stable transfection of WT1-KTS in rhaboid tumour cell lines, there is a marked 
increase in levels of the apoptotic factorBcl-2 (Del Rio-Tsonis et al., 1996). Dax- 
1 and MIS activation by WT1-KTS are essential for gonadal development (Parker 
et al., 1999). It is for these reasons that cell proliferation and apotosis in the 
WT1+/';P3:WT1-KTS were of interest.
There was a marked increase of cell proliferation in all of the abnormal organs. 
The pattern of cell proliferation was also disorganized in comparison to wild type 
animals, with proliferation no longer restricted to the usual areas (e.g. periphery 
of seminiferous tubules). Interestingly, there were also effects on the apoptosis 
levels in the same organs although these may not be as reliable a result as 
hoped for. The exposure differences in the images (Figure 13 C and E) with 
comparison to the other images (Figures A, B, D and E) suggest that the 
apparent dramatic increase seen if mutant sections may not be a true reflection 
of actual apoptotic events. Despite the favorable results provided by the 
negative controls (Figure G and H), it would be beneficial to use alternative 
independent methods to detect apoptosis to duplicate the results such as 
detailed microscopy to detect the presence of altered DNA structures. However, 
analysis of the given results shows that apoptosis was affected in all the 
abnormal organs with a general increase of apoptosis in comparison to wild type 
organs. Increased levels of apoptosis were seen throughout kidneys and livers 
whilst only the periphery of seminiferous tubules in the testes showed a marked 
apoptotic increase. In testes, apoptosis was restricted to areas where WT1 
expression was seen, this was not the case in kidneys and livers where there
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seemed to be no consistent pattern of apoptosis. This feature was not expected 
as there is an overall increase of WT 1, not loss as seen in null animals where the 
mesenchyme undergoes complete apotosis. It is thought that the loss of WT 1 
causes this resulting apoptosis in the kidneys of null mice therefore it would not 
be expected that increased WT1 expression would also result in increased 
apoptosis. The apoptosis levels were not necessarily as high as the levels 
described for the metanephric mesenchyme of null animals however (Kreidberg 
et al., 1993). It may be that the upregulation of apoptosis was an indirect 
response to WT1 as a reaction to the increase in proliferation, or vice verse. 
This data suggests the WT 1 dosage is critical for maintenance of the cell cycle 
and it may be that the reduction of WT1+KTS in conjunction with the increase of 
WT1-KTS is important in controlling the cell cycle process.
Overexpression of WT1-KTS in the WT1+/';P3:WT1-KTS transgenic mice may 
have resulted in the changes in cell proliferation and apoptosis seen in those 
mice with abnormal organs. In the cystic, tumourous or enlarged organs, WT1 
expression was frequently abnormal. Although these changes in WT1 
expression were not consistent among all animals assayed, this may be because 
affected organs from different animals were detected and assayed for WT1 
expression at different pathologic stages. In the testis, ectopic WT1 expression 
may have resulted in increased activation of downstream targets outside of 
sertoli cells. This might result in the ectopic activation or repression of WT1 
target genes in germ cells. The ectopic expression of the protein in the kidney, 
liver or adult eye could similarly result in the activation of downstream targets not 
normally activated in these organs.
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3.4.3 Comparison between WT1+/';P3:WT1-KTS and Ob animals 
WT1+/';P3:WT1-KTS animals with abnormal organs demonstrated changes in 
morphology, renal function, WT1 expression and cell turnover. It was of interest 
to see if this was specific for this animal model in comparison with other animals 
with genito-urinary abnormalities. The Ob mice provided us with an interesting 
comparison. As mentioned earlier in this chapter The Ob transgenic mice were 
identified from a screen for transgene insertional mutants in our laboratory 
(Paisley, 2000). Previous analysis of Ob testes has shown that the testes are 
reduced in mass in comparison to fertile hemizygous littermates. Testes of Ob 
animals also exhibit a significant difference in the relative abundance of various 
spermtatogenic cell-types. In comparison to WT1+/';P3:WT1-KTS animals, 
histological analysis revealed the Ob testes are smaller in size but the tubules 
are maintained in an organised structure that is similar to those of wild type 
testes. Cysts were never seen in Ob testes.
With regards to cell turnover, both proliferation and apoptosis was altered in Ob 
mutants as it was in abnormal organs from WT1+/';P3:WT1-KTS mice. Apoptosis 
was increased in both mutants, however the pattern of apoptosis was somewhat 
different with WT1+/';P3:WT1-KTS animals having apoptotic cells restricted solely 
to the periphery of the seminiferous tubules while Ob mutants had apoptosis of 
peripheral cells and also some apoptotic cells towards the lumen of tubules. 
Although it has not been proved, apoptosis in WT1+/';P3:WT1-KTS is most 
probably affecting only primary spermagonia and/or sertoli cells due to the 
location of the apoptotic cells. In the Ob mutants, the location of apoptotic cells 
within the tubules suggested that more mature germ cells are also being lost. 
This correlates with the general decrease in mass of Ob mutant testes. 
Proliferation in the WT1+/‘;P3:WT1-KTS was generally increased but the pattern 
of proliferation was also changed with a disorganized pattern of proliferating cells
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throughout tubules. Ob mutants also had changes in proliferation, however 
levels were generally decreased in these mutants. Some tubules showed a 
relatively normal amount of proliferating cells at the periphery of tubules whereas 
other tubules were devoid of any proliferating cells. The increase of apoptosis 
together with a decrease of proliferation could account for the small but well- 
proportioned testes of the Ob mutants which are different from the enlarged and 
poorly organised structures in the testes of WT1+/';P3:WT1-KTS mice. However, 
given that the growth of adult testes has reached a steady state it is possible that 
the defects observed in both mutants could have arisen as a consequence of 
earlier events.
The cell turnover changes seen in WT1+/';P3:WT1-KTS mice related with 
changes in expression of WT1 in the affected organs. Ob mice however display 
normal patterns and levels of WT1 expression illustrating the morphological 
differences in Ob mutants are most likely to be unrelated to the WT1 pathway (in 
contrast to the WT1+/';P3:WT1-KTS mice). Interestingly, although the Baspl 
protein was expressed in similar locations to WT1 within the kidney of embryos 
and adult mice, its expression was not affected in WT1+/';P3:WT1-KTS or Ob 
mutant mice, allowing us to conclude that while Baspl may be a WT1 
cosuppressor in at least some cell types, Baspl expression may be regulated 
independently of WT1.
3.5 Conclusions
Taken together, the data from these experiments provides further evidence for 
the requirement of a critical ratio between the WT1+KTS and WT-KTS isoforms 
of WT1. By breeding animals carrying a P3:WT1-KTS transgene with WT1+/’ 
animals we have been able to show that the transgene was not sufficient to
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rescue the null phenotype in WTI'^PSiWTI-KTS embryos. Alteration of the 
isoform balance in WT1+/';P3:WT1-KTS adult mice over the age of 6 months 
however, led to a range of interesting pathological features. Some of these 
features affected the genito-urinary system, mimicking aspects of human 
disorders in which WT1 is implicated. In most abnormal organs, there was an 
ectopic or increased WT1 expression detected using an anti-WT1 antibody. 
However, the absence of defects in WT1+/+;P3:WT1-KTS mice suggests that the 
defects must be due to subtle changes in isoform ratios rather than ectopic 
expression of WT1. The liver tumours, however, most likely result from ectopic 
expression of the transgene as opposed to differences in isoform ratios as WT1 
is not normally expressed in the liver. Considering this, we can assume that it is 
the excess expression of WT1-KTS in combination with the haploinsufficiency of 
WT1+KTS causing the pathological features and not solely a result of the 
haploinsufficiency of WT1+KTS as previously suggested (Hammes et al., 2001; 
Little et al., 1995). The changes in the genito-urinary system in the WT1+/* 
;P3:WT1-KTS mice were distinct and specific to this subset of animals when 
compared with the Ob mice, an alternative model for genital abnormalities. This 
suggests, unsurprisingly, a WT1 -specific path involved in the WT1+/‘;P3:WT1- 
KTS phenotype.
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C h a p t e r  4
INVESTIGATION OF THE SUBCELLULAR LOCALISATION OF
WT1+KTS AND WT1 -KTS
4.1 Summary
The previous chapter described the in vivo experiments investigating the role of 
WT1+KTS and W T1- KTS function in transgenic animals. In order to further 
characterise the mechanisms resulting in the functional differences of the two 
isoforms, a series of cell culture experiments were carried out in which the sub- 
cellular characteristics of the WT1+KTS and WT1-KTS were explored. Using a 
combination of transient transfections of GFP fusion constructs (of wild type and 
mutant KTS isoforms), and immunofluorescence, the experiments in this chapter 
describe their location within the cell, and their colocalisation with other sub 
cellular factors. As a result of this data, it has been possible to propose a model 
by which variations in structure within the zinc fingers, result in alternative 
localisation of the isoforms within cells, and finally affect the functions of these 
proteins. This chapter also describes experiments that investigate the function of 
a putative nucleolar localisation signal within WT1 and demonstrates that 
mutating specific regions of the WT1 isoforms results in the alteration of their 
localisation within the nucleus.
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4.2 Introduction
4.2.1 Subcellular localisation of WT1+KTS and WT1-KTS isoforms 
A detailed introduction to nuclear structure was presented in Chapter 1. WT1 
encodes a zinc finger transcription factor expressed in multiple distinct isoforms 
(Haber et al., 1990). As mentioned in Section 1.2.3, of all WT1 isoforms, 
WT1+KTS and WT1-KTS are two of the most abundant. They also display 
differences in cellular localisation and interactions with different factors. 
Alteration of the critical ratio between WT1+KTS and WT1-KTS has been 
implicated in FS suggesting that these isoforms carry out essential roles in 
genito-urinary development. In generating inducible cell lines expressing wild 
type isoforms of WT1 as well as WT1 mutants, dramatic differences were 
observed in the subnuclear localisation of the induced proteins (Englert et al., 
1995). Englert. et al. (1995) were able to show that the WT1 isoform that binds 
with higher affinity to a defined DNA target, WT1-KTS, was diffusely localised 
throughout the nucleus. In contrast, expression of an alternative splicing variant 
with reduced DNA binding affinity, WT1+KTS, or WT1 mutants with a disrupted 
zinc finger domain resulted in a speckled pattern of expression within the 
nucleus. Though similar in appearance, the localisation of WT1 variants to sub 
nuclear clusters was clearly distinct from that of the essential splicing factor 
SC35, suggesting that WT1 is not directly involved in pre-mRNA splicing. 
Localisation to subnuclear clusters required the N terminus of WT1 and co­
expression of a truncated WT 1 mutant together with wild type WT1-KTS resulted 
in a physical association, the redistribution of WT1-KTS from a diffuse to 
speckled pattern, and the inhibition of its transcriptional transactivation activity 
(Englert et al., 1995). This suggested that different WT1 isoforms and WT1 
mutants occupy distinct subnuclear compartments. As mentioned in Section
1.2.3 additional WT1 isoforms with distinct transcription-regulatory properties,
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indicating further complexity of WT1 expression and activity have been 
described, making a total of 32 known WT1 protein isoforms arising from 
alternative splicing, as well as RNA editing (Scharnhorst et al., 1999). The sub 
nuclear localisation of WT1 has been shown to be dynamic. Actinomycin D 
treatment, known to inhibit cellular transcription, causing some splicing factors to 
relocate to large foci or surround the remnants of the nucleolus, results in the 
relocation of WT1 to areas surrounding the nucleoli. As described by Englert et. 
al. (1995), in Cos7 cells the sub cellular localisation pattern of the protein has 
been shown to be isoform dependent with WT1-KTS localising in a diffuse 
pattern with some domains of localisation but no nucleolar staining, whereas 
WT1+KTS displayed a greater association with nucleoli in speckled areas in a 
similar pattern to that of many splicing factors. In addition, following treatment of 
cells with actinomycin D, WT1-KTS isoforms no longer relocate to the nucleolus, 
whereas relocation of WT1+KTS to the periphery of the nucleolus occurs in a 
pattern resembling that of some splicing factors. In a separate study, staining of 
cells with antibodies specific for splicing and transcription factors identified WT1- 
KTS localisation in a transcription factor-like pattern (colocalisation was observed 
with the transcription factor Sp1), and in contrast to the Englert et. al. (1995) 
data, WT1+KTS colocalised with splicing factor speckles (Larsson et al., 1995). 
More recently, localisation of the protein to potential nuclear assembly sites has 
confirmed the suggested interaction of the WT1+KTS isoform with elements of 
the cell splicing machinery (Davies et al., 1998; Hastie, 2001), reinforcing the 
idea of distinct roles for the two WT1 isoforms, with WT1-KTS being involved in 
transcriptional activation and with WT1+KTS likely to be involved with the 
splicing machinery. As stated in Chapter 1, proteins containing the WTAR 
mutation, missing the entire zinc finger region, and WT1 mutant proteins 
containing deletions of amino acids 76-120, have displayed enhanced speckling. 
This suggests that the amino-terminal region of the protein is essential for the
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speckling characteristics although this region of the protein is not involved in the 
association with splicing factors. As stated in Section 1.2.2, computer modeling 
has demonstrated the presence of a potential RNA recognition motif at the N- 
terminus similar to that in constitutive splicing factors (Kennedy et al., 1996). The 
speckling and splicing characteristics of the protein are therefore distinguishable. 
WT1-KTS has also been seen in speckled patterns however it is known that 
WT1-KTS shows less binding affinity with splicing factors. Overall, the patterns 
of WT1 sub-cellular distribution have been shown to be dynamic, with differences 
in the pattern of expression of isoforms that differ by the insertion or deletion of 
the three amino acids within the zinc finger region altering the location of the 
protein within the nuclei of cells. WT1-KTS has been shown to display a higher 
association with a number of transcription factors as shown by either 
colocalisation experiments in cells or promoter binding studies, for example 
induction of p21, Bcl-2, Dax-1, SF1, MIS and amphiregulin (Del Rio-Tsonis et 
al., 1996; Englert et al., 1995; Ladomery et al., 1999; Parker et al., 1999), while 
the WT1+KTS has been shown to have a stronger association to members of the 
splicing machinery (Bickmore et al., 1992; Davies et al., 1998; Hastie, 2001; 
Larsson et al., 1995), suggesting the isoforms carry out different functions within 
cells.
The ratio of WT1-KTS and WT1+KTS isoforms is essential for correct genito­
urinary development since alteration of the ratio is the cause of Frasier syndrome 
(Barbaux et al., 1997; Klamt et al., 1998; Kohsaka et al., 1999). Also, the KTS 
alternative splice has been widely conserved during vertebrate evolution having 
been found in every species analysed, with the exception of FUGU, where the 
KTS insertion has been replaced with KPS (Miles et al., 1998), and even in this 
divergent instance the U2AF65 binding properties of the KPS sequence were 
shown to be the same as the KTS sequence (Davies et al., 2000). Given these
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facts it seems important that the separate functions of WT1-KTS and WT1+KTS 
are understood and that one important aspect of this is to understand their 
differential localisation within cells.
4.2.2 Mutation o f the KTS sequence
Mutation studies involving the three amino acids have shown that inserting extra 
amino acids, duplicating amino acids or deleting amino acids does not affect the 
binding of the WT1+KTS protein to interacting proteins. Following site directed 
mutagenesis, a number of constructs containing mutation of the KTS region were 
introduced into a yeast two-hybrid system. Mutation, or duplication of any or all 
three amino acids failed to remove the proteins ability to bind to splicing factor 
U2AF65 in this assay. Only upon removal of all three amino acids (AKTS), did 
the protein behave like the WT 1-KTS protein (Davies et al., 2000). We can infer 
from this that the main function of inserting the three amino acids is the alteration 
of the structure of the protein at the zinc finger region resulting in the disruption 
of their normal function, and the specific amino acid sequence of the insertion is 
not necessarily important. It has however been illustrated that the spacing at 
KTS position, driven by the nucleotide sequence, is of fundamental importance in 
controlling the alternative splicing, and hence the generation of WT1+KTS and 
WT1-KTS ratios (Davies et al., 1998). It can therefore be hypotheised that the 
KTS has been widely conserved as a result of the importance of its coding 
nucleotides. Furthermore, mutations in the gene causing Denys Drash 
syndrome are clustered around the zinc finger encoding exons, particularly 
exons encoding ZF2 and ZF3 (Little et al., 1992).
4.2.3 Functional role of zinc finger region
By using WT1 fusion constructs containing different classes of DDS mutations it 
has been possible to show that the mutations do indeed disrupt DNA binding and
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may either be acting in a dominant negative fashion, possibly through 
dimerisation between mutant and wild type WT1 isoforms and subsequent loss 
of DNA binding (Little et al., 1995). Either way, this data provides convincing 
evidence of the necessity of the correct conformation of the zinc finger regions in 
DNA binding and hence the function of the protein. Although the DNA binding of 
the zinc finger region is better characterised, it has also been observed that the 
zinc fingers are able to bind RNA, with zinc finger 1 playing a greater role in RNA 
binding than zinc fingers 2-4 which are structurally related and bind a similar 
consensus sequence to the three zinc fingers of the EGR1 transcription factor 
(Caricasole et al., 1996, Ladomery, 1999 #142). Frasier syndrome also 
highlights the requirement of the KTS region for correct development. The 
mutations in Frasier syndrome patients also affect the zinc finger region, 
however FS generally arises from mutations within the alternative splice donor 
signal that alters the ratio of WT1+KTS: WT1-KTS (Barbaux et al., 1997; Klamt 
et al., 1998; Kohsaka et al., 1999).
4.2.4 Investigation of the subcellular localisation of WT1 isoforms 
The current data provides good evidence that much of the functional activity of 
WT1 resides in the zinc finger region. The DNA and RNA binding activity of the 
zinc finger region can result in the regulation of a number of target genes, and 
the mutations found in DDS that result in genito-urinary abnormalities, 
presumably as a consequence of altered DNA binding capacity, highlight the 
essential requirement of the zinc finger region. At the same time, the normal 
conservation of WT1+KTS and WT1-KTS isoforms is altered in FS, resulting in 
developmental abnormalities (Barbaux et al., 1997). As mentioned in section 
4.2.1, the two isoforms are found in distinct regions of the cell with differing 
binding affinities or profiles of interaction for different groups of proteins. This 
suggests a distinct role for the isoforms in transcriptional and possibly
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posttranscriptional pathways. The experiments described in this chapter were 
aimed at investigating further the sub cellular localisation of the two isoforms, as 
well as related mutants, using GFP fusion proteins and immunofluorescence. 
Following transient transfections of GFP fusion protein constructs, localisation of 
fluorescence was examined in a several cell types at 24 hour and 48 hour time 
points. These experiments were carried out in triplicate with at least 100 cells 
counted for each transfection. In some cases transfection was followed by 
treatment of the cells with actinomycin D and fluorescing cells were counted 
before and after treatment. The first set of experiments in this chapter look at the 
sub cellular localisation of wild type WT1-KTS and WT1+KTS isoforms in a 
number of cell lines, some of which express endogenous WT1 (HeLa, MCF7 and 
HEK293 cells), while others do not (Cos7). Cos7 cells were used for subsequent 
experiments as a matter of convenience.
4.2.5 Investigation o f the nucleolar localisation of WT1
Another set of experiments describes the identification of a putative nucleolar 
localisation signal within zinc finger 2 of the protein. It is known that NoLS 
signals are often basic regions and many proteins that accumulate in the 
nucleolus contain basic elements which, when exposed, destroy nucleolar 
localisation in the protein. For example, the basic region of p80-coilin when 
exposed by the deletion of an acidic region resulted in the accumulation of coilin 
in the nucleolus (Tucker et al., 2000). Herpesvirus protein MEQ and PRRSV 
nucleocaspid protein, and two cellular proteins, rat spermatidal protein TP2 and 
human HICp40 have also been reported to contain NoLSs consisting of stretches 
of basic residues (Andersen et al., 2002). Further reports describe the 
characterisation of specific amino acid sequences that were able to direct fusion 
proteins to the nucleolus. For example, the nucleolar retention of U3 snRNA is 
mediated by a C’D box motif (Speckmann et al., 1999) and the NoLS of human
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angiogenin (amino acids IMRRRGL) was sufficient to import GFP into the 
nucleolus (Lixin et al., 2001). The ING1 candidate tumour suppressor uses the 
RRQR amino acid sequence to direct GFP to the nucleolus. This sequence is 
also conserved in other nucleolar proteins including HIV-Tat and HIV-Ret and 
deletion of this sequence has been shown to ablate nucleolar localisation (Scott 
et al., 2001). Other groups have described proline-rich nucleolar retention motifs 
that require phosphorylation to regulate them (Catez et al., 2002). The presence 
of a bipartite NoLS has been reported, where both signals were required for 
nucleolar retention and the deletion of either signal was sufficient to impede 
localisation (Scott et al., 2001). Many of the sequences involved in nucleolar 
localisation involve Arginine repeats. The following experiments describe the 
identification/investigation of a putative NoLS within the zinc finger region of 
WT1.
4.2.6 Subcellular localisation of WT 1 mutant constructs 
A third set of experiments examined a number of mutant WT1GFP fusion 
constructs to determine how specific mutations might alter localisation in 
comparison with the relevant wild type WT1 isoforms. Site directed mutagenesis 
was used to create 6 mutants. DDS occurs as a result of mutations within the 
zinc finger region of WT1 (Little et al., 1992), highlighting the importance of the 
zinc fingers. A DDS truncation mutant was created that comprised WT 1 protein 
missing part of zinc finger 3 and the entire zinc finger 4 region (WT1DDS), 
representing one of the most common WT 1 mutant proteins found in patients 
with DDS. Examining the localisation of the WT1DDS mutation allowed us to 
identify possible mechanisms by which abnormalities within WT1 could affect 
normal development in DDS patients. Zinc finger-2 point mutations were also 
generated both within the full-length WT1+KTS (WT1+KTSZF2) and WT1-KTS 
(WT1-KTSZF2) proteins and also in the DDS truncated WT1 mutant
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(WT 1DDSZF2). It was thought that the mutation within zinc finger 2 might ablate 
the putative nucleolar localisation signal (mentioned above), hence altering the 
nucleolar localisation of the mutant proteins. The final set of mutants created 
comprised only the zinc finger region from either WT1+KTS (ZF+KTS) or WT1- 
KTS (ZF-KTS), fused to GFP. This addressed the function of the zinc fingers in 
isolation, within the cell. Truncated WT1 protein containing the zinc-finger 
domains was previously shown to be sufficient to confer nuclear localisation 
(Davies et al., 2000), but our experiments assess the influence of both WT1-KTS 
and WT1+KTS zinc finger regions on sub-nuclear distribution.
4.2.7 Colocalisation studies of WT1 isoforms
The final set of experiments in this chapter considers the co-localisation of WT 1 
isoforms with other nuclear factors known to associate with the nucleolus. 
Findings from recent research have shown that the nucleus is a highly dynamic 
organelle containing distinct sub-compartments (Dundr and Misteli, 2001). 
These structures are characterised by the absence of delineating membranes 
but are still considered compartments for several reasons. Firstly, they contain 
specific resident proteins and can be morphologically identified by light and 
electron microscopy. More recently, a number of these proteins have been 
visualised in living cells by the use of green fluorescent protein (GFP) 
technology. Finally, some of these compartments have been isolated 
biochemically (Lamond and Earnshaw, 1998). As described in Section 4.2.1, 
WT1-KTS co-localises with transcription factors and WT1+KTS shows co­
localisation with splicing factors generally found to be restricted to specific areas 
of the nucleus (Dundr and Misteli, 2002). Using two antibodies, one recognising 
nucleolar protein B23, which is expressed within the dense granular regions of 
the nucleolus, and the other recognising PSP1 protein, which is associated with 
a new group of peri-nucleolar organelles termed paraspeckles (Fox et al., 2002),
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we have examined WT1-KTS localisation to speckles and investigated the sub- 
nucleolar localisation of both wild type WT1+KTS and mutant fusion proteins.
4.3 Results
4.3.1 Subcellular localisation of WT1+KTS and WT1-KTS 
The subcellular localisation of a number of GFP fusion proteins and mutants 
were investigated (Figure 18) in Cos7 cells both before and after actinomycin D 
treatment. Examination of expression patterns of GFP WT1+KTS and W T1- 
KTS isoforms allowed the two protein isoforms to be distinguished (Figure 19). 
At 24 hours following transfection of a GFP: WT1+KTS expression construct into 
Cos7 cells, the majority of cells presented a diffuse pattern of fluorescence within 
the nuclei combined with accumulation in the nucleolus (Figure 19 A and B). 
Examining the cells under DIC confirms the nucleolar expression. The pattern of 
accumulation within the nucleoli was patchy, with fluorescence occurring in an 
uneven configuration (Figure 19 A). After treatment of the cells with actinomycin 
D, virtually all the cells showed GFP accumulation in and around the nucleolus 
with a diffuse pattern within the rest of the nucleus (Figure 19 B). WT1-KTS on 
the other hand showed a completely different pattern of localisation, with the 
protein being expressed in punctate configurations with patchy expression 
throughout the nucleus. Fewer cells showed accumulation of the GFP: WT1- 
KTS fusion protein in the nucleolus than in the GFP: WT1+KTS transfections 
(Figure 19 C). Treatment with actinomycin D also yielded results that differed 
from those of WT1+KTS with actinomycin D treatment. Upon actinomycin D 
treatment WT1-KTS did not accumulate in the nucleolus and the transient 
punctate pattern, seen prior to treatment, was lost (Figure 19 D).
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Figure 18. Diagrammatic representation of WT1 constructs 
investigated
All proteins were expressed as GFP fusion proteins, with GFP fused at the 
N-terminus and therefore distant from the zinc finger region in most 
constructs. The native isoforms WT1+KTS and WT1-KTS were full length 
WT1 (A and B). WT1DDS construct was truncated at zinc finger three 
representing a mutant protein found in DDS patients (C). The WT1DDSZF2 
mutant was truncated at zinc finger 3 and also carried a mutation in the 
putative NoLS within zinc finger 2 (D). WT1+KTSZF2 and WT1-KTSZF2 
were full-length isoforms carrying the same mutation in the putative NoLS 
in zinc finger 2 (E and F). ZFWT1+KTS and ZFWT1-KTS were the isolated 
zinc finger regions from WT1+KTS and WT1-KTS respectively (G and H). 












Figure 19. Nuclear distribution patterns typical of WT1-KTS and 
WT1+KTS GFP fusion protieins
Expression of WT1+KTS (A and B) and WT1-KTS (C and D) fusion 
proteins in Cos7 cells 24 hours post transfection both before (A and C) and 
after actinomycin D treatment (B and D). WT1+KTS typically shows diffuse 
nuclear expression and accumulation within nucleoli of Cos7 cells (A) and 
after actinomycin D treatment nucleolar expression was restricted to areas 
at the periphery of nucleoli (Figure B). In WT1-KTS transfected cells, GFP 
expression was seen in speckles and discreet domains throughout the 
nucleus (C) and this pattern remained after treatment with actinomycin D 
(D). Scale bars 5|nm
c D
The isoform-specific nature of the expression patterns was quantified by 
counting, in duplicate and in a blind fashion, at least 100 cells transfected with 
each construct to determine the numbers of cells expressing GFP in the different 
patterns (Figure 20). Before treatment with actinomycin D, 68% of the cells 
transfected with WT1+KTS displayed a strong nucleolar pattern on a diffuse 
background; 12% of cells showed a diffuse pattern of expression throughout the 
cell; 18% of cells showed a diffuse GFP expression in the nucleus without 
expression in the nucleolus. Cells expressing GFP diffusely throughout, with 
patchy nuclear expression and accumulation in the nucleolus was the smallest 
subsets of cells seen with only 2% of cells showing this pattern. These numbers 
changed dramatically upon treatment of transfected cells with actinomycin D, 
with almost all the cells (95%) showing accumulation of GFP within the nucleolus 
against a background of diffuse nuclear expression. The remainder of 
transfected cells either had a diffuse (2%) or patchy (3%) nuclear expression 
with diffuse nucleolar accumulation. For cells expressing WT1-KTS the patterns 
were significantly different (Table A). Patchy non-nucleolar patterns 
predominated and counted for 28% of patterns seen. Another group of patterns 
seen in cells transfected with WT1-KTS, the punctate, speckled patterns, were 
never seen in cells transfected with WT1+KTS. The large amount of cells 
expressing nucleolar staining in WT+KTS compared to the nucleolar staining of 
WT1-KTS and the presence of speckles in WT1-KTS transfection compared to 
the lack of speckles in WT1+KTS transfections were both significant 
observations. The speckled patterns for WT1-KTS accounted for 29% of cells 
but were transient and had disappeared at 48 hours after transfection. The 
speckled patterns also disappeared following actinomycin D treatment, and 
although an increase in nucleolar expression was seen in actinomycin D treated 
cells transfected with WT1-KTS (from 16% before treatment to 38% after 
treatment), this was not significant (Table A) whereas the change seen before
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Figure 20. Cell counts of subcellular localisation patterns following 
transfections of Cos7 cells with expression vectors encoding 
WT1+KTS and WT1-KTS GFP fusion proteins
Cells were scored at 24 hours post transfection, before (left panels) and 
after actinomycin D (A D) treatment.
Patterns of interest between WT1+KTS and WT1-KTS constructs were 
analysed using the Mann Whitney U Statistocal tests to identify significant 






□  Non Nucleolar
■  Nucleolar
■  Patchy Nucleolar
□  Patchy Non Nucleolar 
E3 Speckled Non Nucleolar
□  Speckled Nucleolar
WT1+KTS AD
□  Diffuse
□  Non Nucleolar
■  Nucleolar
■  Patchy Nucleolar
O Patchy Non Nucleolar 
B Speckled Non Nucleolar
□  Speckled Nucleolar
WT1-KTS
□  Diffuse
□  Non Nucleolar
■  Nucleolar
■  Patchy Nucleolar
□  Patchy Non Nucleolar
■  Speckled Non Nucleolar








□  Non Nucleolar
■  Nucleolar
■  Patchy Nucleolar
□  Patchy Non Nucleolar
□  Speckled Non Nucleolar
□  Speckled Nucleolar
Constructs Pattern Significant difference (p)
WT1+KTS WT1-KTS Nucleolar 0.0002
WT1+KTS WT1-KTS Speckled 0.0004
WT1+KTS WT1+KTS AD Nucleolar 0.004
WT1-KTS WT1-KTS AD Speckled 0.0008
WT1-KTS AD WT1-KTS AD Nucleolar 0.064
and after actinomycin D treatment of WT1+KTS transfected cells was highly 
significant (Table A).
4.3.2 Subcellular localisation of the DDS mutant protein 
A common mutation seen in DDS patients, involves an insertion of an arginine at 
nucleotide 1156 of exon 9, resulting in a frame-shift at amino acid 386 and the 
truncation of WT1 in zinc finger 3. This creates a mutant protein lacking part of 
zinc finger 3 and all of zinc finger 4. Upon transfection of cells with a mutant 
WT1: GFP fusion protein that mimics this DDS truncation mutant (WT1DDS), the 
observed patterns of expression in some cells showed similarities to either the 
native WT1+KTS or WT1-KTS isoforms (Figure 21; described below). However, 
another subset of cells displayed patterns seen neither in WT1+KTS or W T1- 
KTS transfected cells with void nucleoli, lacking any GFP expression (Figure 21
A). These void nucleoli were only seen in cells transfected with the WT1DDS 
mutant. A minority of cells displayed punctate expression (Figure 21 B) as seen 
in WT1-KTS transfected cells. Following actinomycin D treatment, the 
expression pattern was similar to that of WT1+KTS with accumulation of GFP 
into the nucleolus of the majority of cells (Figure 21 C).
Scoring of at least 200 cells at 24 hours after transfection (Figure 22 and Table
B) revealed that 51% had the void pattern, this was a statistically significant 
difference between the WT1DDS mutant and wild type WT1+KTS, while 29% 
had a pattern of nucleolar accumulation, making this the second most abundant 
group (not a statistically significant difference in this pattern between the wild 
type and WT1DDS mutant). The remaining 20% of cells expressed diffuse 
patterns (11%), patchy nucleolar (5%) and patchy non-nucleolar patterns (5%). 
After actinomycin D treatment there was a dramatic increase in the number of
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Figure 21. Expression of GFP WT1 truncation mutants (WT1DDS) in 
Cos7 cells 24 hours post transfection
Mutant WT1 protein truncated within zinc finger 3 (WT1DDS mutant) was 
expressed in a variety of patterns. Many of the transfected cells displayed 
void patterns with no expression in the nucleolus (A). Other cells showed 
similar patterns to WT1-KTS with speckles throughout the nucleus and 
also discreet domains of fluorescence (B). After actinomycin D treatment, 
the majority of cells showed the same pattern as the WT1+KTS isoform, 
with accumulation of GFP in the nucleolus (C). Scale bars 5pm
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Figure 22. Cell counts of subcellular localisation following 
transfection of Cos7 cells with an expression vector encoding 
WT1DDS mutant protein as a GFP fusion
Cells were scored at 24 hour post transfection, both before (upper panel) 
and after actinomycin D (A D) treatment.
Patterns of interest between WT1DDS mutants and wild type WT1+KTS 
constructs with and without AD treatment were analysed using the Mann 
Whitney U Statistocal tests to identify significant differences (p>0.05) in 
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Constructs compared Pattern Significant difference (p)
WT1+KTS WT1DDS Nucleolar 0.058
WT1+KTS WT1DDS Non Nucleolar 0.001
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WT1DDS WT1DDS AD Non Nucleolar 0.0001
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Figure 23. Alignment of WT1 putative NoLS amino acid sequence 
with characterised NoLSs
Letters highlighted in red identify amino acids with greater 
homology/conservation, e.g. (present in at least half of the aligned 
sequences). Black box surrounding two arginine residues within the WT1 
sequence identifies the amino acids that were mutated by site-directed 










Figure 24. Typical expression patterns of zinc finger 2 mutant 
(WT1ZF2) GFP fusion proteins in Cos7 cells 24 hours post 
transfection
Mutation of the putative nucleolar localisation signal does not alter 
distribution patterns of WT1 isoforms. WT1+KTSZF2 expression was 
maintained in the nucleolus with a diffuse pattern throughout the nucleus, 
the pattern typical for WT1+KTS(A). WT1-KTSZF2 was located to 
discreet domains throughout the nucleus, as was WT1-KTS (B). The 
WT1DDSZF2 mutant was expressed in a similar pattern to the WT1DDS 
mutant. Scale bars 5|im
AB
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cells displaying nucleolar accumulation with 91% of cells presenting this 
expression pattern. This difference in nucleolar staining before and after AD 
treatment for the WT1DDS mutant was significant and similar to the change in 
nucleolar staining seen in pre and post AD treatment of WT+KTS. There was 
also a significant decrease in the number of cells displaying the void non- 
nucleolar pattern of expression. Most of the remaining cells had a pattern of 
nucleolar accumulation with patchy nuclear expression (6%), while a small 
subset had a speckled pattern (as in cells transfected with WT1-KTS) combined 
with nucleolar localisation (4%). It can be said that the DDS truncation mutant, 
therefore behaved in a fashion that includes features reminiscent of both native 
protein isoforms.
4.3.3 Investigation of a putative nucleolar localisation signal 
The following experiments investigate properties of a putative nucleolar 
localisation signal identified in the WT1 zinc finger region. Carrying out a Blast 
search of the zinc finger region of the WT1 protein with the NCBI database 
resulted in the identification of a sequence of 8 amino acids in WT1 zinc finger 2. 
This region showed some homology to the nucleolar localisation signal of six 
proteins, and most closely resembled the NoLS motifs of hlNG1 and HTLV- 
1REX (Figure 23). Two arginines within the WT1 putative NoLS were particularly 
well conserved, with at least one being present in almost all of the aligned NoLS 
sequences. Site directed mutagenesis was used to mutate these arginines to a 
serine and a glycine in GFP fusions of both native WT1 isoforms (WT1-KTSZF2 
and WT1+KTSZF2) and also in the DDS truncation mutant (WT1DDSZF2). The 
majority of COS7 cells transfected with WT1+KTSZF2 (Figure 24 A), WT1- 
KTSZF2 (Figure 24 B) and WT1DDSZF2 (Figure 24 C), showed patterns that 
were indistinguishable from those seen with the respective original protein 
isoforms.
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Scoring of at least 200 cells from duplicate experiments showed the WT1ZF2 
mutants localised within the cell in a similar fashion to their wild type isoform 
counterparts and the only significant change seen was the lack of speckles seen 
in the WT1ZF2-KTS while speckles are present in wild type WT1-KTS (Figure 25 
and Table C). 69% of WT1+KTSZF2 showed a diffuse nucleolar localisation and 
this number increased to 92% following actinomycin D treatment. These 
numbers were similar to the figures for wild type WT1+KTS of 68% and 95%, 
respectively (Figure 19). The WT1-KTSZF2 data showed a fairly equal 
distribution of cells expressing in diffuse (20%), diffuse non-nucleolar (20%), 
diffuse nucleolar (19%), patchy non-nucleolar (19%) and patchy nucleolar 
patterns (18%). After treatment with actinomycin D, numbers remained fairly 
similar. This is similar to the numbers seen for transfections with wild type WT1- 
KTS (Section 4.3.1).
While the majority of WT1DDSZF2 cells displayed diffuse nucleolar patterns 
(48% before actinomycin D and 94% following treatment), the second most 
abundant group were those cells with void nucleoli (22% of transfected cells) and 
there were a further 18% of cells displaying speckled patterns. Following 
actinomycin D treatment these patterns were almost entirely replaced, with 96% 
of cells exhibiting nucleolar accumulation of WT1DDSZF2. Again, these results 
show that the WT1DDSZF2 mutant was behaving in a similar fashion to 
transfections of cells with the WT1DDS (Section 4.3.2). Data from these 
experiments showed that the mutation of the putative nucleolar localisation 
signal within WT1 zinc finger 2 was not sufficient to alter localisation of the 
different protein isoforms following their transfection into Cos7 cells.
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Figure 25. Cell counts of subcellular localisation patterns following 
transfections of Cos 7 cells with expression vectors encoding 
WT1+KTSZF2, WT1-KTSZF2 and WT1DDSZF2 mutants as GFP 
fusions. Cells were scored at 24 hours post transfection, both before (left 
panels) and after actinomycin D (AD) treatment.
Patterns of interest between WT1ZF2 mutants and wild type WT1 
constructs with and without AD treatment were analysed using the Mann 
Whitney U Statistocal tests to identify significant differences (p>0.05) in the 
subcellular localisation patterns between constructs (Table C).
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4.3.4 Localisation of the zinc finger regions o f WT 1
The next set of experiments in this chapter investigated the function of the zinc 
finger region of the protein. The zinc finger region GFP fusion mutants, 
ZFWT1+KTS and ZFWT1-KTS were created by N-terminal truncation of the 
native protein fusions, resulting in removal of all of the WT 1 sequence except for 
the zinc finger region. These mutants were transfected into Cos7 cells and the 
resulting expression scored at 24 hours post transfection both with and without 
actinomycin D treatment. The results show interesting isoform-specific 
differences, with the ZFWT1+KTS fusion protein localising to nucleoli at all times 
and the ZFWT1-KTS fusion protein localizing in a similar fashion to the wild type 
(full length) WT1-KTS isoform. The behaviour of the ZFWT1+KTS mutant was 
very different to wild type WT1+KTS, with 97% of ZFWT1+KTS cells displaying 
nucleolar localisation, significantly higher to that of WT1+KTS (Figures 26 and 27 
and Table D). This increased to over 99% after treatment with actinomycin D 
and at 72 hours post transfection, GFP expression remained strong in the 
nucleolus. These results were markedly different from those of wild type 
WT1+KTS (Section 4.3.1) where only 68% of cells transfected showed nucleolar 
accumulation whilst the others showed a variety of patterns. Only after 
actinomycin D treatment did 95% of the cells show nucleolar accumulation a 
similar figure to that of ZFWT1+KTS. The ZFWT1-KTS showed expression 
patterns similar to wild type WT1-KTS (Section 4.3.1). These results 
demonstrate the different sub-cellular localisation properties of the native WT1 
protein isoforms may result primarily from the zinc finger region and although the 
zinc finger region of WT1+KTS is sufficient for nucleolar localisation, there may 
be a region elsewhere in the protein responsible for directing the protein out of 
the nucleolus.
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Figure 26. Expression of the zinc finger region of WT1+KTS 
(ZFWT1+KTS) in Cos 7 celts 24 hours after transfection
Expression of the zinc finger region of WT1+KTS in Cos7 cells 24 hours 
after transfection both before (upper panel) and after actinomycin D 
treatment. Almost all transfected cells showed accumulation of the 
ZFWT1+KTS mutant within the nucleolus. Scale bars 5|am
Figure 27. Cell counts of subcellular localization patterns following 
transfections of Cos 7 cells with an expression vector encoding the 
zinc finger regions ofWT1+KTS (ZFWT1+KTS) fused with GFP
Cells were scored at 24 hours post transfection, both before (upper panel) 
and after actinomycin D treatment.
Patterns of interest between ZFWT1 mutants and wild type WT1+KTS 
constructs with and without AD treatment were analysed using the Mann 
Whitney U Statistocal tests to identify significant differences (p>0.05) in the 
subcellular localisation patterns between constructs (Table D).
ZF+KTS





0 ~\-----------1 i i---------- 1---------- r
□ Diffuse
□ Non Nucleolar 
■  Nucleolar
n Patchy Nucleolar
□ Patchy Non Nucleolar










□ Non Nucleolar 
■ Nucleolar
□ Patchy Nucleolar
□ Patchy Non Nucleolar
□ Speckled Non Nucleolar
□ Speckled Nucleolar
Constructs compared Pattern Significant difference (p)
WT1+KTS ZF+KTS Nucleolar 0.0002
ZF+KTS ZF+KTS AD Nucleolar 0.09
WT1+KTS AD ZF+KTS AD Nucleolar 0.087
4.3.5 Comparing the distribution ofWT1 isoforms with other nuclear factors
4.3.5.1 Distribution o f WT1 isoforms compared with nucleolar factor B23 
The final sets of experiments investigated further the differential localisation of 
WT1 isoforms. The WT1: GFP fusion constructs were transfected into cells and 
localisation was compared with two nucleolar markers by immunofluorescence. 
The first colocalisation experiments investigated the distribution of green 
fluorescence associated with the WT1: GFP fusion proteins, together with an 
antibody recognizing the nucleolar protein B23 and detected using a red 
fluorescent secondary antibody (Figure 28). The B23 protein is known to localise 
to the dense granular compartment (DGR) of nucleoli and the anti-B23 antibody 
stains the nucleolus of Cos7 cells in a characteristic manner (Okuwaki, 2001) 
(Figure 28 A, D and G). Cells were transiently transfected with WT1: GFP 
constructs, WT1-KTS (Figure 28 B), WT1+KTS (Figure 28 E) and ZFWT1+KTS 
(Figure 28 H) and co-localisation was examined (merged images, Figures 28 C, 
F and I). B23 and WT1-KTS do not co-localise, as expected since WT1-KTS 
distribution is largely non-nucleolar (Figures 28 A, B and C). It was expected that 
B23 and WT1+KTS might co-localise as both are expressed in the nucleolus. 
However, this was not the case (Figures 28 D, E and F). B23 is known to 
colocalise to the DGR (Figure 28 A, D and G) of the nucleolus, whereas 
WT1+KTS was localised at the surface of the nucleolus (28 Figure E and F), 
either in peri-nucleolar regions or to the interchromatin regions of the nucleolus 
where B23 is not found (28 Figure F). However, transfection of the ZFWT1+KTS 
mutant resulted in a different pattern of expression within the nucleolus (Figures 
28 G, H and I), with the isolated zinc fingers co-localising with B23 in the dense 
granular regions. This suggests that the zinc fingers are required for the 
nucleolar localisation of WT1, with the zinc finger region of WT1+KTS being 
sufficient for nucleolar localisation, but with signals elsewhere in the protein 
being involved in its localisation to specific areas of the nucleolus.
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Figure 28. Colocalisation of WT1 isoforms with nucleolar factor B23 
in Cos7 cells
Nucleolar localisation of B23 (A, D and G), WT1 GFP fusion proteins 
expressed in the same Cos7 cells (B, E and H), merged images of the 
same (C, F and I). WT1-KTS (B) did not show any colocalisation with B23 
(C). WT1+KTS (E) was localized to different regions of the nucleolus to 
B23 (F). ZFWT1+KTS (H) colocalised with B23 in the nucleolus (Figure I). 
Scale bars 5jim

4.3.5.2 Distribution o f WT1 isoforms compared with the paraspeckle protein 
PSP1
The following set of experiments investigated the colocalisation of WT1 with the 
paraspeckle protein, PSP1 (Figure 29). PSP1 has been found to localise to 
paraspeckles within the nucleus (Fox et al., 2002) and exhibits similar patterns to 
the speckles seen in WT1-KTS. The function of these paraspeckles is as yet 
unknown but anti-PSP1 was used in experiments with WT1+KTS and WT1-KTS 
in an attempt to identify areas to which WT1-KTS could be localising. 
Interestingly, it was found that 2 patterns of PSP1 expression occurred in Cos7 
cells. PSP1 was expressed in nuclear speckles (Figure 29 A and L) similar to 
those previously reported (Fox et al., 2002). However, PSP1 was also observed 
in nucleolar patterns (Figure 29 I) similar to those seen in WT1+KTS transfected 
cells (Figure 29 J), a pattern not previously reported for PSP1. Although WT1- 
KTS localises to speckles within the nucleus (Figure 29 B and E), they are 
distinct from the PSP 1-positive speckles (Figures 29 A, and C) suggesting that 
the organelles or regions to which WT1-KTS localise have a separate function. 
As expected, cells in which PSP1 expression is seen in the nucleolus (Figure 29 
D) show no colocalisation with WT1-KTS (Figures 28 E and F). Nucleolar PSP1 
however (Figure 29 I and K), colocalises in precisely the same pattern as 
nucleolar WT1+KTS (Figure 29 J and K), indicating that both proteins localise to 
the same regions of the nucleolus. These experiments illustrate the diverse 
compartmentalisation of the nucleus with different proteins being restricted to 
specific regions.
The similarities between the expression of PSP1 in the nucleoli of Cos7 cells 
with patterns seen for nucleolar WT1+KTS prompted the final set of experiments 
in this chapter. Expression of PSP1 was examined in the nucleus before and
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Figure 29. Comparison of distribution of Paraspeckie protein Psp1 
with WT1 iso forms in Cos7 cells
Detection of the presence of paraspeckles with the anti psp1 paraspeckle 
protein within Cos7 cells (A, D, G and J), compared with WT1GFP fusion 
protein expression within the same cells after transient transfection with 
WT1-KTS (B and E) or WT1+KTS (H and K), and merged images of the 
same (C, F, I and L). Localisation of psp1 within paraspeckles (A). WT1- 
KTS expression seen in a speckled pattern (B). WT1-KTS did not 
colocalise with psp1 in paraspeckles (C). Psp1 was also found in a 
nucleolar pattern in some cells (D). WT1-KTS was expressed in discreet 
domains within the nucleus (E). The nucleolar psp1 expression did not 
colocalise with WT1-KTS domains (F). The nucleolar pattern of 
paraspeckles (G) did colocalise with the nuclear pattern of WT1+KTS (I). 
In a separate subset of cells, the paraspeckle pattern of psp1 (J) did not 
colocalise with WT1+KTS (L). Scale bars 5pm

after actinomycin D treatment. PSP1 has been reported to be associated with 
paraspeckles in the nucleus (Fox et al., 2002) (Figure 30 A). While there were 
cells showing this characteristic speckled pattern of expression, a subset of cells 
showed a nucleolar pattern similar to that seen in WT1+KTS cells (Figure 30 B). 
Upon treatment of WT1+KTS transfected cells with actinomycin D some 
WT1+KTS localised to peri-nucleolar regions of the nucleus (Figure 30 C). 
Immunofluorescence of actinomycin D treated Cos7 cells with anti-PSP1 showed 
a similar pattern of expression to that of WT1+KTS (Figure 30 D).
4.4 Discussion
4.4.1 Distinct transient sub nuclear patterns o f nuclear WT1 distribution 
The differential GFPWT1+KTS and GFPWT1-KTS localisation patterns in live 
Cos7 cells (Section 4.3.1, Figure 19 and 20) recapitulate the characteristic 
nuclear patterns previously reported using WT1 antibodies in fixed cells (Englert 
et al., 1995; Larsson et al., 1995) GFPWT1-KTS was located mostly in a patchy, 
non-nucleolar and speckled patterns. Whereas WT1+KTS was seen in diffuse 
patterns throughout the nucleus with nucleolar localisation of the isoform seen in 
68% of cells. Furthermore, no cells transfected with WT1+KTS displayed the 
speckled pattern seen in WT1-KTS transfected cells. These patterns showed 
that the nuclear distribution may be determined by isoform type, consistent with 
the hypothesis that the WT1+KTS and WT1-KTS isoforms might each control a 
separate aspect of gene expression (Bickmore et al., 1992; Englert, 1998). It 
should be noted that the presence of the variety of different patterns seen in 
each transfection suggests that within each transfection, there are cells at 
varying stages of the cell cycle. The differing patterns arise because WT1 
expression may differ throughout the cell cycle. Using cell cycle specific
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Figure 30. Comparison of Psp Paraspeckles and WT1+KTS GFP 
fusion protein localisation in Cos7 cells 24 hours post transfection
Psp1 stains paraspeckle structures within the nucleus of Cos7 cells (A). 
In another subset of cells psp1 includes expression in a nucleolar pattern 
(B). Upon treatment with actinomycin D, WT1+KTS expression was seen 
associate with the periphery of the nucleolus (C). After actinomycin D 
treatment Psp1 showed expression at the periphery of the nucleolus in a 
pattern similar to that of W T1+KTS in treated cells (D). Scale bars 5|um
D
markers, it would be possible to identify stages of the cell cycle. The alternate 
location of the two isoforms within nuclei suggests that the isoforms may be 
interacting with different subsets of proteins associated with different functions 
and subnuclear locations. Particularly, the intimate interaction between 
WT1+KTS and the nucleolus may enable this isoform to become incorporated 
into the splicing machinery. Results in this chapter are from experiments in 
which Cos7 cells lacking endogenous WT1 were transiently transfected with 
GFP fusion proteins of the two WT1 isoforms. The characteristic expression 
patterns of the two WT1 isoforms were also seen in cells expressing 
endogenous WT1 (Dutton, 2003), but only transiently. Thus, in HeLa, MCF7 and 
HEK cells, the pattern of expression of WT1+KTS and WT1-KTS seven hours 
after transfection showed the distinct patterns of distribution described here for 
Cos7 cells but expression patterns becoming indistinguishable at 24 hours post 
transfection (the time at which most of the results were collected from Cos7 
cells). It should also be noted that it became difficult, if not impossible to 
distinguish between the isoforms in Cos7 cells at 48 hours post transfection. 
Taken together, our observations of WT1: GFP fusion proteins in several cell 
types suggest that WT1-KTS and WT1+KTS are initially localised in an isoform- 
specific manner before being expressed in a complex, overlapping pattern within 
the cell. Progression to the indistinguishable patterns of distribution appears to 
be more rapid in some cell types than in others and may correlate with the 
presence of endogenous WT1 in the host cell type. The presence of cells within 
the population of transfected Cos7 cells that displayed more complicated 
patterns of nuclear staining (Figure 20) (cells with both diffuse and patchy areas 
and nucleolar staining) can be described as transient patterns of expression as 
these patterns disappear over time or actinomycin D treatment, reflecting the 
dynamic nature of the nucleus with proteins moving rapidly between structures 
and accumulating transiently (Misteli, 2001b).
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4.4.2 Subnuclear patterns of WT1 isoform distribution also differ in 
transcriptionally quiescent cells
Actinomycin D treatment causes cells to become transctriptionally quiescent 
resulting in a rearrangement of the nuclear architecture and a relocation of 
proteins to different areas within the cell. Following actinomycin D treatment of 
Cos7 cells transfected with GFPWT1+KTS and GFPWT1-KTS characteristic 
isoform-specific distribution patterns were again observed (Section 4.3.2, Figure 
18), further suggestive of different nuclear functions. 98% of WT1+KTS cells 
displayed nucleolar accumulation. WT1-KTS speckles disappeared suggesting 
that these speckles may have been due to transient accumulation or lost as a 
direct consequence of transcriptional quiescence. The majority of WT1-KTS 
transfected cells instead exhibited a patchy pattern, typical of transcription 
factors locating to sites of transcription in the nucleus suggesting that within one 
experiment, the cells within each transfection may be at different stages of 
transcriptional activity. Some would therefore be transcriptionally active and 
express one pattern of WT1-KTS and others would be transcriptionally quiescent 
and express alternative patterns. Treatment of cells with Actinomycin D allows a 
distinction of the isoform dependent patterns seen in Cos7 cells at 24 hours post­
transfection and in the HeLa, MCF7 and HEK cells at 48 hours post-transfection. 
Given that Acinomycin D treatment causes the inhibition of transcription, this 
suggests that the distinct patterns of expression can only be completely identified 
in transcriptionally quiescent cells.
4.4.3 Alternative subnuclear localisation of WT1DDS
The subnuclear localisation of a GFP fused WT1 truncation mutant found in 
some Denys Drash patients (WT1DDS) showed that this mutant protein could 
locate to areas in the cell reminiscent of either WT1+KTS or WT1-KTS protein
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(Section 4.3.2, Figure 21 and 22). At 24 hours after transfection most cells 
(51%) had a pattern unlike the typical patterns of either native isoform, with 
diffuse nucleoplasmic fluorescence and dark nucleoli devoid of any GFP. There 
was also a subset of cells with a speckled pattern such as that seen in WT1-KTS 
transfected cells. However following actinomycin D treatment, the expression 
pattern of WT1DDS was more like the pattern typical of WT1+KTS, with the 
majority of cells accumulating the protein in the nucleolus. The mutant protein 
lacks part of the third zinc finger and the entire fourth WT1 zinc finger. The KTS 
motif is therefore absent in the WT1DDS mutant, yet it was able to locate to the 
nucleolus in a similar fashion to WT1+KTS. Substitution of KTS with other 
sequences between the third and fourth zinc finger, resulted in proteins with 
WT1+KTS-like properties, suggesting that the KTS amino acid sequence is not 
critical for the differences between WT1+KTS and WT1-KTS (Davies et al., 
2000; Hastie, 2001). Removal of the fourth zinc finger in the WT1DDS mutant 
construct may have had a similar structural affect on the protein as insertion of 
KTS, for instance, if the essential role of the KTS insertion is to alter the 
conformation of the fourth zinc finger with respect to other parts of the folded 
protein. This could possibly allow the protein to associate with an alternative 
interacting protein, or proteins, allowing trafficking of the WT1+KTS isoform to 
the nucleolus. It has been hypotheised that mutations in WT 1 of DDS patients 
result in proteins that act in a dominant fashion by dimerizing with wild type 
protein. It has alternatively been suggested that haploinsufficiency may be a 
cause with a reduction of wild-type protein being sufficient to result in a disease 
phenotype (Little et al., 1993). The mutant protein described in this chapter 
behaved more like the WT1+KTS and production of this protein from a mutated 
allele could therefore cause a perturbation of the isoform ratio with increased 
WT 1+KTS activity. The presence of speckles in cells transfected with WT 1 DDS 
was suggestive of WT1-KTS and these speckles also disappeared after time or
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actinomycin D treatment suggesting they were transient patterns as in WT1-KTS 
transfections.
4.4.4 Significance of the putative NoLs within WT 1 zinc finger 2 
Zinc finger 2 of the WT1 protein includes a region with some homology with the 
NoLs of a number of nucleolar factors, suggesting that WT1 zinc finger 2 might 
contain all or part of the signal directing WT1+KTS to the nucleolus. The 
potential NoLS identified for WT1 aligns with a number of characterised nucleolar 
proteins such as hlNG1 and HIV-1 REX nucleolar proteins. Consistent with the 
observation that WT1+KTS is intimately associated with the nucleolus, the 
discovery of a putative NoLS within the protein suggested a mechanism by which 
WT1+KTS could enter the nucleolus. Mutation of the two central arginine 
residues in the signal (which are the most highly conserved amino acids across 
other NoLS sequences) to a serine and a glycine resulted in the production of 
the ZF2 mutants, WT1+KTSZF2, WT1-KTSZF2 and WT 1DDSZF2 (Section 
4.3.4, Figures 24 and 25). These mutants allowed a functional investigation of 
the NoLs function in the subcellular localisation of WT 1 in live Cos7 cells. The 
subcellular localisation of the mutants was not changed from wild type patterns 
of distribution and failed to ablate nucleolar localisation. This can be 
interpretated in a number of ways. Firstly, the amino acid sequence in WT1 may 
not be a functional NoLS. Alternatively, it is possible that the mutation does not 
sufficiently alter the structure of the signal. Here, it should be noted that when 
the central residues were mutated in p80 Coilin, this was sufficient to cause 
aberrant localisation of the mutated protein, preventing its entry into the 
nucleolus. Equivalent amino acids were not mutated in both proteins. Although 
the central arginine was affected in both proteins, the p80 Coilin mutants also 
had a mutated serine whereas a second arginine was affected in the WT1 
mutants. In the alignment of the NoLSs of different proteins (Figure 23) from the
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NCBI database, the signals contain serines or arginines as their central residues. 
It may be that there is a certain degree of redundancy between these amino 
acids in the activity if a NoLS and it was for this reason that both arginines were 
mutated in the WT1 mutants. Another possibility is that a second NoLS, located 
elsewhere in the protein, may be involved in the nucleolar localisation of WT1 
and that, at least under some circumstances, this second signal may be 
sufficient for this purpose. Another group has reported the presence of bipartite 
signals for nucleolar localisation. For instance, in the ING1 protein, two signals 
were required for nucleolar retention and mutation of one site was not sufficient 
to affect nucleolar localisation, however upon mutation of both sites together, 
nucleolar localisation was prevented (Scott et al., 2001). This suggests the 
possibility that WT1 might also have a second NoLS elsewhere in the protein. 
Clearly, further experiments would be needed to test this idea and unfortunately 
examination of other nucleolar proteins does not allow us to assemble a strong 
consensus sequence for the second part of a bipartite NoLS.
Interestingly, the putative signal was present on zinc finger 2 in both WT1+KTS 
and WT1-KTS, yet WT1-KTS does not locate to regions of the nucleolus. This 
scenario is consistent with the earlier suggestion that the role of the KTS 
insertion could be to alter zinc finger conformation and that this is the mechanism 
by which differences in isoform function are carried out. Insertion of KTS could 
change the conformation of WT1, preventing the fourth zinc finger from blocking 
the NoLs. Removal of this fourth zinc finger would then allow the NoLs to 
relocate the protein to the nucleolus via trafficking proteins or by association with 
proteins residing within the nucleolus. Inversely, the fourth zinc finger might 
block the NoLs on zinc finger 2 in WT1-KTS preventing the association with 
trafficking or nucleolar proteins, and hence, preventing nucleolar localisation of 
WT 1 -KTS. The failure for the database to identify further regions of homology to
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nucleolar factors may have been due to the nature of NoLs sequences. As yet, 
only a few sequences have been identified. The signals are often encoded by 
small stretches of amino acids falling into broad, undistinguished groups. These 
range from basic stretches of amino acids (Speckmann et al., 1999; Tucker et 
al., 2000), to small stretches of amino acids with no homology to other signals 
(Lixin et al., 2001; Scott et al., 2001), and proline-rich sequence requiring 
phosphorylation to become active (Catez et al., 2002). It is therefore possible 
that the putative NoLs is part of a bipartite signal allowing the relocation of 
WT1+KTS to the nucleolus. Mutation of both signals may be required to abolish 
nucleolar localisation, however mutation of the identified NoLs was not sufficient 
for this purpose.
4.4.5 Requirement o f the zinc fingers for nucleolar localisation 
Transfection of the zinc finger fusion protein mutant constructs (ZFWT1+KTS 
and ZFWT1-KTS) in live Cos 7 cells (Section 4.3.5, Figures 26 and 27) allowed 
further characterisation of the zinc finger region and differences within this region 
with relation to the WT1+KTS and WT1-KTS isoforms. A putative NoLs was 
identified within the zinc finger region (Section 4.4.4) suggesting the involvement 
of this region in nucleolar localisation. The KTS insert within the zinc finger 
region of the protein has also been implicated in altering the DNA and RNA 
binding properties of the protein (Davies et al., 1998; Haber et al., 1990; Larsson 
et al., 1995; Renshaw et al., 1997). Major functional differences between 
WT1+KTS and WT1-KTS may therefore be located within the zinc finger region, 
highlighting the importance of this region of the protein. The differences in 
subcellular localisation of the isoforms were discussed earlier (Section 4.4.1) 
suggesting functional differences exist between WT1-KTS and WT1+KTS. The 
observation that the zinc finger regions of the two isoforms behave differently
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from one another when isolated from the rest of the protein helps to reinforce 
this.
ZFWT1-KTS behaved in a similar fashion to full-length WT1-KTS, suggesting 
that the zinc fingers continued to interact with at least some of the appropriate 
proteins complexes. A dramatic change was seen when comparing the full- 
length WT1+KTS fusion protein and ZFWT1+KTS, with all of the mutant protein 
entering and remaining in the nucleolus. It is possible to draw several 
conclusions from these observations. Differences in isoform function do result 
from differences in the zinc finger region, with the two isolated zinc finger regions 
regulating distinct localisation patterns. The presence of a putative NoLS within 
the zinc finger-2 region is consistent with the nucleolar localisation of the isolated 
ZFWT1+KTS. In the context of the entire protein, this sequence might work in 
parallel with a second sequence to confer nucleolar localisation to the protein (as 
discussed in the previous section). In the absence of the rest of the protein, 
however, the signal might be sufficient to direct the protein into the nucleolus. 
Interestingly, ZFWT1-KTS failed to enter the nucleolus, suggesting structural 
differences between the zinc finger regions of the two isoforms results in 
suppression of a NoLS specifically in WT1-KTS. Accumulation of ZFWT1+KTS 
protein in the nucleolus suggests there may be signals located outside of the 
zinc finger region that are required for transport of the protein out of the 
nucleolus which are as yet uncharacterised.
4.4.6 Colocalisation o f WT 1 isoforms with nuclear factors 
A further insight into the subcellular localisation of the two isoforms came from 
the colocalisation studies using antibodies recognizing the paraspeckle protein 
PSP1 and nucleolar factor B23 (Section 4.3.6, Figures 28 and 29). 
Paraspeckles have been reported to be a distinct set of speckles within the
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nucleus, characterised by the PSP1 marker (Fox et al., 2002). PSP1 has been 
found to localise to paraspeckles within the nucleus and exhibits similar patterns 
to the speckles seen in WT1-KTS. The function of these paraspeckles is as yet 
unknown but given that WT1-KTS localises to a subset of speckles within the 
nucleus anti-PSP1 was used in experiments with WT1+KTS and WT1-KTS in an 
attempt to identify areas to which WT1 could be localising. The failure of WT1- 
KTS to colocalise with paraspeckles suggests that WT1-KTS compartmentalises 
within distinct domains that differ from PSP1. Interestingly, a novel PSP1 pattern 
of distribution was seen in the nucleolus, following actinomycin D treatment, 
strongly resembled patterns seen for WT1+KTS also after actinomycin D 
treatment (Figure 30). Both proteins preferentially relocated to the nucleolus with 
a perinucleolar pattern in transcriptionally quiescent cells. Many splicing factors 
have been shown to be located in a characteristic speckled pattern within the 
nucleus, that some have termed “splicing speckles”. The nucleolus is the centre 
of rDNA transcription and ribosome biogenesis (Olson et al., 2000). More 
recently additional functions have been attributed to the nucleolus. For example, 
it may also be a site for the biogenesis and maturation of other ribonucleoprotein 
machinery including the signal recognition particle (Politz, 2000), the 
spliceosomal small nuclear RNPs (Lange, 2000), and telomerase (Mitchell, 
1999). The nucleolus may also participate in processing or export of some 
mRNAs and tRNAs (Bertrand, 1998; Schneiter, 1995) and can control the 
activities of P53 by a sequestration mechanism (Visitin and Amon, 2000). 
Moreover, association between the nucleolus and other nuclear bodies, such as 
the perinucleolar compartment (Huang, 2000) and the cajal body also raise the 
possibility that nucleoli have additional functions (Gall, 2000). A recent study 
identified 271 nucleolar proteins and a subset of these factors were shown to 
accumulate in nucleoli specifically when transcription is inhibited (Andersen et 
al., 2002). These proteins included P80 Coilin, and various RNA binding
155
proteins. The feature of proteins associating and dissociating with the nucleolus 
through the cell cycle may be involved in regulating the localisation of nuclear 
factors and thereby controlling their access to interaction partners. 
Photobleaching experiments for PSP1 have revealed that PSP1 constantly 
traffics through the nucleolus yet has a steady state accumulation within 
paraspeckles. However when transcription is inhibited, PSP1 rapidly relocalises 
to the nucleolar periphery (Fox et al., 2002). Interestingly, it has been reported 
that many of the proteins that associate with the nucleoli after actinomycin D 
treatment contain RNA and DNA binding motifs (Andersen et al., 2002). This 
suggests a possible novel role for the nucleolus in the cell cycle and. It is 
possible to hypothesise that WT1+KTS cycles throughout the nucleus but 
relocates to the nucleolus following transcriptional inhibition to interact with other 
proteins, for example proteins involved in the splicing machinery.
The B23 protein is known to localise to the dense granular compartment (DGR) 
of nucleoli and the anti-B23 antibody stains the nucleolus of Cos7 cells in a 
characteristic manner (Okuwaki, 2001). Interestingly, WT1+KTS failed to 
colocalise with the B23 protein, illustrating the presence of different subnucleolar 
compartments. It is evident from these experiments that WT1+KTS is not 
expressed within the DGR of the nucleolus. The patterns of localisation for 
WT1+KTS in the nucleolus were similar to that of the paraspeckle protein after 
actinomycin D treatment. It has been reported that PSP1 locates to the 
perinucleolar caps following actinomycin D treatment (Fox et al., 2002) so it is 
fair to assume that WT1+KTS may also be located at the perinucleolar caps. It 
may be at these locations that the protein interacts with components of the 
splicing machinery that also associate with the perinucleolar caps. Surprisingly, 
the zinc finger region of WT1+KTS (ZFWT1+KTS) which accumulated in the 
nucleolus showed a striking difference in nucleolar localisation to full length
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WT1+KTS. Whereas WT1+KTS fails to colocalise with B23 and displays a 
pattern similar to the perinucleolar staining of PSP1, ZFWT1+KTS showed 
complete colocalisation with B23 in the DGR of the nucleolus. One can assume 
from this that although the WT1 zinc fingers may be sufficient for nucleolar 
localisation of the protein, the amino-terminal region of the protein is essential for 
the protein to localise correctly within the nucleolus. It may be that the amino 
terminus interacts with WT1-associated proteins or alters WT1+KTS 
conformation hence allowing the zinc finger region to interact with factors 
necessary for its correct sub-nucleolar distribution.
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4.5 Conclusions
The experiments in this chapter have allowed a detailed investigation of the 
subcellular localisation of WT1. Transfection of WT1 GFP fusion proteins of 
WT1+KTS, WT1-KTS and mutant isoforms into live Cos7 cells has enabled the 
identification of a number of characteristic distribution patterns for these proteins. 
WT1-KTS is distributed in a patchy pattern throughout the nuclei of cells in 
patterns reminiscent of transcription factors (Larsson et al., 1995), whilst 
WT1+KTS is expressed more evenly throughout nuclei and tends to accumulate 
in the nucleolus. This intimate association of WT1+KTS with nucleoli is 
increased following actinomycin D treatment suggesting a metabolic control of 
nucleolar association, which may allow WT1+KTS to come into contact and 
interact with other proteins involved in the splicing machinery. WT1+KTS is not 
present in the DGR of the nucleolus, as it failed to colocalise with the DGR 
expressed B23 protein, but it does exhibit some overlap in pattern with PSP1, 
particularly at the perinucleolar caps.
The presence of a putative NoLs suggested a mechanism by which WT1+KTS 
preferentially could be entering the nucleolus. Experiments aimed at proving the 
function of the putative NoLS within zinc finger two were inconclusive. Mutation 
of the putative NoLS did not prevent nucleolar targeting of WT1+KTS, however, 
this signal could be part of a bipartite signal as has been seen in some other 
nucleolar proteins. The signal is also present in WT1-KTS isoforms but the 
structural differences caused by the insertion of KTS could prevent the signal 
from functioning in WT1-KTS. Alternatively, a NoLS sequence may reside 
elsewhere within the WT1 zinc finger region. Investigation of the isolated zinc 
finger regions of both isoforms illustrated the requirement of the zinc fingers for
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the nucleolar localisation of WT1+KTS since ZFWT1+KTS, and not ZFWT1-KTS 
was found to accumulate in the nucleolus. The structural differences arising 
from the KTS insertion may again be the explanation for ZFWT1-KTS not 
accumulating in the nucleoli. Colocalisation experiments using antibodies for the 
nucleolar protein B23 showed that the ZFWT1+KTS mutant shows a changed 
localisation from wild type WT1+KTS suggesting that while the zinc fingers may 
be necessary for nucleolar localisation, the amino terminus is also required for 
the correct function. Finally, analysis of the WT1DDS construct showed that this 
mutation found in patients with DDS results in a protein that behaves in a similar 
fashion to wild type WT1+KTS and could cause a perturbation of the isoform 
ratio if expressed from the mutant allele in DDS patients. In conclusion the 
differences in subcellular distribution between the WT1+KTS and WT1-KTS 
isoforms parallel functional differences between them. Differences between their 
locations in the cell could result in association with diverse groups of proteins 
resulting in functional differences, with WT1+KTS involved predominantly in 
posttranscriptional processes such as splicing, and WT1-KTS involved in 
transcriptional processes. The KTS insertion is essential for these differences in 
function, maybe due to conformation changes between the third and fourth zinc 
fingers. Finally, the mutant constructs highlight the role of the zinc finger region 
in the subcellular localisation and more specifically, the nucleolar localisation of 
the protein as illustrated by accumulation of ZFWT1+KTS to nucleoli of Cos7 
cells.
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C h a p t e r  5
GENERAL CONCLUSIONS
The studies carried out in this report were aimed at investigating the functions of 
WT1-KTS and WT1+KTS isoforms in the development of the murine genito­
urinary system, as well as the mechanisms by which the isoforms exert these 
functions at a cellular level. That WT 1 is essential for the correct development of 
the genito-urinary system has been extensively discussed earlier in this thesis 
(Kreidberg et al., 1993). It has also been argued that the WT1-KTS and 
WT1+KTS isoforms have distinct and diverse functions, as indicated in both 
animal models and cell lines. It was therefore necessary to examine further the 
relationship between these WT1 isoforms and this was done using a two- 
pronged approach:
5.1 Transgenic experiments
The first experimental strategy utilised transgenic mice in order to explore the 
effects on developmental processes when WT1 isoform ratios were altered. By 
breeding animals with a P3: WT1-KTS transgene with animals heterozygous for 
the WT1 null allele, it was possible to obtain litters of animals with various 
WT1+KTS : WT1-KTS ratios. Analysis of the gross morphology of both embryos 
and adult mouse organs revealed that WT1+/';P3 :WT1-KTS animals over the 
age of 6 months displayed a number of pathological features, some of which 
affected the genito-urinary system. These mice had reduced amounts of 
endogenous WT1 and expression of the P3: WT1-KTS transgene, would 
therefore tend to alter the normal WT1+KTS : WT1-KTS ratios towards higher
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levels of WT1-KTS. The pathological features of the WT1+/';P3 :WT1-KTS mice 
mimic certain aspects of the human disorder, Frasier syndrome, where a similar 
change in WT1 isoform ratios is implicated.
The failure for the WT1+/+;P3: WT1-KTS mice to develop pathological 
abnormalities, suggests that the observed effects are not simply due to ectopic 
transgene expression. Instead, a critical ratio exists between WT1+KTS and WT- 
KTS and the effect of the transgene was insufficient to alter this when both 
endogenous Wt1 alleles were intact, but was sufficient when one endogenous 
allele was disrupted, in WT1+/‘;P3 :WT1-KTS mice.
The expression pattern of WT1 was changed in the affected WT1+/*;P3 :WT1- 
KTS organs with ectopic foci of expression seen in the kidneys. The testis, 
showed a general disorganisation of structure that was associated with ectopic 
WT1 expression. Given that WT1 expression is normally restricted to the 
podocytes of the kidneys and the sertoli cells of the testes in adult life, the 
presence of ectopic foci within the kidneys and testes could suggest the 
presence of ectopic podocytes and sertoli cells in affected organs. WT1 
expression within podocytes and sertoli cells may have similar functions, to 
maintain the expression of key downstream genes, which in turn maintain the 
critical equilibrium between cell proliferation and division within the testes and 
kidneys. Ectopic expression of WT1 was also seen in abnormal livers where 
WT1 is not normally expressed. This abnormal expression in the liver could 
have been due to the expression of the transgene in the liver driven by the IGF2 
P3 promoter and H19 enhancer but could also have arisen from endogenous 
Wt1 as an indirect consequence of transgene expression. Ectopic expression 
was not always seen in affected organs however.
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The changes in proliferation and apoptosis observed in affected kidney and testis 
samples suggested that a critical dose of WT1 levels is essential for 
maintenance of the cell cycle and it may be that the reduction of WT1+KTS, in 
conjunction with the increase of WT1-KTS, is critical in the cell cycle process.
The P3: WT1-KTS transgene failed to rescue the null phenotype in WTI'^PS 
:WT1-KTS embryos. This may have been due to the fact that WT1-KTS was not 
alone sufficient to compensate for intact WT1 function and cannot be substituted 
for the other isoforms lost in the knockout embryos.
The changes in the genito-urinary system in the WT1+/';P3:WT1-KTS mice were 
distinct and specific to this subset of animals when compared with Ob mutant 
mice, an alternative model for genital abnormalities. This further suggests that a 
WT1-specific path is responsible for the WT1+/';P3:WT1-KTS phenotype.
In conclusion, the transgenic data illustrates the requirement for maintenance of 
a critical ratio of WT1KTS isoforms in adult murine development. Alteration of 
this ratio can result in the development of pathological abnormalities, some of 
which mimic those seen in human disorders where WT1 is implicated. 
Abnormalities within the genito-urinary system of affected animals resulting from 
altered isoform ratios suggest that while these isoforms may have overlapping 
roles, they may also carry out separate functions within developmental 
processes.
3.6 Future Directions
Most importantly, it would be of value to detect the presence of the P3:WT1-KTS 
in affected organs and in embryos. As illustrated by the embryo data, the anti- 
WT1 antibody was not sufficiently sensitive to detect protein expressed from the 
transgene. Ectopic expression of the transgene was however detectable in
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affected livers using the same antibody. This detection could be carried out with 
RT-PCR of organs from embryos in the future. Although we have not analysed 
the hearts of the WT1+/';P3:WT1-KTS animals, these might be another 
interesting organ to analyse. No obvious abnormalities of the heart were 
observed in our animals upon dissection but histological analysis may have 
revealed cardiac abnormalities given that WT1 null animals die from cardiac 
defects and the protein is known to be expressed in the developing heart and is 
implicated in cardiac development. It would be interesting to identify other 
factors, possibly downstream targets of WT1 in tissue samples derived from 
WT1+/‘;P3:WT1-KTS animals, and investigate possible abnormal expression of 
these targets as a means of understanding of the role of WT 1 in genito-urinary 
development and its interaction with other molecules essential in these 
processes.
5.2 Cell culture experiments
The transgenic models allowed the examination of the effects of changing WT1 
isoform ratios in vivo. An alternative experimental approach was to identify the 
possible mechanisms by which the two isoforms exert their different functions at 
the cellular level. The second approach utilised cell biology techniques to 
elucidate the way in which the WT1-KTS and WT1+KTS isoforms function at the 
cellular level. The aim of the cell biology experiments was to identify differences 
between the isoforms with regards to their cellular localisation and interactions 
within cells, as a means of understanding how the KTS insertion might affect 
WT1 function. This was achieved by using a combination of transient 
transfections of GFP fusion constructs (made with both wild type and mutant 
WT1 isoforms), and immunofluorescence.
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Upon examination of the subcellular localisation of GFP fusion constructs of the 
two isoforms it has been possible to reiterate previous findings that the two 
isoforms can be found in distinct regions of the cell with WT1+KTS associating 
with the nucleolus [Englert, 1995 #81]. This intimate association of WT1+KTS 
with nucieoli is increased following actinomycin D treatment, suggesting a 
metabolic control of nucleolar association that may allow WT 1+KTS to interact 
with a specific pool of proteins, including those involved in mRNA splicing.
The identification of a putative NoLS within zinc finger-2 illustrated a possible 
mechanism by which WT1+KTS could enter the nucleolus. Although this motif 
was also present in WT1-KTS the structural differences in the zinc finger region 
between the two isoforms, caused by the KTS insertion, could render the NoLS 
inactive in WT1-KTS. Mutation of this motif failed to prevent the nucleolar 
accumulation of the protein however the presence of a bipartite NoLS has been 
reported in at least one other protein [Scott, 2001 #253]. Further analysis of the 
zinc finger region demonstrated that the zinc finger region of WT1+KTS was 
required for the nucleolar localisation of WT1+KTS, with mutant GFP constructs 
consisting solely of the zinc finger region of WT 1 retaining the capacity to localise 
to the nucleolus. Again, structural differences within the zinc finger region arising 
from the insertion could explain the failure of the isolated zinc finger region of 
WT1-KTS to enter the nucleolus.
The differential co-localisation of the WT1-KTS and WT1+KTS isoforms to other 
subcellular proteins suggests that they have differing binding affinities or profiles 
of interaction for different groups of proteins. This highlights the possibility of 
distinct roles for the isoforms in transcriptional and possibly posttranscriptional 
pathways. Again, the KTS insertion may be essential for these differences in
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function, possibly due to conformational changes involving the third and fourth 
zinc fingers.
Frasier syndrome also highlights the requirement of the WT1 KTS region for 
correct genito-urinary development, with mutations in Frasier syndrome patients 
also affect the zinc finger region. Examination of the subcellular localisation of a 
mutant WT1 protein, carrying a mutation found in another human disease, DDS, 
showed that the mutation resulted in a protein that behaves in a similar fashion to 
wild type WT1+KTS. This was despite the absence of the KTS amino acids in 
the DDS mutant protein, which was prematurely truncated within the third zinc 
finger. The result suggested that this type of mutation could act by causing what 
is effectively a perturbation of the WT1-KTS and WT1+KTS isoform ratio when 
expressed from the mutant allele in DDS patients.
In conclusion, these observations draw a parallel with the reports that the two 
WT1 isoforms have different functions within cells. Differences between the 
localization of WT1-KTS and WT1+KTS in the cell could result in their 
association with diverse groups of proteins, resulting in functional differences. 
Conformational differences between the third and fourth zinc finger arising from 
the KTS insertion could be essential for distinguishing the protein isoforms in at 
least two possible ways: first, being involved in locating the isoforms to different 
regions within the cell; second, by changing the capacity of the two isoforms to 
associate with interacting proteins. The result of the insertion would therefore 
enable WT1+KTS to be involved predominantly in posttranscriptional processes 
such as splicing, and WT1-KTS in transcriptional processes. Taken together, the 
differences in WT1 isoform function might also help explain the abnormalities 
seen in WT1+/‘;P3: WT1-KTS transgenic models with differences in isoform ratio.
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4.6 Future Directions
A number of experiments would be required to fully understand the mechanisms 
by which WT1+KTS and WT1-KTS function in cells. In order to fully characterise 
the effects that structure would have on the subcellular localisation of the 
proteins, a number of mutant constructs would be helpful. Firstly, the subcellular 
localisation of a zinc finger region construct containing the DDS truncation could 
help to characterise the critical region required for nucleolar localisation. If this 
continued to accumulate within the nucleolus one could presume that the 
nucleolar localisation region was in zinc fingers one or two. The next step would 
be to create mutations within the putative NoLS signal in GFP zinc finger fusion 
proteins to ask whether these were still capable of nucleolar localisation. Should 
this indicate that the identified sequence does not act as a NoLS, deletion 
mutation analysis of the zinc fingers could be used to determine the zinc finger 
sequences required for nucleolar localisation empirically. Conversely, if zinc 
finger 2 in isolation were still able to accumulate in the nucleolus this would 
provide further evidence in favour of the zinc finger-2 localisation signal. In 
parallel, further truncation mutants could help detect the presence of a second 
signal within the amino terminus of the protein. Although the mechanisms by 
which nucleolar localisation signals function is still unknown, it seems likely that 
trafficking proteins are involved in this process.
Another area of interest would be the identification of putative trafficking proteins 
involved in the direction of WT1+KTS to areas of splicing and perhaps other, 
WT-KTS interacting proteins that could allow WT1-KTS to move to areas of 
transcriptional activity. It is possible that the movement of the isoforms occurs by 
diffusion, however, identification of associating proteins would still be helpful in 
identifying the mechanisms by which the isoforms function. Finally, it would be 
interesting to see what effect the inhibition of WT1+KTS translocation to the
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nucleolus might have on the cell cycle, on cell death, proliferation or 
differentiation. In parallel, the forced accumulation of WT1-KTS within the 
nucleolus could be attempted, by fusing the protein with a characterised NoLS, 
and might also have effects on live cells that could aid our understanding of 
isoform-specific functions of WT 1.
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